{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:42:59Z","timestamp":1794814979202,"version":"4.9.1"},"reference-count":748,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270950"],"award-info":[{"award-number":["32270950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002787"],"award-info":[{"award-number":["82002787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030036"],"award-info":[{"award-number":["32030036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"and the Startup Foundation of the Zhuhai People\u2019s Hospital","id":[{"id":"https:\/\/ror.org\/01k1x3b35","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Major International (Regional) Joint Research Program of the National Natural Science Foundation of China","id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and hyperactivation, highlights the potential of immune renormalization as a promising strategy in disease treatment. In recent years, our primary focus has centered on \u03b3\u03b4 T cell-based immunotherapy, particularly pioneering the use of allogeneic V\u03b42\n                    <jats:sup>+<\/jats:sup>\n                    \u03b3\u03b4 T cells for treating late-stage solid tumors and tuberculosis patients. However, we recognize untapped potential and optimization opportunities to fully harness \u03b3\u03b4 T cell effector functions in immunotherapy. This review aims to thoroughly examine \u03b3\u03b4 T cell immunology and its role in diseases. Initially, we elucidate functional differences between \u03b3\u03b4 T cells and their \u03b1\u03b2 T cell counterparts. We also provide an overview of major milestones in \u03b3\u03b4 T cell research since their discovery in 1984. Furthermore, we delve into the intricate biological processes governing their origin, development, fate decisions, and T cell receptor (TCR) rearrangement within the thymus. By examining the mechanisms underlying the anti-tumor functions of distinct \u03b3\u03b4 T cell subtypes based on \u03b3\u03b4TCR structure or cytokine release, we emphasize the importance of accurate subtyping in understanding \u03b3\u03b4 T cell function. We also explore the microenvironment-dependent functions of \u03b3\u03b4 T cell subsets, particularly in infectious diseases, autoimmune conditions, hematological malignancies, and solid tumors. Finally, we propose future strategies for utilizing allogeneic \u03b3\u03b4 T cells in tumor immunotherapy. Through this comprehensive review, we aim to provide readers with a holistic understanding of the molecular fundamentals and translational research frontiers of \u03b3\u03b4 T cells, ultimately contributing to further advancements in harnessing the therapeutic potential of \u03b3\u03b4 T cells.\n                  <\/jats:p>","DOI":"10.1038\/s41392-023-01653-8","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:02:38Z","timestamp":1700596958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":409,"title":["\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy"],"prefix":"10.1038","volume":"8","author":[{"given":"Yi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-9449","authenticated-orcid":false,"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-0052","authenticated-orcid":false,"given":"Ligong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6524-8777","authenticated-orcid":false,"given":"Zhinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-7103","authenticated-orcid":false,"given":"Dieter","family":"Kabelitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1653_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"1653_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785\u2013797 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022.02.007","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro, J. et al. Tissue architecture in tumor initiation and progression. Trends Cancer 8, 494\u2013505 (2022).","journal-title":"Trends Cancer"},{"key":"1653_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"1653_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646\u2013674 (2011).","journal-title":"Cell."},{"key":"1653_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/ni.3726","volume":"18","author":"PH Papotto","year":"2017","unstructured":"Papotto, P. H., Ribot, J. C. & Silva-Santos, B. IL-17(+) gammadelta T cells as kick-starters of inflammation. Nat. Immunol. 18, 604\u2013611 (2017).","journal-title":"Nat. Immunol."},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos, B., Mensurado, S. & Coffelt, S. B. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer 19, 392\u2013404 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado, S., Blanco-Dominguez, R. & Silva-Santos, B. The emerging roles of gammadelta T cells in cancer immunotherapy. Nat. Rev. Clin. Oncol. 20, 178\u2013191 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1653_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","volume":"21","author":"JC Ribot","year":"2021","unstructured":"Ribot, J. C., Lopes, N. & Silva-Santos, B. gammadelta T cells in tissue physiology and surveillance. Nat. Rev. Immunol. 21, 221\u2013232 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41423-020-0515-7","volume":"18","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Allogeneic Vgamma9Vdelta2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cell Mol. Immunol. 18, 427\u2013439 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40425-019-0501-8","volume":"7","author":"M Alnaggar","year":"2019","unstructured":"Alnaggar, M. et al. Allogenic Vgamma9Vdelta2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma. J. Immunother. Cancer 7, 36 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1653_CR13","doi-asserted-by":"publisher","first-page":"756495","DOI":"10.3389\/fimmu.2021.756495","volume":"12","author":"J Liang","year":"2021","unstructured":"Liang, J. et al. Allogeneic Vgamma9Vdelta2 T-cell therapy promotes pulmonary lesion repair: an open-label, single-arm pilot study in patients with multidrug-resistant tuberculosis. Front. Immunol. 12, 756495 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","volume":"19","author":"Z Sebestyen","year":"2020","unstructured":"Sebestyen, Z. et al. Translating gammadelta (gammadelta) T cells and their receptors into cancer cell therapies. Nat. Rev. Drug Discov. 19, 169\u2013184 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1653_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41423-020-0503-y","volume":"17","author":"M Deseke","year":"2020","unstructured":"Deseke, M. & Prinz, I. Ligand recognition by the \u03b3\u03b4 TCR and discrimination between homeostasis and stress conditions. Cell Mol. Immunol. 17, 914\u2013924 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat. Rev. Immunol. 13, 88\u2013100 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nri3904","volume":"15","author":"B Silva-Santos","year":"2015","unstructured":"Silva-Santos, B., Serre, K. & Norell, H. gammadelta T cells in cancer. Nat. Rev. Immunol. 15, 683\u2013691 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. T cells in health and disease. Sig. Transduct. Target Ther. 8, 235 (2023).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR19","doi-asserted-by":"publisher","first-page":"891687","DOI":"10.3389\/fimmu.2022.891687","volume":"13","author":"G Qu","year":"2022","unstructured":"Qu, G. et al. Comparing mouse and human tissue-resident gammadelta T cells. Front. Immunol. 13, 891687 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2017.11.006","volume":"87","author":"PH Papotto","year":"2018","unstructured":"Papotto, P. H., Reinhardt, A., Prinz, I. & Silva-Santos, B. Innately versatile: gammadelta17 T cells in inflammatory and autoimmune diseases. J. Autoimmun. 87, 26\u201337 (2018).","journal-title":"J. Autoimmun."},{"key":"1653_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509\u20131518 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter, D. L. et al. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725\u2013733 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June, C. H. et al. CAR T cell immunotherapy for human cancer. Science 359, 1361\u20131365 (2018).","journal-title":"Science"},{"key":"1653_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","volume":"353","author":"CT Ellebrecht","year":"2016","unstructured":"Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179\u2013184 (2016).","journal-title":"Science"},{"key":"1653_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.canlet.2016.07.001","volume":"380","author":"HR Mirzaei","year":"2016","unstructured":"Mirzaei, H. R. et al. Prospects for chimeric antigen receptor (CAR) gammadelta T cells: a potential game changer for adoptive T cell cancer immunotherapy. Cancer Lett. 380, 413\u2013423 (2016).","journal-title":"Cancer Lett."},{"key":"1653_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41375-021-01385-0","volume":"36","author":"PA Wawrzyniecka","year":"2022","unstructured":"Wawrzyniecka, P. A. et al. Chimeric antigen receptor T cells for gamma-delta T cell malignancies. Leukemia 36, 577\u2013579 (2022).","journal-title":"Leukemia"},{"key":"1653_CR27","doi-asserted-by":"publisher","first-page":"e14511","DOI":"10.1200\/JCO.2021.39.15_suppl.e14511","volume":"39","author":"A Makkouk","year":"2021","unstructured":"Makkouk, A. et al. Allogeneic V\u03b41 gamma delta T cells engineered with glypican-3 (GPC3)-specific CAR expressing soluble IL-15 have enhanced antitumor efficacy against hepatocellular carcinoma in preclinical models. J. Clin. Oncol. 39, e14511\u2013e14511 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1653_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/309757a0","volume":"309","author":"H Saito","year":"1984","unstructured":"Saito, H. et al. Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309, 757\u2013762 (1984).","journal-title":"Nature"},{"key":"1653_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0092-8674(85)90140-0","volume":"40","author":"AC Hayday","year":"1985","unstructured":"Hayday, A. C. et al. Structure, organization, and somatic rearrangement of T cell gamma genes. Cell 40, 259\u2013269 (1985).","journal-title":"Cell"},{"key":"1653_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/316464a0","volume":"316","author":"M-P Lefranc","year":"1985","unstructured":"Lefranc, M.-P. & Rabbitts, T. Two tandemly organized human genes encoding the T-cell \u03b3 constant-region sequences show multiple rearrangement in different T-cell types. Nature 316, 464\u2013466 (1985).","journal-title":"Nature"},{"key":"1653_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/316549a0","volume":"316","author":"C Murre","year":"1985","unstructured":"Murre, C. et al. Human \u03b3-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7. Nature 316, 549\u2013552 (1985).","journal-title":"Nature"},{"key":"1653_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/322179a0","volume":"322","author":"I Bank","year":"1986","unstructured":"Bank, I. et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 322, 179\u2013181 (1986).","journal-title":"Nature"},{"key":"1653_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/322145a0","volume":"322","author":"MB Brenner","year":"1986","unstructured":"Brenner, M. B. et al. Identification of a putative second T-cell receptor. Nature 322, 145\u2013149 (1986).","journal-title":"Nature"},{"key":"1653_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/325683a0","volume":"325","author":"J Borst","year":"1987","unstructured":"Borst, J. et al. A T-cell receptor \u03b3\/CD3 complex found on cloned functional lymphocytes. Nature 325, 683\u2013688 (1987).","journal-title":"Nature"},{"key":"1653_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.1695022","volume":"249","author":"W Born","year":"1990","unstructured":"Born, W. et al. Recognition of a peptide antigen by heat shock-reactive \u03b3\u03b4 T lymphocytes. Science 249, 67\u201369 (1990).","journal-title":"Science"},{"key":"1653_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0092-8674(89)90135-9","volume":"57","author":"RL O\u2019Brien","year":"1989","unstructured":"O\u2019Brien, R. L. et al. Stimulation of a major subset of lymphocytes expressing T cell receptor \u03b3\u03b4 by an antigen derived from Mycobacterium tuberculosis. Cell 57, 667\u2013674 (1989).","journal-title":"Cell"},{"key":"1653_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/339226a0","volume":"339","author":"J Holoshttz","year":"1989","unstructured":"Holoshttz, J. et al. Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 339, 226\u2013229 (1989).","journal-title":"Nature"},{"key":"1653_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.2524098","volume":"244","author":"EM Janis","year":"1989","unstructured":"Janis, E. M., Kaufmann, S. H., Schwartz, R. H. & Pardoll, D. M. Activation of \u03b3\u03b4 T cells in the primary immune response to Mycobacterium tuberculosis. Science 244, 713\u2013716 (1989).","journal-title":"Science"},{"key":"1653_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/339544a0","volume":"339","author":"RL Modlin","year":"1989","unstructured":"Modlin, R. L. et al. Lymphocytes bearing antigen-specific \u03b3\u03b4 T-cell receptors accumulate in human infectious disease lesions. Nature 339, 544\u2013548 (1989).","journal-title":"Nature"},{"key":"1653_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/340239a0","volume":"340","author":"A Augustin","year":"1989","unstructured":"Augustin, A., Kubo, R. T. & Sim, G.-K. Resident pulmonary lymphocytes expressing the \u03b3\/\u03b4 T-cell receptor. Nature 340, 239\u2013241 (1989).","journal-title":"Nature"},{"key":"1653_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/340309a0","volume":"340","author":"A Haregewoin","year":"1989","unstructured":"Haregewoin, A., Soman, G., Horn, R. C. & Finberg, R. W. Human \u03b3\u03b4\u2009+\u2009T cells respond to mycobacterial heat-shock protein. Nature 340, 309\u2013312 (1989).","journal-title":"Nature"},{"key":"1653_CR42","first-page":"206","volume":"75","author":"B Autran","year":"1989","unstructured":"Autran, B. et al. T cell receptor gamma\/delta+ lymphocyte subsets during HIV infection. Clin. Exp. Immunol. 75, 206 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"1653_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/373255a0","volume":"373","author":"DA Ferrick","year":"1995","unstructured":"Ferrick, D. A. et al. Differential production of interferon-\u03b3 and interleukin-4 in response to Th1-and Th2-stimulating pathogens by \u03b3\u03b4 T cells in vivo. Nature 373, 255\u2013257 (1995).","journal-title":"Nature"},{"key":"1653_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/1074-7613(95)90178-7","volume":"3","author":"CT Morita","year":"1995","unstructured":"Morita, C. T. et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human \u03b3\u03b4 T cells. Immunity 3, 495\u2013507 (1995).","journal-title":"Immunity"},{"key":"1653_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2249.1991.tb05612.x","volume":"83","author":"P De Paoli","year":"1991","unstructured":"De Paoli, P. et al. A subset of \u03b3\u03b4 lymphocytes is increased during HIV\u20101 infection. Clin. Exp. Immunol. 83, 187\u2013191 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"1653_CR46","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/infdis\/165.5.917","volume":"165","author":"A De Maria","year":"1992","unstructured":"De Maria, A. et al. Selective increase of a subset of T cell receptor \u03b3\u03b4 T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 165, 917\u2013919 (1992).","journal-title":"J. Infect. Dis."},{"key":"1653_CR47","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.4049\/jimmunol.154.3.1418","volume":"154","author":"S Boullier","year":"1995","unstructured":"Boullier, S., Cochet, M., Poccia, F. & Gougeon, M.-L. CDR3-independent gamma delta V delta 1\u2009+\u2009T cell expansion in the peripheral blood of HIV-infected persons. J. Immunol. 154, 1418\u20131431 (1995).","journal-title":"J. Immunol."},{"key":"1653_CR48","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.7973709","volume":"266","author":"R Boismenu","year":"1994","unstructured":"Boismenu, R. & Havran, W. L. Modulation of epithelial cell growth by intraepithelial \u03b3\u03b4 T cells. Science 266, 1253\u20131255 (1994).","journal-title":"Science"},{"key":"1653_CR49","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1084\/jem.184.6.2167","volume":"184","author":"LC Harrison","year":"1996","unstructured":"Harrison, L. C., Dempsey-Collier, M., Kramer, D. R. & Takahashi, K. Aerosol insulin induces regulatory CD8 \u03b3\u03b4 T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167\u20132174 (1996).","journal-title":"J. Exp. Med."},{"key":"1653_CR50","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.280.5367.1265","volume":"280","author":"C Zuany-Amorim","year":"1998","unstructured":"Zuany-Amorim, C. et al. Requirement for \u03b3\u03b4 T cells in allergic airway inflammation. Science 280, 1265\u20131267 (1998).","journal-title":"Science"},{"key":"1653_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/0923-2494(96)89648-9","volume":"147","author":"JJ Fourni\u00e9","year":"1996","unstructured":"Fourni\u00e9, J. J. & Bonneville, M. Stimulation of \u03b3\u03b4 T cells by phosphoantigens. Res. Immunol. 147, 338\u2013347 (1996).","journal-title":"Res. Immunol."},{"key":"1653_CR52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4049\/jimmunol.161.2.1045","volume":"161","author":"DF Hoft","year":"1998","unstructured":"Hoft, D. F., Brown, R. M. & Roodman, S. T. Bacille Calmette-Gu\u00e9rin vaccination enhances human \u03b3\u03b4 T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161, 1045\u20131054 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1126\/science.1063916","volume":"294","author":"M Girardi","year":"2001","unstructured":"Girardi, M. et al. Regulation of cutaneous malignancy by \u03b3\u03b4 T cells. Science 294, 605\u2013609 (2001).","journal-title":"Science"},{"key":"1653_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","volume":"102","author":"M Wilhelm","year":"2003","unstructured":"Wilhelm, M. et al. T cells for immune therapy of patients with lymphoid malignancies. Blood 102, 200\u2013206 (2003).","journal-title":"Blood"},{"key":"1653_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2141.2004.05077.x","volume":"126","author":"M Rischer","year":"2004","unstructured":"Rischer, M. et al. Human \u03b3\u03b4 T cells as mediators of chimaeric\u2010receptor redirected anti\u2010tumour immunity. Br. J. Haematol. 126, 583\u2013592 (2004).","journal-title":"Br. J. Haematol."},{"key":"1653_CR56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human \u03b3\u03b4 T cells. Science 309, 264\u2013268 (2005).","journal-title":"Science"},{"key":"1653_CR57","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","volume":"177","author":"E Lockhart","year":"2006","unstructured":"Lockhart, E., Green, A. M. & Flynn, J. L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662\u20134669 (2006).","journal-title":"J. Immunol."},{"key":"1653_CR58","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","volume":"178","author":"M Umemura","year":"2007","unstructured":"Umemura, M. et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178, 3786\u20133796 (2007).","journal-title":"J. Immunol."},{"key":"1653_CR59","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","volume":"178","author":"K Shibata","year":"2007","unstructured":"Shibata, K. et al. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466\u20134472 (2007).","journal-title":"J. Immunol."},{"key":"1653_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/cmi.2008.25","volume":"5","author":"M Peng","year":"2008","unstructured":"Peng, M. et al. Interleukin 17-producing \u03b3\u03b4 T cells increased in patients with active pulmonary tuberculosis. Cell Mol. Immunol. 5, 203\u2013208 (2008).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR61","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1182\/blood-2009-01-198028","volume":"113","author":"D Fenoglio","year":"2009","unstructured":"Fenoglio, D. et al. Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113, 6611\u20136618 (2009).","journal-title":"Blood"},{"key":"1653_CR62","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331\u2013341 (2009).","journal-title":"Immunity"},{"key":"1653_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ni.1717","volume":"10","author":"JC Ribot","year":"2009","unstructured":"Ribot, J. C. et al. CD27 is a thymic determinant of the balance between interferon-\u03b3-and interleukin 17\u2013producing \u03b3\u03b4 T cell subsets. Nat. Immunol. 10, 427\u2013436 (2009).","journal-title":"Nat. Immunol."},{"key":"1653_CR64","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1002\/eji.200939922","volume":"39","author":"JD Haas","year":"2009","unstructured":"Haas, J. D. et al. CCR6 and NK1. 1 distinguish between IL\u201017\u2009A and IFN\u2010\u03b3\u2010producing \u03b3\u03b4 effector T cells. Eur. J. Immunol. 39, 3488\u20133497 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR65","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nm.1999","volume":"15","author":"T Shichita","year":"2009","unstructured":"Shichita, T. et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946\u2013950 (2009).","journal-title":"Nat. Med."},{"key":"1653_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","volume":"31","author":"B Martin","year":"2009","unstructured":"Martin, B. et al. Interleukin-17-producing \u03b3\u03b4 T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321\u2013330 (2009).","journal-title":"Immunity"},{"key":"1653_CR67","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1172\/JCI40891","volume":"120","author":"JS Cho","year":"2010","unstructured":"Cho, J. S. et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762\u20131773 (2010).","journal-title":"J. Clin. Invest."},{"key":"1653_CR68","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.immuni.2010.08.013","volume":"33","author":"F Petermann","year":"2010","unstructured":"Petermann, F. et al. gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33, 351\u2013363 (2010).","journal-title":"Immunity"},{"key":"1653_CR69","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI61862","volume":"122","author":"S Pantelyushin","year":"2012","unstructured":"Pantelyushin, S. et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252\u20132256 (2012).","journal-title":"J. Clin. Invest."},{"key":"1653_CR70","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","volume":"187","author":"U Laggner","year":"2011","unstructured":"Laggner, U. et al. Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42 T cell subset with a potential role in psoriasis. J. Immunol. 187, 2783\u20132793 (2011).","journal-title":"J. Immunol."},{"key":"1653_CR71","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","volume":"35","author":"Y Cai","year":"2011","unstructured":"Cai, Y. et al. Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation. Immunity 35, 596\u2013610 (2011).","journal-title":"Immunity"},{"key":"1653_CR72","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.4049\/jimmunol.1101817","volume":"187","author":"T Mabuchi","year":"2011","unstructured":"Mabuchi, T., Takekoshi, T. & Hwang, S. T. Epidermal CCR6+ \u03b3\u03b4 T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J. Immunol. 187, 5026\u20135031 (2011).","journal-title":"J. Immunol."},{"key":"1653_CR73","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/nm.3016","volume":"18","author":"B Becher","year":"2012","unstructured":"Becher, B. & Pantelyushin, S. Hiding under the skin: Interleukin-17\u2013producing \u03b3\u03b4 T cells go under the skin? Nat. Med. 18, 1748\u20131750 (2012).","journal-title":"Nat. Med."},{"key":"1653_CR74","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/nm.3025","volume":"18","author":"JG Krueger","year":"2012","unstructured":"Krueger, J. G. Hiding under the skin: a welcome surprise in psoriasis. Nat. Med. 18, 1750\u20131751 (2012).","journal-title":"Nat. Med."},{"key":"1653_CR75","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ni.2585","volume":"14","author":"EE Gray","year":"2013","unstructured":"Gray, E. E. et al. Deficiency in IL-17-committed V\u03b34\u2009+\u2009\u03b3\u03b4 T cells in a spontaneous Sox13-mutant CD45. 1+ congenic mouse substrain provides protection from dermatitis. Nat. Immunol. 14, 584\u2013592 (2013).","journal-title":"Nat. Immunol."},{"key":"1653_CR76","doi-asserted-by":"publisher","first-page":"E3562","DOI":"10.1073\/pnas.1403424111","volume":"111","author":"M Rei","year":"2014","unstructured":"Rei, M. et al. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc. Natl Acad. Sci. USA 111, E3562\u2013E3570 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR77","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/eji.200940157","volume":"40","author":"D Wakita","year":"2010","unstructured":"Wakita, D. et al. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur. J. Immunol. 40, 1927\u20131937 (2010).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR78","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.4049\/jimmunol.1002901","volume":"186","author":"Y Carmi","year":"2011","unstructured":"Carmi, Y. et al. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J. Immunol. 186, 3462\u20133471 (2011).","journal-title":"J. Immunol."},{"key":"1653_CR79","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1158\/0008-5472.CAN-13-2534","volume":"74","author":"S Ma","year":"2014","unstructured":"Ma, S. et al. IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res. 74, 1969\u20131982 (2014).","journal-title":"Cancer Res."},{"key":"1653_CR80","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu, P. et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40, 785\u2013800 (2014).","journal-title":"Immunity"},{"key":"1653_CR81","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","volume":"118","author":"N Caccamo","year":"2011","unstructured":"Caccamo, N. et al. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 118, 129\u2013138 (2011).","journal-title":"Blood"},{"key":"1653_CR82","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","volume":"120","author":"C Harly","year":"2012","unstructured":"Harly, C. et al. Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gammadelta T-cell subset. Blood 120, 2269\u20132279 (2012).","journal-title":"Blood"},{"key":"1653_CR83","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.immuni.2013.06.015","volume":"39","author":"BS Sheridan","year":"2013","unstructured":"Sheridan, B. S. et al. gammadelta T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity 39, 184\u2013195 (2013).","journal-title":"Immunity"},{"key":"1653_CR84","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.4049\/jimmunol.1303420","volume":"192","author":"AG Murphy","year":"2014","unstructured":"Murphy, A. G. et al. Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection. J. Immunol. 192, 3697\u20133708 (2014).","journal-title":"J. Immunol."},{"key":"1653_CR85","doi-asserted-by":"publisher","first-page":"e1005201","DOI":"10.1371\/journal.ppat.1005201","volume":"11","author":"N Soriano-Sarabia","year":"2015","unstructured":"Soriano-Sarabia, N. et al. Peripheral Vgamma9Vdelta2 T Cells Are a Novel Reservoir of Latent HIV Infection. PLoS Pathog. 11, e1005201 (2015).","journal-title":"PLoS Pathog."},{"key":"1653_CR86","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938\u2013945 (2015).","journal-title":"Nat. Med."},{"key":"1653_CR87","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41423-020-0473-0","volume":"17","author":"G Rijkers","year":"2020","unstructured":"Rijkers, G., Vervenne, T. & van der Pol, P. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells. Cell Mol. Immunol. 17, 771\u2013772 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19080-6","volume":"11","author":"G Carissimo","year":"2020","unstructured":"Carissimo, G. et al. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat. Commun. 11, 5243 (2020).","journal-title":"Nat. Commun."},{"key":"1653_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20200872","volume":"217","author":"Y Jouan","year":"2020","unstructured":"Jouan, Y. et al. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients. J. Exp. Med. 217, 1\u20139 (2020).","journal-title":"J. Exp. Med."},{"key":"1653_CR90","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41590-023-01447-8","volume":"24","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Dectin-1 signaling on colonic gammadelta T cells promotes psychosocial stress responses. Nat. Immunol. 24, 625\u2013636 (2023).","journal-title":"Nat. Immunol."},{"key":"1653_CR91","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41577-020-00426-6","volume":"21","author":"H Hosokawa","year":"2021","unstructured":"Hosokawa, H. & Rothenberg, E. V. How transcription factors drive choice of the T cell fate. Nat. Rev. Immunol. 21, 162\u2013176 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR92","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/imm.13032","volume":"156","author":"N Sumaria","year":"2019","unstructured":"Sumaria, N., Martin, S. & Pennington, D. J. Developmental origins of murine gammadelta T-cell subsets. Immunology 156, 299\u2013304 (2019).","journal-title":"Immunology"},{"key":"1653_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2020.12.005","volume":"95","author":"EV Rothenberg","year":"2021","unstructured":"Rothenberg, E. V. Single-cell insights into the hematopoietic generation of T-lymphocyte precursors in mouse and human. Exp. Hematol. 95, 1\u201312 (2021).","journal-title":"Exp. Hematol."},{"key":"1653_CR94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-065X.2006.00478.x","volume":"215","author":"N Xiong","year":"2007","unstructured":"Xiong, N. & Raulet, D. H. Development and selection of gammadelta T cells. Immunol. Rev. 215, 15\u201331 (2007).","journal-title":"Immunol. Rev."},{"key":"1653_CR95","doi-asserted-by":"publisher","first-page":"101662","DOI":"10.1016\/j.smim.2022.101662","volume":"61","author":"L Boehme","year":"2022","unstructured":"Boehme, L., Roels, J. & Taghon, T. Development of gammadelta T cells in the thymus - a human perspective. Semin Immunol. 61\u201364, 101662 (2022).","journal-title":"Semin Immunol."},{"key":"1653_CR96","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.it.2017.01.007","volume":"38","author":"M Munoz-Ruiz","year":"2017","unstructured":"Munoz-Ruiz, M., Sumaria, N., Pennington, D. J. & Silva-Santos, B. Thymic determinants of gammadelta T cell differentiation. Trends Immunol. 38, 336\u2013344 (2017).","journal-title":"Trends Immunol."},{"key":"1653_CR97","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.4049\/jimmunol.1302259","volume":"192","author":"DK Shah","year":"2014","unstructured":"Shah, D. K. & Zuniga-Pflucker, J. C. An overview of the intrathymic intricacies of T cell development. J. Immunol. 192, 4017\u20134023 (2014).","journal-title":"J. Immunol."},{"key":"1653_CR98","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","volume":"20","author":"DG Pellicci","year":"2020","unstructured":"Pellicci, D. G., Koay, H. F. & Berzins, S. P. Thymic development of unconventional T cells: how NKT cells, MAIT cells and gammadelta T cells emerge. Nat. Rev. Immunol. 20, 756\u2013770 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR99","first-page":"431","volume":"19","author":"LD McVay","year":"1999","unstructured":"McVay, L. D. & Carding, S. R. Generation of human gammadelta T-cell repertoires. Crit. Rev. Immunol. 19, 431\u2013460 (1999).","journal-title":"Crit. Rev. Immunol."},{"key":"1653_CR100","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1101\/gad.4.8.1304","volume":"4","author":"SR Carding","year":"1990","unstructured":"Carding, S. R. et al. Developmentally regulated fetal thymic and extrathymic T-cell receptor gamma delta gene expression. Genes Dev. 4, 1304\u20131315 (1990).","journal-title":"Genes Dev."},{"key":"1653_CR101","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clim.2006.08.010","volume":"121","author":"PA Velilla","year":"2006","unstructured":"Velilla, P. A., Rugeles, M. T. & Chougnet, C. A. Defective antigen-presenting cell function in human neonates. Clin. Immunol. 121, 251\u2013259 (2006).","journal-title":"Clin. Immunol."},{"key":"1653_CR102","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0092-8674(00)81929-7","volume":"88","author":"T Washburn","year":"1997","unstructured":"Washburn, T. et al. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell 88, 833\u2013843 (1997).","journal-title":"Cell"},{"key":"1653_CR103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/leu.2011.324","volume":"26","author":"S Van Coppernolle","year":"2012","unstructured":"Van Coppernolle, S. et al. Notch induces human T-cell receptor gammadelta+ thymocytes to differentiate along a parallel, highly proliferative and bipotent CD4 CD8 double-positive pathway. Leukemia 26, 127\u2013138 (2012).","journal-title":"Leukemia"},{"key":"1653_CR104","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.4049\/jimmunol.177.6.3711","volume":"177","author":"M Garcia-Peydro","year":"2006","unstructured":"Garcia-Peydro, M., de Yebenes, V. G. & Toribio, M. L. Notch1 and IL-7 receptor interplay maintains proliferation of human thymic progenitors while suppressing non-T cell fates. J. Immunol. 177, 3711\u20133720 (2006).","journal-title":"J. Immunol."},{"key":"1653_CR105","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2005.04.003","volume":"22","author":"MC Haks","year":"2005","unstructured":"Haks, M. C. et al. Attenuation of gammadeltaTCR signaling efficiently diverts thymocytes to the alphabeta lineage. Immunity 22, 595\u2013606 (2005).","journal-title":"Immunity"},{"key":"1653_CR106","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1073\/pnas.1312872111","volume":"111","author":"P Zarin","year":"2014","unstructured":"Zarin, P. et al. Enforcement of gammadelta-lineage commitment by the pre-T-cell receptor in precursors with weak gammadelta-TCR signals. Proc. Natl Acad. Sci. USA 111, 5658\u20135663 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR107","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2005.03.014","volume":"22","author":"SM Hayes","year":"2005","unstructured":"Hayes, S. M., Li, L. & Love, P. E. TCR signal strength influences alphabeta\/gammadelta lineage fate. Immunity 22, 583\u2013593 (2005).","journal-title":"Immunity"},{"key":"1653_CR108","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni1436","volume":"8","author":"AC Hayday","year":"2007","unstructured":"Hayday, A. C. & Pennington, D. J. Key factors in the organized chaos of early T cell development. Nat. Immunol. 8, 137\u2013144 (2007).","journal-title":"Nat. Immunol."},{"key":"1653_CR109","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/blood-2002-10-3261","volume":"102","author":"M Garcia-Peydro","year":"2003","unstructured":"Garcia-Peydro, M., de Yebenes, V. G. & Toribio, M. L. Sustained Notch1 signaling instructs the earliest human intrathymic precursors to adopt a gammadelta T-cell fate in fetal thymus organ culture. Blood 102, 2444\u20132451 (2003).","journal-title":"Blood"},{"key":"1653_CR110","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1084\/jem.20121798","volume":"210","author":"I Van de Walle","year":"2013","unstructured":"Van de Walle, I. et al. Specific Notch receptor-ligand interactions control human TCR-alphabeta\/gammadelta development by inducing differential Notch signal strength. J. Exp. Med. 210, 683\u2013697 (2013).","journal-title":"J. Exp. Med."},{"key":"1653_CR111","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2008-06-164871","volume":"113","author":"I Van de Walle","year":"2009","unstructured":"Van de Walle, I. et al. An early decrease in Notch activation is required for human TCR-alphabeta lineage differentiation at the expense of TCR-gammadelta T cells. Blood 113, 2988\u20132998 (2009).","journal-title":"Blood"},{"key":"1653_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01963-w","volume":"8","author":"TB Buus","year":"2017","unstructured":"Buus, T. B., Odum, N., Geisler, C. & Lauritsen, J. P. H. Three distinct developmental pathways for adaptive and two IFN-gamma-producing gammadelta T subsets in adult thymus. Nat. Commun. 8, 1911 (2017).","journal-title":"Nat. Commun."},{"key":"1653_CR113","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/imr.12918","volume":"298","author":"GJ Fiala","year":"2020","unstructured":"Fiala, G. J., Gomes, A. Q. & Silva-Santos, B. From thymus to periphery: molecular basis of effector gammadelta-T cell differentiation. Immunol. Rev. 298, 47\u201360 (2020).","journal-title":"Immunol. Rev."},{"key":"1653_CR114","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.4049\/jimmunol.1300369","volume":"192","author":"D Gogoi","year":"2014","unstructured":"Gogoi, D., Dar, A. A. & Chiplunkar, S. V. Involvement of Notch in activation and effector functions of gammadelta T cells. J. Immunol. 192, 2054\u20132062 (2014).","journal-title":"J. Immunol."},{"key":"1653_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0118-2","volume":"6","author":"B Di Lorenzo","year":"2019","unstructured":"Di Lorenzo, B., Ravens, S. & Silva-Santos, B. High-throughput analysis of the human thymic Vdelta1(+) T cell receptor repertoire. Sci. Data 6, 115 (2019).","journal-title":"Sci. Data"},{"key":"1653_CR116","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.4049\/jimmunol.160.12.5851","volume":"160","author":"LD McVay","year":"1998","unstructured":"McVay, L. D. et al. The generation of human gammadelta T cell repertoires during fetal development. J. Immunol. 160, 5851\u20135860 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR117","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2006.05.010","volume":"25","author":"M Ciofani","year":"2006","unstructured":"Ciofani, M. et al. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity 25, 105\u2013116 (2006).","journal-title":"Immunity"},{"key":"1653_CR118","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nri2820","volume":"10","author":"M Ciofani","year":"2010","unstructured":"Ciofani, M. & Zuniga-Pflucker, J. C. Determining gammadelta versus alphass T cell development. Nat. Rev. Immunol. 10, 657\u2013663 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR119","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1084\/jem.20072425","volume":"205","author":"T Kreslavsky","year":"2008","unstructured":"Kreslavsky, T., Garbe, A. I., Krueger, A. & von Boehmer, H. T cell receptor-instructed alphabeta versus gammadelta lineage commitment revealed by single-cell analysis. J. Exp. Med. 205, 1173\u20131186 (2008).","journal-title":"J. Exp. Med."},{"key":"1653_CR120","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ni1371","volume":"7","author":"I Prinz","year":"2006","unstructured":"Prinz, I. et al. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat. Immunol. 7, 995\u20131003 (2006).","journal-title":"Nat. Immunol."},{"key":"1653_CR121","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1182\/blood-2005-08-3412","volume":"107","author":"F Weerkamp","year":"2006","unstructured":"Weerkamp, F. et al. Human thymus contains multipotent progenitors with T\/B lymphoid, myeloid, and erythroid lineage potential. Blood 107, 3131\u20133137 (2006).","journal-title":"Blood"},{"key":"1653_CR122","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/eji.1830250910","volume":"25","author":"S Ktorza","year":"1995","unstructured":"Ktorza, S. et al. CD34-positive early human thymocytes: T cell receptor and cytokine receptor gene expression. Eur. J. Immunol. 25, 2471\u20132478 (1995).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR123","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.172.3.847","volume":"172","author":"MS Krangel","year":"1990","unstructured":"Krangel, M. S., Yssel, H., Brocklehurst, C. & Spits, H. A distinct wave of human T cell receptor gamma\/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production. J. Exp. Med. 172, 847\u2013859 (1990).","journal-title":"J. Exp. Med."},{"key":"1653_CR124","doi-asserted-by":"publisher","first-page":"e20190834","DOI":"10.1084\/jem.20190580","volume":"217","author":"P Tieppo","year":"2020","unstructured":"Tieppo, P. et al. The human fetal thymus generates invariant effector gammadelta T cells. J. Exp. Med. 217, e20190834 (2020).","journal-title":"J. Exp. Med."},{"key":"1653_CR125","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.4049\/jimmunol.1900592","volume":"203","author":"M Papadopoulou","year":"2019","unstructured":"Papadopoulou, M. et al. TCR sequencing reveals the distinct development of fetal and adult human Vgamma9Vdelta2 T cells. J. Immunol. 203, 1468\u20131479 (2019).","journal-title":"J. Immunol."},{"key":"1653_CR126","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/331627a0","volume":"331","author":"JF Elliott","year":"1988","unstructured":"Elliott, J. F. et al. The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature 331, 627\u2013631 (1988).","journal-title":"Nature"},{"key":"1653_CR127","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1084\/jem.170.5.1521","volume":"170","author":"G Casorati","year":"1989","unstructured":"Casorati, G., De Libero, G., Lanzavecchia, A. & Migone, N. Molecular analysis of human gamma\/delta+ clones from thymus and peripheral blood. J. Exp. Med. 170, 1521\u20131535 (1989).","journal-title":"J. Exp. Med."},{"key":"1653_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04076-0","volume":"9","author":"MS Davey","year":"2018","unstructured":"Davey, M. S. et al. The human Vdelta2(+) T-cell compartment comprises distinct innate-like Vgamma9(+) and adaptive Vgamma9(\u2212) subsets. Nat. Commun. 9, 1760 (2018).","journal-title":"Nat. Commun."},{"key":"1653_CR129","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1126\/science.1978758","volume":"250","author":"P Fisch","year":"1990","unstructured":"Fisch, P. et al. Recognition by human V gamma 9\/V delta 2 T cells of a GroEL homolog on Daudi Burkitt\u2019s lymphoma cells. Science 250, 1269\u20131273 (1990).","journal-title":"Science"},{"key":"1653_CR130","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/cmi.2017.157","volume":"16","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Profiling the pattern of the human T-cell receptor gammadelta complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis. Cell Mol. Immunol. 16, 250\u2013259 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR131","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/1074-7613(95)90173-6","volume":"3","author":"Y Zhang","year":"1995","unstructured":"Zhang, Y. et al. The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity 3, 439\u2013447 (1995).","journal-title":"Immunity"},{"key":"1653_CR132","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fimmu.2018.00448","volume":"9","author":"MJ Kallemeijn","year":"2018","unstructured":"Kallemeijn, M. J. et al. Next-generation sequencing analysis of the human TCRgammadelta+ T-cell repertoire reveals shifts in Vgamma- and Vdelta-usage in memory populations upon aging. Front. Immunol. 9, 448 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR133","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.4049\/jimmunol.172.9.5544","volume":"172","author":"C Couedel","year":"2004","unstructured":"Couedel, C. et al. Allelic exclusion at the TCR delta locus and commitment to gamma delta lineage: different modalities apply to distinct human gamma delta subsets. J. Immunol. 172, 5544\u20135552 (2004).","journal-title":"J. Immunol."},{"key":"1653_CR134","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2002-08-2438","volume":"101","author":"V Asnafi","year":"2003","unstructured":"Asnafi, V. et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101, 2693\u20132703 (2003).","journal-title":"Blood"},{"key":"1653_CR135","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1126\/science.8390096","volume":"260","author":"F Davodeau","year":"1993","unstructured":"Davodeau, F. et al. Surface expression of two distinct functional antigen receptors on human gamma delta T cells. Science 260, 1800\u20131802 (1993).","journal-title":"Science"},{"key":"1653_CR136","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1084\/jem.20081922","volume":"206","author":"S Gonzalez-Garcia","year":"2009","unstructured":"Gonzalez-Garcia, S. et al. CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7Ralpha gene expression in early human thymopoiesis and leukemia. J. Exp. Med. 206, 779\u2013791 (2009).","journal-title":"J. Exp. Med."},{"key":"1653_CR137","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1074-7613(00)80052-7","volume":"10","author":"C Pallard","year":"1999","unstructured":"Pallard, C. et al. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 10, 525\u2013535 (1999).","journal-title":"Immunity"},{"key":"1653_CR138","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1074-7613(01)00230-8","volume":"15","author":"SK Ye","year":"2001","unstructured":"Ye, S. K. et al. The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity 15, 813\u2013823 (2001).","journal-title":"Immunity"},{"key":"1653_CR139","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1074-7613(00)80096-5","volume":"11","author":"SK Ye","year":"1999","unstructured":"Ye, S. K. et al. Induction of germline transcription in the TCRgamma locus by Stat5: implications for accessibility control by the IL-7 receptor. Immunity 11, 213\u2013223 (1999).","journal-title":"Immunity"},{"key":"1653_CR140","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.4049\/jimmunol.1302456","volume":"195","author":"K Wagatsuma","year":"2015","unstructured":"Wagatsuma, K. et al. STAT5 orchestrates local epigenetic changes for chromatin accessibility and rearrangements by direct binding to the TCRgamma locus. J. Immunol. 195, 1804\u20131814 (2015).","journal-title":"J. Immunol."},{"key":"1653_CR141","doi-asserted-by":"publisher","first-page":"960918","DOI":"10.3389\/fimmu.2022.960918","volume":"13","author":"J Roels","year":"2022","unstructured":"Roels, J. et al. Transcriptional dynamics and epigenetic regulation of E and ID protein encoding genes during human T cell development. Front. Immunol. 13, 960918 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR142","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.193.6.769","volume":"193","author":"JK Ghosh","year":"2001","unstructured":"Ghosh, J. K., Romanow, W. J. & Murre, C. Induction of a diverse T cell receptor gamma\/delta repertoire by the helix-loop-helix proteins E2A and HEB in nonlymphoid cells. J. Exp. Med. 193, 769\u2013776 (2001).","journal-title":"J. Exp. Med."},{"key":"1653_CR143","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1182\/blood.V98.8.2456","volume":"98","author":"AW Langerak","year":"2001","unstructured":"Langerak, A. W. et al. Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood 98, 2456\u20132465 (2001).","journal-title":"Blood"},{"key":"1653_CR144","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1093\/emboj\/cdg567","volume":"22","author":"L Nie","year":"2003","unstructured":"Nie, L., Xu, M., Vladimirova, A. & Sun, X. H. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22, 5780\u20135792 (2003).","journal-title":"EMBO J."},{"key":"1653_CR145","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.4049\/jimmunol.1801650","volume":"202","author":"A Rodriguez-Caparros","year":"2019","unstructured":"Rodriguez-Caparros, A. et al. Notch signaling controls transcription via the recruitment of RUNX1 and MYB to enhancers during T cell development. J. Immunol. 202, 2460\u20132472 (2019).","journal-title":"J. Immunol."},{"key":"1653_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11171","volume":"7","author":"I Van de Walle","year":"2016","unstructured":"Van de Walle, I. et al. GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate. Nat. Commun. 7, 11171 (2016).","journal-title":"Nat. Commun."},{"key":"1653_CR147","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1084\/jem.20060474","volume":"203","author":"AI Garbe","year":"2006","unstructured":"Garbe, A. I. et al. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J. Exp. Med. 203, 1579\u20131590 (2006).","journal-title":"J. Exp. Med."},{"key":"1653_CR148","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1182\/blood-2005-02-0496","volume":"106","author":"M De Smedt","year":"2005","unstructured":"De Smedt, M. et al. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic\/dendritic-, or T-cell lineage in thymus microenvironment. Blood 106, 3498\u20133506 (2005).","journal-title":"Blood"},{"key":"1653_CR149","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1038\/leu.2017.70","volume":"31","author":"VL Ha","year":"2017","unstructured":"Ha, V. L. et al. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation. Leukemia 31, 2503\u20132514 (2017).","journal-title":"Leukemia"},{"key":"1653_CR150","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fimmu.2017.00032","volume":"8","author":"K Cante-Barrett","year":"2017","unstructured":"Cante-Barrett, K. et al. Loss of CD44(dim) expression from early progenitor cells marks T-cell lineage commitment in the human thymus. Front. Immunol. 8, 32 (2017).","journal-title":"Front. Immunol."},{"key":"1653_CR151","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/3877","volume":"20","author":"A Puel","year":"1998","unstructured":"Puel, A., Ziegler, S. F., Buckley, R. H. & Leonard, W. J. Defective IL7R expression in T(-)B(\u2009+\u2009)NK(+) severe combined immunodeficiency. Nat. Genet. 20, 394\u2013397 (1998).","journal-title":"Nat. Genet."},{"key":"1653_CR152","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1365-2141.2000.01962.x","volume":"109","author":"T Hinz","year":"2000","unstructured":"Hinz, T. et al. Cell-surface expression of transrearranged Vgamma-cbeta T-cell receptor chains in healthy donors and in ataxia telangiectasia patients. Br. J. Haematol. 109, 201\u2013210 (2000).","journal-title":"Br. J. Haematol."},{"key":"1653_CR153","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.180.5.1685","volume":"180","author":"F Davodeau","year":"1994","unstructured":"Davodeau, F. et al. Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes. J. Exp. Med. 180, 1685\u20131691 (1994).","journal-title":"J. Exp. Med."},{"key":"1653_CR154","doi-asserted-by":"publisher","first-page":"e20190834","DOI":"10.1084\/jem.20190834","volume":"217","author":"SC Edwards","year":"2020","unstructured":"Edwards, S. C. et al. A population of proinflammatory T cells coexpresses alphabeta and gammadelta T cell receptors in mice and humans. J. Exp. Med. 217, e20190834 (2020).","journal-title":"J. Exp. Med."},{"key":"1653_CR155","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.immuni.2019.09.008","volume":"51","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y. et al. Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos. Immunity 51, 930\u2013948.e936 (2019).","journal-title":"Immunity"},{"key":"1653_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33488-2","volume":"13","author":"G Sanchez Sanchez","year":"2022","unstructured":"Sanchez Sanchez, G. et al. Identification of distinct functional thymic programming of fetal and pediatric human gammadelta thymocytes via single-cell analysis. Nat. Commun. 13, 5842 (2022).","journal-title":"Nat. Commun."},{"key":"1653_CR157","doi-asserted-by":"publisher","first-page":"eabo4365","DOI":"10.1126\/sciimmunol.abo4365","volume":"8","author":"L Perriman","year":"2023","unstructured":"Perriman, L. et al. A three-stage developmental pathway for human V\u03b39V\u03b42\u2009T cells within the postnatal thymus. Sci. Immunol. 8, eabo4365 (2023).","journal-title":"Sci. Immunol."},{"key":"1653_CR158","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","volume":"6","author":"K Shah","year":"2021","unstructured":"Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Sig. Transduct. Target Ther. 6, 412 (2021).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR159","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nri2416","volume":"8","author":"A Singer","year":"2008","unstructured":"Singer, A., Adoro, S. & Park, J. H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8, 788\u2013801 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR160","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.immuni.2018.09.010","volume":"49","author":"NA Spidale","year":"2018","unstructured":"Spidale, N. A. et al. Interleukin-17-producing gammadelta T cells originate from SOX13(+) progenitors that are independent of gammadeltaTCR signaling. Immunity 49, 857\u2013872.e5 (2018).","journal-title":"Immunity"},{"key":"1653_CR161","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1126\/science.1135344","volume":"315","author":"HJ Melichar","year":"2007","unstructured":"Melichar, H. J. et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 315, 230\u2013233 (2007).","journal-title":"Science"},{"key":"1653_CR162","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ni.3424","volume":"17","author":"M Munoz-Ruiz","year":"2016","unstructured":"Munoz-Ruiz, M. et al. TCR signal strength controls thymic differentiation of discrete proinflammatory gammadelta T cell subsets. Nat. Immunol. 17, 721\u2013727 (2016).","journal-title":"Nat. Immunol."},{"key":"1653_CR163","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/84273","volume":"2","author":"G Bain","year":"2001","unstructured":"Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165\u2013171 (2001).","journal-title":"Nat. Immunol."},{"key":"1653_CR164","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.immuni.2014.10.021","volume":"41","author":"SY Lee","year":"2014","unstructured":"Lee, S. Y. et al. Noncanonical mode of ERK action controls alternative alphabeta and gammadelta T cell lineage fates. Immunity 41, 934\u2013946 (2014).","journal-title":"Immunity"},{"key":"1653_CR165","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ncb822","volume":"4","author":"LO Murphy","year":"2002","unstructured":"Murphy, L. O. et al. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556\u2013564 (2002).","journal-title":"Nat. Cell Biol."},{"key":"1653_CR166","doi-asserted-by":"publisher","first-page":"e20182009","DOI":"10.1084\/jem.20182009","volume":"217","author":"M Yukawa","year":"2020","unstructured":"Yukawa, M. et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J. Exp. Med. 217, e20182009 (2020).","journal-title":"J. Exp. Med."},{"key":"1653_CR167","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41590-020-0747-9","volume":"21","author":"J Roels","year":"2020","unstructured":"Roels, J. et al. Distinct and temporary-restricted epigenetic mechanisms regulate human alphabeta and gammadelta T cell development. Nat. Immunol. 21, 1280\u20131292 (2020).","journal-title":"Nat. Immunol."},{"key":"1653_CR168","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1074-7613(00)80155-7","volume":"12","author":"RR Rivera","year":"2000","unstructured":"Rivera, R. R. et al. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17\u201326 (2000).","journal-title":"Immunity"},{"key":"1653_CR169","doi-asserted-by":"publisher","first-page":"e104159","DOI":"10.15252\/embj.2019104159","volume":"39","author":"Sagar","year":"2020","unstructured":"Sagar et al. Deciphering the regulatory landscape of fetal and adult gammadelta T-cell development at single-cell resolution. EMBO J. 39, e104159 (2020).","journal-title":"EMBO J."},{"key":"1653_CR170","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni979","volume":"4","author":"DJ Pennington","year":"2003","unstructured":"Pennington, D. J. et al. The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells. Nat. Immunol. 4, 991\u2013998 (2003).","journal-title":"Nat. Immunol."},{"key":"1653_CR171","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.smim.2015.01.001","volume":"27","author":"N Schmolka","year":"2015","unstructured":"Schmolka, N., Wencker, M., Hayday, A. C. & Silva-Santos, B. Epigenetic and transcriptional regulation of gammadelta T cell differentiation: programming cells for responses in time and space. Semin Immunol. 27, 19\u201325 (2015).","journal-title":"Semin Immunol."},{"key":"1653_CR172","doi-asserted-by":"crossref","first-page":"G455","DOI":"10.1152\/ajpcell.1998.274.2.C455","volume":"274","author":"MF Kagnoff","year":"1998","unstructured":"Kagnoff, M. F. Current concepts in mucosal immunity. III. Ontogeny and function of gamma delta T cells in the intestine. Am. J. Physiol. 274, G455\u2013G458 (1998).","journal-title":"Am. J. Physiol."},{"key":"1653_CR173","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nri.2017.101","volume":"17","author":"MM Nielsen","year":"2017","unstructured":"Nielsen, M. M., Witherden, D. A. & Havran, W. L. gammadelta T cells in homeostasis and host defence of epithelial barrier tissues. Nat. Rev. Immunol. 17, 733\u2013745 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR174","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.4049\/jimmunol.1001612","volume":"185","author":"Y Jin","year":"2010","unstructured":"Jin, Y. et al. CCR10 is important for the development of skin-specific gammadeltaT cells by regulating their migration and location. J. Immunol. 185, 5723\u20135731 (2010).","journal-title":"J. Immunol."},{"key":"1653_CR175","doi-asserted-by":"publisher","first-page":"875076","DOI":"10.3389\/fimmu.2022.875076","volume":"13","author":"W Hu","year":"2022","unstructured":"Hu, W. et al. Skin gammadelta T cells and their function in wound healing. Front. Immunol. 13, 875076 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR176","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2023.01.025","volume":"56","author":"M Frascoli","year":"2023","unstructured":"Frascoli, M. et al. Skin gammadelta T cell inflammatory responses are hardwired in the thymus by oxysterol sensing via GPR183 and calibrated by dietary cholesterol. Immunity 56, 562\u2013575.e566 (2023).","journal-title":"Immunity"},{"key":"1653_CR177","doi-asserted-by":"publisher","first-page":"9020234","DOI":"10.1155\/2019\/9020234","volume":"2019","author":"AS Marshall","year":"2019","unstructured":"Marshall, A. S. et al. Skin-Resident gammadelta T cells exhibit site-specific morphology and activation states. J. Immunol. Res. 2019, 9020234 (2019).","journal-title":"J. Immunol. Res."},{"key":"1653_CR178","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00018-020-03613-9","volume":"78","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Epidermal resident gammadelta T cell development and function in skin. Cell. Mol. Life Sci. CMLS 78, 573\u2013580 (2021).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"1653_CR179","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.jaci.2020.11.023","volume":"147","author":"R Castillo-Gonzalez","year":"2021","unstructured":"Castillo-Gonzalez, R., Cibrian, D. & Sanchez-Madrid, F. Dissecting the complexity of gammadelta T-cell subsets in skin homeostasis, inflammation, and malignancy. J. Allergy Clin. Immunol. 147, 2030\u20132042 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1653_CR180","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3389\/fimmu.2018.01304","volume":"9","author":"MS Cruz","year":"2018","unstructured":"Cruz, M. S., Diamond, A., Russell, A. & Jameson, J. M. Human alphabeta and gammadelta T cells in skin immunity and disease. Front. Immunol. 9, 1304 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR181","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imr.12915","volume":"298","author":"MA Fischer","year":"2020","unstructured":"Fischer, M. A., Golovchenko, N. B. & Edelblum, K. L. gammadelta T cell migration: separating trafficking from surveillance behaviors at barrier surfaces. Immunol. Rev. 298, 165\u2013180 (2020).","journal-title":"Immunol. Rev."},{"key":"1653_CR182","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3389\/fimmu.2018.00985","volume":"9","author":"NE McCarthy","year":"2018","unstructured":"McCarthy, N. E. & Eberl, M. Human gammadelta T-cell control of mucosal immunity and inflammation. Front. Immunol. 9, 985 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR183","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien, Y. H., Meyer, C. & Bonneville, M. gammadelta T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121\u2013155 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"1653_CR184","doi-asserted-by":"publisher","first-page":"849954","DOI":"10.3389\/fimmu.2022.849954","volume":"13","author":"F Rampoldi","year":"2022","unstructured":"Rampoldi, F. & Prinz, I. Three layers of intestinal gammadelta T cells talk different languages with the microbiota. Front. Immunol. 13, 849954 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR185","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/cells9030686","volume":"9","author":"MD Johnson","year":"2020","unstructured":"Johnson, M. D., Witherden, D. A. & Havran, W. L. The role of tissue-resident T cells in stress surveillance and tissue maintenance. Cells. 9, 686 (2020).","journal-title":"Cells."},{"key":"1653_CR186","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4049\/jimmunol.168.1.134","volume":"168","author":"S Uehara","year":"2002","unstructured":"Uehara, S., Song, K., Farber, J. M. & Love, P. E. Characterization of CCR9 expression and CCL25\/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25. J. Immunol. 168, 134\u2013142 (2002).","journal-title":"J. Immunol."},{"key":"1653_CR187","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","volume":"103","author":"A Poggi","year":"2004","unstructured":"Poggi, A. et al. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 103, 2205\u20132213 (2004).","journal-title":"Blood"},{"key":"1653_CR188","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.4049\/jimmunol.168.10.4920","volume":"168","author":"A Glatzel","year":"2002","unstructured":"Glatzel, A. et al. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2\/V gamma 9\u2009gamma delta T cells. J. Immunol. 168, 4920\u20134929 (2002).","journal-title":"J. Immunol."},{"key":"1653_CR189","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.187.1.129","volume":"187","author":"R Bonecchi","year":"1998","unstructured":"Bonecchi, R. et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1\u2009T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129\u2013134 (1998).","journal-title":"J. Exp. Med."},{"key":"1653_CR190","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1615\/CritRevImmunol.v23.i56.10","volume":"23","author":"D Kabelitz","year":"2003","unstructured":"Kabelitz, D. & Wesch, D. Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit. Rev. Immunol. 23, 339\u2013370 (2003).","journal-title":"Crit. Rev. Immunol."},{"key":"1653_CR191","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.4049\/jimmunol.1300434","volume":"190","author":"T Lan\u00e7a","year":"2013","unstructured":"Lan\u00e7a, T. et al. Protective role of the inflammatory CCR2\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic \u03b3\u03b4 T lymphocytes to tumor beds. J. Immunol. 190, 6673\u20136680 (2013).","journal-title":"J. Immunol."},{"key":"1653_CR192","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.4049\/jimmunol.157.7.2873","volume":"157","author":"LD McVay","year":"1996","unstructured":"McVay, L. D. & Carding, S. R. Extrathymic origin of human gamma delta T cells during fetal development. J. Immunol. 157, 2873\u20132882 (1996).","journal-title":"J. Immunol."},{"key":"1653_CR193","doi-asserted-by":"publisher","first-page":"E556","DOI":"10.1073\/pnas.1412058112","volume":"112","author":"T Dimova","year":"2015","unstructured":"Dimova, T. et al. Effector Vgamma9Vdelta2 T cells dominate the human fetal gammadelta T-cell repertoire. Proc. Natl Acad. Sci. USA 112, E556\u2013E565 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR194","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3389\/fimmu.2018.01501","volume":"9","author":"CR Willcox","year":"2018","unstructured":"Willcox, C. R., Davey, M. S. & Willcox, B. E. Development and selection of the human Vgamma9Vdelta2(+) T-cell repertoire. Front. Immunol. 9, 1501 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR195","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/cells9051181","volume":"9","author":"W Xu","year":"2020","unstructured":"Xu, W., Lau, Z. W. X., Fulop, T. & Larbi, A. The aging of gammadelta T cells. Cells. 9, 1181 (2020).","journal-title":"Cells."},{"key":"1653_CR196","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.4049\/jimmunol.153.9.3979","volume":"153","author":"CT Morita","year":"1994","unstructured":"Morita, C. T., Parker, C. M., Brenner, M. B. & Band, H. TCR usage and functional capabilities of human gamma delta T cells at birth. J. Immunol. 153, 3979\u20133988 (1994).","journal-title":"J. Immunol."},{"key":"1653_CR197","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.4049\/jimmunol.1303119","volume":"192","author":"JC Ribot","year":"2014","unstructured":"Ribot, J. C. et al. Human gammadelta thymocytes are functionally immature and differentiate into cytotoxic type 1 effector T cells upon IL-2\/IL-15 signaling. J. Immunol. 192, 2237\u20132243 (2014).","journal-title":"J. Immunol."},{"key":"1653_CR198","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1084\/jem.171.5.1597","volume":"171","author":"CM Parker","year":"1990","unstructured":"Parker, C. M. et al. Evidence for extrathymic changes in the T cell receptor gamma\/delta repertoire. J. Exp. Med. 171, 1597\u20131612 (1990).","journal-title":"J. Exp. Med."},{"key":"1653_CR199","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","volume":"19","author":"JJ Goronzy","year":"2019","unstructured":"Goronzy, J. J. & Weyand, C. M. Mechanisms underlying T cell ageing. Nat. Rev. Immunol. 19, 573\u2013583 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR200","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn, M. & Kroemer, G. Hallmarks of T cell aging. Nat. Immunol. 22, 687\u2013698 (2021).","journal-title":"Nat. Immunol."},{"key":"1653_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/srep13107","volume":"5","author":"L Tserel","year":"2015","unstructured":"Tserel, L. et al. Age-related profiling of DNA methylation in CD8\u2009+\u2009T cells reveals changes in immune response and transcriptional regulator genes. Sci. Rep. 5, 13107 (2015).","journal-title":"Sci. Rep."},{"key":"1653_CR202","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.it.2021.04.005","volume":"42","author":"LA Urban","year":"2021","unstructured":"Urban, L. A. et al. The impact of age-related hypomethylated DNA on immune signaling upon cellular demise. Trends Immunol. 42, 464\u2013468 (2021).","journal-title":"Trends Immunol."},{"key":"1653_CR203","doi-asserted-by":"publisher","first-page":"863703","DOI":"10.3389\/fimmu.2022.863703","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. DNA methylation of T lymphocytes as a therapeutic target: implications for rheumatoid arthritis etiology. Front. Immunol. 13, 863703 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR204","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12872-022-02616-7","volume":"22","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. MicroRNA profile of circulating CD4\u2009+\u2009T cells in aged patients with atherosclerosis obliterans. BMC Cardiovasc. Disord. 22, 172 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1653_CR205","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12979-021-00240-1","volume":"18","author":"C Kim","year":"2021","unstructured":"Kim, C., Ye, Z., Weyand, C. M. & Goronzy, J. J. miR-181a-regulated pathways in T-cell differentiation and aging. Immun. Ageing 18, 28 (2021).","journal-title":"Immun. Ageing"},{"key":"1653_CR206","doi-asserted-by":"publisher","first-page":"756042","DOI":"10.3389\/fimmu.2021.756042","volume":"12","author":"M Taheri","year":"2021","unstructured":"Taheri, M. et al. Emerging role of non-coding RNAs in regulation of T-lymphocyte function. Front. Immunol. 12, 756042 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR207","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2020.01.023","volume":"120","author":"AC Wells","year":"2020","unstructured":"Wells, A. C., Pobezinskaya, E. L. & Pobezinsky, L. A. Non-coding RNAs in CD8 T cell biology. Mol. Immunol. 120, 67\u201373 (2020).","journal-title":"Mol. Immunol."},{"key":"1653_CR208","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1189\/jlb.72.1.65","volume":"72","author":"K Argentati","year":"2002","unstructured":"Argentati, K. et al. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J. Leukoc. Biol. 72, 65\u201371 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"1653_CR209","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s43657-023-00106-0","volume":"3","author":"Z Jia","year":"2023","unstructured":"Jia, Z. et al. Immune-ageing evaluation of peripheral T and NK lymphocyte subsets in Chinese healthy adults. Phenomics 3, 360\u2013374 (2023).","journal-title":"Phenomics"},{"key":"1653_CR210","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin, C. et al. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"1653_CR211","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0008-8749(90)90053-T","volume":"128","author":"R Ullrich","year":"1990","unstructured":"Ullrich, R. et al. gamma delta T cells in the human intestine express surface markers of activation and are preferentially located in the epithelium. Cell Immunol. 128, 619\u2013627 (1990).","journal-title":"Cell Immunol."},{"key":"1653_CR212","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1084\/jem.20081787","volume":"206","author":"A Toulon","year":"2009","unstructured":"Toulon, A. et al. A role for human skin-resident T cells in wound healing. J. Exp. Med. 206, 743\u2013750 (2009).","journal-title":"J. Exp. Med."},{"key":"1653_CR213","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/1523-1747.ep12873333","volume":"94","author":"JD Bos","year":"1990","unstructured":"Bos, J. D. et al. T-cell receptor gamma delta bearing cells in normal human skin. J. Invest. Dermatol. 94, 37\u201342 (1990).","journal-title":"J. Invest. Dermatol."},{"key":"1653_CR214","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","volume":"18","author":"S Ravens","year":"2017","unstructured":"Ravens, S. et al. Human gammadelta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat. Immunol. 18, 393\u2013401 (2017).","journal-title":"Nat. Immunol."},{"key":"1653_CR215","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ni.3705","volume":"18","author":"B Silva-Santos","year":"2017","unstructured":"Silva-Santos, B. & Strid, J. gammadelta T cells get adaptive. Nat. Immunol. 18, 370\u2013372 (2017).","journal-title":"Nat. Immunol."},{"key":"1653_CR216","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s41590-018-0253-5","volume":"19","author":"D Melandri","year":"2018","unstructured":"Melandri, D. et al. The gammadeltaTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness. Nat. Immunol. 19, 1352\u20131365 (2018).","journal-title":"Nat. Immunol."},{"key":"1653_CR217","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","volume":"106","author":"M Brandes","year":"2009","unstructured":"Brandes, M. et al. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc. Natl Acad. Sci. USA 106, 2307\u20132312 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR218","doi-asserted-by":"publisher","first-page":"894315","DOI":"10.3389\/fimmu.2022.894315","volume":"13","author":"KF Chan","year":"2022","unstructured":"Chan, K. F., Duarte, J. D. G., Ostrouska, S. & Behren, A. gammadelta T cells in the tumor microenvironment-interactions with other immune cells. Front. Immunol. 13, 894315 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR219","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.4049\/jimmunol.178.7.4304","volume":"178","author":"D Vermijlen","year":"2007","unstructured":"Vermijlen, D. et al. Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy. J. Immunol. 178, 4304\u20134314 (2007).","journal-title":"J. Immunol."},{"key":"1653_CR220","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309\u2013314 (2000).","journal-title":"Nature"},{"key":"1653_CR221","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.183.5.2271","volume":"183","author":"L Wen","year":"1996","unstructured":"Wen, L. et al. Germinal center formation, immunoglobulin class switching, and autoantibody production driven by \u201cnon alpha\/beta\u201d T cells. J. Exp. Med. 183, 2271\u20132282 (1996).","journal-title":"J. Exp. Med."},{"key":"1653_CR222","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.4049\/jimmunol.177.8.5290","volume":"177","author":"N Caccamo","year":"2006","unstructured":"Caccamo, N. et al. CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J. Immunol. 177, 5290\u20135295 (2006).","journal-title":"J. Immunol."},{"key":"1653_CR223","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4049\/jimmunol.174.1.252","volume":"174","author":"L Conti","year":"2005","unstructured":"Conti, L. et al. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J. Immunol. 174, 252\u2013260 (2005).","journal-title":"J. Immunol."},{"key":"1653_CR224","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4049\/jimmunol.176.3.1386","volume":"176","author":"MC Devilder","year":"2006","unstructured":"Devilder, M. C. et al. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 176, 1386\u20131393 (2006).","journal-title":"J. Immunol."},{"key":"1653_CR225","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/eji.200636220","volume":"36","author":"N Caccamo","year":"2006","unstructured":"Caccamo, N. et al. gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis. Eur. J. Immunol. 36, 2681\u20132690 (2006).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR226","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2174\/156652407782564345","volume":"7","author":"A Martino","year":"2007","unstructured":"Martino, A. & Poccia, F. Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies. Curr. Mol. Med. 7, 658\u2013673 (2007).","journal-title":"Curr. Mol. Med."},{"key":"1653_CR227","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.4049\/jimmunol.171.12.6488","volume":"171","author":"JE Dalton","year":"2003","unstructured":"Dalton, J. E., Pearson, J., Scott, P. & Carding, S. R. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. J. Immunol. 171, 6488\u20136494 (2003).","journal-title":"J. Immunol."},{"key":"1653_CR228","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1365-2567.2003.01600.x","volume":"108","author":"E Ferrero","year":"2003","unstructured":"Ferrero, E. et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology 108, 365\u2013374 (2003).","journal-title":"Immunology"},{"key":"1653_CR229","doi-asserted-by":"publisher","first-page":"e1003119","DOI":"10.1371\/journal.ppat.1003119","volume":"9","author":"CT Spencer","year":"2013","unstructured":"Spencer, C. T. et al. Granzyme A produced by gamma(9)delta(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. PLoS Pathog. 9, e1003119 (2013).","journal-title":"PLoS Pathog."},{"key":"1653_CR230","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3","volume":"30","author":"F Dieli","year":"2000","unstructured":"Dieli, F. et al. Vgamma9\/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 30, 1512\u20131519 (2000).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR231","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood-2009-07-234211","volume":"116","author":"A Maniar","year":"2010","unstructured":"Maniar, A. et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 116, 1726\u20131733 (2010).","journal-title":"Blood"},{"key":"1653_CR232","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1182\/blood-2011-01-328526","volume":"118","author":"O Nussbaumer","year":"2011","unstructured":"Nussbaumer, O., Gruenbacher, G., Gander, H. & Thurnher, M. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gammadelta T lymphocytes. Blood. 118, 2743\u20132751 (2011).","journal-title":"Blood."},{"key":"1653_CR233","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2019.00477","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. gammadeltaT cells suppress liver fibrosis via strong cytolysis and enhanced NK cell-mediated cytotoxicity against hepatic stellate cells. Front. Immunol. 10, 477 (2019).","journal-title":"Front. Immunol."},{"key":"1653_CR234","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.immuni.2012.01.016","volume":"36","author":"NA Roberts","year":"2012","unstructured":"Roberts, N. A. et al. Rank signaling links the development of invariant gammadelta T cell progenitors and Aire(+) medullary epithelium. Immunity 36, 427\u2013437 (2012).","journal-title":"Immunity"},{"key":"1653_CR235","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri1030","volume":"3","author":"A Hayday","year":"2003","unstructured":"Hayday, A. & Tigelaar, R. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3, 233\u2013242 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR236","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41590-018-0304-y","volume":"20","author":"BE Willcox","year":"2019","unstructured":"Willcox, B. E. & Willcox, C. R. gammadelta TCR ligands: the quest to solve a 500-million-year-old mystery. Nat. Immunol. 20, 121\u2013128 (2019).","journal-title":"Nat. Immunol."},{"key":"1653_CR237","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcdb.2017.10.009","volume":"84","author":"D Vermijlen","year":"2018","unstructured":"Vermijlen, D. et al. gammadelta T cell responses: how many ligands will it take till we know? Semin Cell Dev. Biol. 84, 75\u201386 (2018).","journal-title":"Semin Cell Dev. Biol."},{"key":"1653_CR238","doi-asserted-by":"publisher","first-page":"eaav4036","DOI":"10.1126\/sciimmunol.aav4036","volume":"3","author":"PM Benveniste","year":"2018","unstructured":"Benveniste, P. M. et al. Generation and molecular recognition of melanoma-associated antigen-specific human gammadelta T cells. Sci. Immunol. 3, eaav4036 (2018).","journal-title":"Sci. Immunol."},{"key":"1653_CR239","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1182\/bloodadvances.2019032409","volume":"3","author":"GJJ Kierkels","year":"2019","unstructured":"Kierkels, G. J. J. et al. Identification of a tumor-specific allo-HLA-restricted gammadeltaTCR. Blood Adv. 3, 2870\u20132882 (2019).","journal-title":"Blood Adv."},{"key":"1653_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey, M. S. et al. Clonal selection in the human Vdelta1 T cell repertoire indicates gammadelta TCR-dependent adaptive immune surveillance. Nat. Commun. 8, 14760 (2017).","journal-title":"Nat. Commun."},{"key":"1653_CR241","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jhep.2018.05.007","volume":"69","author":"S Hunter","year":"2018","unstructured":"Hunter, S. et al. Human liver infiltrating gammadelta T cells are composed of clonally expanded circulating and tissue-resident populations. J. Hepatol. 69, 654\u2013665 (2018).","journal-title":"J. Hepatol."},{"key":"1653_CR242","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/cells9040800","volume":"9","author":"AS Fichtner","year":"2020","unstructured":"Fichtner, A. S., Ravens, S. & Prinz, I. Human gammadelta TCR Repertoires in Health and Disease. Cells 9, 800 (2020).","journal-title":"Cells"},{"key":"1653_CR243","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.2020005469","volume":"139","author":"A Carbone","year":"2022","unstructured":"Carbone, A., Vaccher, E. & Gloghini, A. Hematologic cancers in individuals infected by HIV. Blood 139, 995\u20131012 (2022).","journal-title":"Blood"},{"key":"1653_CR244","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1182\/blood-2011-05-356535","volume":"118","author":"H Li","year":"2011","unstructured":"Li, H. & Pauza, C. D. HIV envelope-mediated, CCR5\/alpha4beta7-dependent killing of CD4-negative gammadelta T cells which are lost during progression to AIDS. Blood 118, 5824\u20135831 (2011).","journal-title":"Blood"},{"key":"1653_CR245","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.4049\/jimmunol.168.3.1484","volume":"168","author":"C Gioia","year":"2002","unstructured":"Gioia, C. et al. Lack of CD27-CD45RA-V gamma 9\u2009V delta 2\u2009+\u2009T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J. Immunol. 168, 1484\u20131489 (2002).","journal-title":"J. Immunol."},{"key":"1653_CR246","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1172\/JCI130711","volume":"130","author":"P Ogongo","year":"2020","unstructured":"Ogongo, P. et al. Differential skewing of donor-unrestricted and gammadelta T cell repertoires in tuberculosis-infected human lungs. J. Clin. Invest. 130, 214\u2013230 (2020).","journal-title":"J. Clin. Invest."},{"key":"1653_CR247","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/JLB.5MR0722-777R","volume":"112","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. gammadelta T cell exhaustion: opportunities for intervention. J. Leukoc. Biol. 112, 1669\u20131676 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"1653_CR248","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","volume":"118","author":"DV Correia","year":"2011","unstructured":"Correia, D. V. et al. Differentiation of human peripheral blood Vdelta1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 118, 992\u20131001 (2011).","journal-title":"Blood"},{"key":"1653_CR249","doi-asserted-by":"publisher","first-page":"e76008","DOI":"10.1371\/journal.pone.0076008","volume":"8","author":"MR Dunne","year":"2013","unstructured":"Dunne, M. R. et al. Persistent changes in circulating and intestinal gammadelta T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS One 8, e76008 (2013).","journal-title":"PLoS One"},{"key":"1653_CR250","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2004.05.003","volume":"113","author":"T Kenna","year":"2004","unstructured":"Kenna, T. et al. Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver. Clin. Immunol. 113, 56\u201363 (2004).","journal-title":"Clin. Immunol."},{"key":"1653_CR251","doi-asserted-by":"publisher","first-page":"e2110288118","DOI":"10.1073\/pnas.2110288118","volume":"118","author":"MT Rice","year":"2021","unstructured":"Rice, M. T. et al. Recognition of the antigen-presenting molecule MR1 by a Vdelta3(+) gammadelta T cell receptor. Proc. Natl Acad. Sci. USA. 118, e2110288118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1653_CR252","doi-asserted-by":"publisher","first-page":"807765","DOI":"10.3389\/fimmu.2022.807765","volume":"13","author":"X Leon-Lara","year":"2022","unstructured":"Leon-Lara, X. et al. Evidence for an adult-like type 1-immunity phenotype of Vdelta1, Vdelta2 and Vdelta3 T cells in ghanaian children with repeated exposure to Malaria. Front. Immunol. 13, 807765 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR253","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/v13101987","volume":"13","author":"J Tuengel","year":"2021","unstructured":"Tuengel, J. et al. Characterization of adaptive-like gammadelta T cells in ugandan infants during primary cytomegalovirus infection. Viruses. 13, 1987 (2021).","journal-title":"Viruses."},{"key":"1653_CR254","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fimmu.2018.00510","volume":"9","author":"S Ravens","year":"2018","unstructured":"Ravens, S. et al. Human gammadelta T cell receptor repertoires in peripheral blood remain stable despite clearance of persistent Hepatitis C virus infection by direct-acting antiviral drug therapy. Front. Immunol. 9, 510 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR255","doi-asserted-by":"publisher","first-page":"241246","DOI":"10.1155\/2014\/241246","volume":"2014","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. The feature of distribution and clonality of TCR gamma\/delta subfamilies T cells in patients with B-cell non-Hodgkin lymphoma. J. Immunol. Res. 2014, 241246 (2014).","journal-title":"J. Immunol. Res."},{"key":"1653_CR256","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","volume":"613","author":"NL de Vries","year":"2023","unstructured":"de Vries, N. L. et al. gammadelta T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 613, 743\u2013750 (2023).","journal-title":"Nature"},{"key":"1653_CR257","doi-asserted-by":"publisher","first-page":"108797","DOI":"10.1016\/j.clim.2021.108797","volume":"229","author":"AM Melo","year":"2021","unstructured":"Melo, A. M. et al. Tissue distribution of gammadelta T cell subsets in oesophageal adenocarcinoma. Clin. Immunol. 229, 108797 (2021).","journal-title":"Clin. Immunol."},{"key":"1653_CR258","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2326-6066.CIR-20-0817","volume":"9","author":"NA Gherardin","year":"2021","unstructured":"Gherardin, N. A. et al. gammadelta T cells in merkel cell carcinomas have a proinflammatory profile prognostic of patient survival. Cancer Immunol. Res. 9, 612\u2013623 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"1653_CR259","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.imlet.2018.02.002","volume":"196","author":"A Petrasca","year":"2018","unstructured":"Petrasca, A., Melo, A. M., Breen, E. P. & Doherty, D. G. Human Vdelta3(+) gammadelta T cells induce maturation and IgM secretion by B cells. Immunol. Lett. 196, 126\u2013134 (2018).","journal-title":"Immunol. Lett."},{"key":"1653_CR260","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1084\/jem.191.6.937","volume":"191","author":"FM Spada","year":"2000","unstructured":"Spada, F. M. et al. Self-recognition of CD1 by gamma\/delta T cells: implications for innate immunity. J. Exp. Med. 191, 937\u2013948 (2000).","journal-title":"J. Exp. Med."},{"key":"1653_CR261","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ni.2713","volume":"14","author":"AP Uldrich","year":"2013","unstructured":"Uldrich, A. P. et al. CD1d-lipid antigen recognition by the gammadelta TCR. Nat. Immunol. 14, 1137\u20131145 (2013).","journal-title":"Nat. Immunol."},{"key":"1653_CR262","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.immuni.2013.11.001","volume":"39","author":"AM Luoma","year":"2013","unstructured":"Luoma, A. M. et al. Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity 39, 1032\u20131042 (2013).","journal-title":"Immunity"},{"key":"1653_CR263","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.it.2014.09.003","volume":"35","author":"AM Luoma","year":"2014","unstructured":"Luoma, A. M., Castro, C. D. & Adams, E. J. gammadelta T cell surveillance via CD1 molecules. Trends Immunol. 35, 613\u2013621 (2014).","journal-title":"Trends Immunol."},{"key":"1653_CR264","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4049\/jimmunol.1502202","volume":"196","author":"S Roy","year":"2016","unstructured":"Roy, S. et al. Molecular analysis of lipid-reactive Vdelta1 gammadelta T cells identified by CD1c tetramers. J. Immunol. 196, 1933\u20131942 (2016).","journal-title":"J. Immunol."},{"key":"1653_CR265","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.immuni.2013.11.016","volume":"39","author":"A Hayday","year":"2013","unstructured":"Hayday, A. & Vantourout, P. A long-playing CD about the gammadelta TCR repertoire. Immunity 39, 994\u2013996 (2013).","journal-title":"Immunity"},{"key":"1653_CR266","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1073\/pnas.1621052114","volume":"114","author":"R Marlin","year":"2017","unstructured":"Marlin, R. et al. Sensing of cell stress by human gammadelta TCR-dependent recognition of annexin A2. Proc. Natl Acad. Sci. USA. 114, 3163\u20133168 (2017).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1653_CR267","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279, 1737\u20131740 (1998).","journal-title":"Science"},{"key":"1653_CR268","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","volume":"96","author":"V Groh","year":"1999","unstructured":"Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879\u20136884 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR269","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1073\/pnas.1015433108","volume":"108","author":"B Xu","year":"2011","unstructured":"Xu, B. et al. Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA. Proc. Natl Acad. Sci. USA 108, 2414\u20132419 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR270","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams, E. J., Gu, S. & Luoma, A. M. Human gamma delta T cells: evolution and ligand recognition. Cell Immunol. 296, 31\u201340 (2015).","journal-title":"Cell Immunol."},{"key":"1653_CR271","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1182\/blood-2012-05-432427","volume":"120","author":"C Grunder","year":"2012","unstructured":"Grunder, C. et al. gamma9 and delta2CDR3 domains regulate functional avidity of T cells harboring gamma9delta2TCRs. Blood 120, 5153\u20135162 (2012).","journal-title":"Blood"},{"key":"1653_CR272","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober, H. J. et al. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197, 163\u2013168 (2003).","journal-title":"J. Exp. Med."},{"key":"1653_CR273","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/0008-5472.CAN-10-3862","volume":"71","author":"I Benzaid","year":"2011","unstructured":"Benzaid, I. et al. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res. 71, 4562\u20134572 (2011).","journal-title":"Cancer Res."},{"key":"1653_CR274","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.bbrc.2015.05.118","volume":"463","author":"E Ashihara","year":"2015","unstructured":"Ashihara, E. et al. Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of gammadeltaT cells. Biochem. Biophys. Res. Commun. 463, 650\u2013655 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1653_CR275","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/375155a0","volume":"375","author":"Y Tanaka","year":"1995","unstructured":"Tanaka, Y. et al. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375, 155\u2013158 (1995).","journal-title":"Nature"},{"key":"1653_CR276","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","volume":"40","author":"A Sandstrom","year":"2014","unstructured":"Sandstrom, A. et al. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vgamma9Vdelta2 T cells. Immunity 40, 490\u2013500 (2014).","journal-title":"Immunity"},{"key":"1653_CR277","doi-asserted-by":"publisher","first-page":"eaay5516","DOI":"10.1126\/science.aay5516","volume":"367","author":"M Rigau","year":"2020","unstructured":"Rigau, M. et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by gammadelta T cells. Science 367, eaay5516 (2020).","journal-title":"Science"},{"key":"1653_CR278","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2020.02.014","volume":"52","author":"MM Karunakaran","year":"2020","unstructured":"Karunakaran, M. M. et al. Butyrophilin-2A1 directly binds germline-encoded regions of the Vgamma9Vdelta2 TCR and is essential for phosphoantigen sensing. Immunity 52, 487\u2013498.e486 (2020).","journal-title":"Immunity"},{"key":"1653_CR279","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","volume":"17","author":"D Kabelitz","year":"2020","unstructured":"Kabelitz, D. et al. Cancer immunotherapy with gammadelta T cells: many paths ahead of us. Cell Mol. Immunol. 17, 925\u2013939 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR280","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.02.016","volume":"50","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. A structural change in butyrophilin upon phosphoantigen binding underlies phosphoantigen-mediated Vgamma9Vdelta2 T cell activation. Immunity 50, 1043\u20131053.e1045 (2019).","journal-title":"Immunity"},{"key":"1653_CR281","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.immuni.2004.11.012","volume":"22","author":"E Scotet","year":"2005","unstructured":"Scotet, E. et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22, 71\u201380 (2005).","journal-title":"Immunity"},{"key":"1653_CR282","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.1074\/jbc.M708067200","volume":"283","author":"H Chen","year":"2008","unstructured":"Chen, H. et al. Identification of human T cell receptor gammadelta-recognized epitopes\/proteins via CDR3delta peptide-based immunobiochemical strategy. J. Biol. Chem. 283, 12528\u201312537 (2008).","journal-title":"J. Biol. Chem."},{"key":"1653_CR283","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1074\/jbc.M111.327650","volume":"287","author":"Y Dai","year":"2012","unstructured":"Dai, Y. et al. Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human gammadelta T cells to induce innate anti-tumor\/virus immunity. J. Biol. Chem. 287, 16812\u201316819 (2012).","journal-title":"J. Biol. Chem."},{"key":"1653_CR284","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1073\/pnas.1909474117","volume":"117","author":"AS Fichtner","year":"2020","unstructured":"Fichtner, A. S. et al. Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive Vgamma9Vdelta2 T cell subset. Proc. Natl Acad. Sci. USA 117, 6697\u20136707 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR285","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727\u2013729 (1999).","journal-title":"Science"},{"key":"1653_CR286","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4049\/jimmunol.175.4.2144","volume":"175","author":"B Rincon-Orozco","year":"2005","unstructured":"Rincon-Orozco, B. et al. Activation of V gamma 9V delta 2 T cells by NKG2D. J. Immunol. 175, 2144\u20132151 (2005).","journal-title":"J. Immunol."},{"key":"1653_CR287","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01963.x","volume":"66","author":"P Wrobel","year":"2007","unstructured":"Wrobel, P. et al. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand. J. Immunol. 66, 320\u2013328 (2007).","journal-title":"Scand. J. Immunol."},{"key":"1653_CR288","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1182\/blood-2009-08-237123","volume":"115","author":"T Lanca","year":"2010","unstructured":"Lanca, T. et al. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia\/lymphoma susceptibility to gammadelta T-cell cytotoxicity. Blood 115, 2407\u20132411 (2010).","journal-title":"Blood"},{"key":"1653_CR289","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3389\/fimmu.2018.00929","volume":"9","author":"AE Simoes","year":"2018","unstructured":"Simoes, A. E., Di Lorenzo, B. & Silva-Santos, B. Molecular determinants of target cell recognition by human gammadelta T cells. Front. Immunol. 9, 929 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR290","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/eji.200838409","volume":"39","author":"O Toutirais","year":"2009","unstructured":"Toutirais, O. et al. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Eur. J. Immunol. 39, 1361\u20131368 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR291","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/ijc.23365","volume":"122","author":"H Tokuyama","year":"2008","unstructured":"Tokuyama, H. et al. V gamma 9\u2009V delta 2\u2009T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs-rituximab and trastuzumab. Int. J. Cancer 122, 2526\u20132534 (2008).","journal-title":"Int. J. Cancer"},{"key":"1653_CR292","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4049\/jimmunol.1100681","volume":"187","author":"AH Capietto","year":"2011","unstructured":"Capietto, A. H., Martinet, L. & Fournie, J. J. Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer. J. Immunol. 187, 1031\u20131038 (2011).","journal-title":"J. Immunol."},{"key":"1653_CR293","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1182\/blood-2008-08-172296","volume":"113","author":"J Gertner-Dardenne","year":"2009","unstructured":"Gertner-Dardenne, J. et al. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies. Blood 113, 4875\u20134884 (2009).","journal-title":"Blood"},{"key":"1653_CR294","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-13-3464","volume":"20","author":"JP Fisher","year":"2014","unstructured":"Fisher, J. P. et al. Neuroblastoma killing properties of Vdelta2 and Vdelta2-negative gammadeltaT cells following expansion by artificial antigen-presenting cells. Clin. Cancer Res. 20, 5720\u20135732 (2014).","journal-title":"Clin. Cancer Res."},{"key":"1653_CR295","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1084\/jem.20031981","volume":"199","author":"SE Street","year":"2004","unstructured":"Street, S. E. et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J. Exp. Med. 199, 879\u2013884 (2004).","journal-title":"J. Exp. Med."},{"key":"1653_CR296","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.4049\/jimmunol.180.9.6044","volume":"180","author":"Z Liu","year":"2008","unstructured":"Liu, Z. et al. Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer. J. Immunol. 180, 6044\u20136053 (2008).","journal-title":"J. Immunol."},{"key":"1653_CR297","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.20030584","volume":"198","author":"Y Gao","year":"2003","unstructured":"Gao, Y. et al. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J. Exp. Med. 198, 433\u2013442 (2003).","journal-title":"J. Exp. Med."},{"key":"1653_CR298","doi-asserted-by":"publisher","first-page":"e1168554","DOI":"10.1080\/2162402X.2016.1168554","volume":"5","author":"U Jarry","year":"2016","unstructured":"Jarry, U. et al. Stereotaxic administrations of allogeneic human Vgamma9Vdelta2 T cells efficiently control the development of human glioblastoma brain tumors. Oncoimmunology 5, e1168554 (2016).","journal-title":"Oncoimmunology"},{"key":"1653_CR299","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00262-015-1662-z","volume":"64","author":"L Pereboeva","year":"2015","unstructured":"Pereboeva, L., Harkins, L., Wong, S. & Lamb, L. S. The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation. Cancer Immunol. Immunother. 64, 551\u2013562 (2015).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR300","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1158\/0008-5472.CAN-17-1416","volume":"78","author":"EC Patin","year":"2018","unstructured":"Patin, E. C. et al. Type I IFN receptor signaling controls IL7-dependent accumulation and activity of protumoral IL17A-producing gammadelta T cells in breast cancer. Cancer Res. 78, 195\u2013204 (2018).","journal-title":"Cancer Res."},{"key":"1653_CR301","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/cas.13005","volume":"107","author":"Y Kimura","year":"2016","unstructured":"Kimura, Y. et al. IL-17A-producing CD30(+) Vdelta1 T cells drive inflammation-induced cancer progression. Cancer Sci. 107, 1206\u20131214 (2016).","journal-title":"Cancer Sci."},{"key":"1653_CR302","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"SB Coffelt","year":"2015","unstructured":"Coffelt, S. B. et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345\u2013348 (2015).","journal-title":"Nature"},{"key":"1653_CR303","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-15-0154","volume":"4","author":"P Kulig","year":"2016","unstructured":"Kulig, P. et al. IL17A-Mediated Endothelial Breach Promotes Metastasis Formation. Cancer Immunol Res. 4, 26\u201332 (2016).","journal-title":"Cancer Immunol Res."},{"key":"1653_CR304","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fimmu.2020.00042","volume":"11","author":"ME Parker","year":"2020","unstructured":"Parker, M. E. & Ciofani, M. Regulation of gammadelta T cell effector diversification in the thymus. Front. Immunol. 11, 42 (2020).","journal-title":"Front. Immunol."},{"key":"1653_CR305","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.immuni.2008.04.022","volume":"29","author":"KD Jensen","year":"2008","unstructured":"Jensen, K. D. et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29, 90\u2013100 (2008).","journal-title":"Immunity"},{"key":"1653_CR306","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.trecan.2017.06.003","volume":"3","author":"C Fleming","year":"2017","unstructured":"Fleming, C., Morrissey, S., Cai, Y. & Yan, J. gammadelta T cells: unexpected regulators of cancer development and progression. Trends Cancer 3, 561\u2013570 (2017).","journal-title":"Trends Cancer"},{"key":"1653_CR307","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fimmu.2014.00607","volume":"5","author":"E Lo Presti","year":"2014","unstructured":"Lo Presti, E., Dieli, F. & Meraviglia, S. Tumor-infiltrating gammadelta T lymphocytes: pathogenic role, clinical significance, and differential programing in the tumor microenvironment. Front. Immunol. 5, 607 (2014).","journal-title":"Front. Immunol."},{"key":"1653_CR308","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1158\/0008-5472.CAN-13-0348","volume":"73","author":"J Ye","year":"2013","unstructured":"Ye, J. et al. Specific recruitment of gammadelta regulatory T cells in human breast cancer. Cancer Res. 73, 6137\u20136148 (2013).","journal-title":"Cancer Res."},{"key":"1653_CR309","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1080\/02770903.2021.1980585","volume":"59","author":"YE Yao","year":"2022","unstructured":"Yao, Y. E., Qin, C. C., Yang, C. M. & Huang, T. X. gammadeltaT17\/gammadeltaTreg cell subsets: a new paradigm for asthma treatment. J. Asthma 59, 2028\u20132038 (2022).","journal-title":"J. Asthma"},{"key":"1653_CR310","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/thno.47860","volume":"11","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. Tofacitinib restores the balance of gammadeltaTreg\/gammadeltaT17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome. Theranostics 11, 1446\u20131457 (2021).","journal-title":"Theranostics"},{"key":"1653_CR311","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1519-2","volume":"16","author":"L Xuan","year":"2018","unstructured":"Xuan, L. et al. Regulatory gammadelta T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation. J. Transl. Med. 16, 144 (2018).","journal-title":"J. Transl. Med."},{"key":"1653_CR312","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/cmi.2015.07","volume":"13","author":"Y Mao","year":"2016","unstructured":"Mao, Y. et al. A new effect of IL-4 on human gammadelta T cells: promoting regulatory Vdelta1 T cells via IL-10 production and inhibiting function of Vdelta2 T cells. Cell Mol. Immunol. 13, 217\u2013228 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR313","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-020-0129-7","volume":"5","author":"C Ni","year":"2020","unstructured":"Ni, C. et al. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+gammadelta1 Treg cells. Sig. Transduct. Target Ther. 5, 41 (2020).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR314","doi-asserted-by":"publisher","first-page":"e1277305","DOI":"10.1080\/2162402X.2016.1277305","volume":"6","author":"G Hu","year":"2017","unstructured":"Hu, G. et al. Tumor-infiltrating CD39(+)gammadeltaTregs are novel immunosuppressive T cells in human colorectal cancer. Oncoimmunology 6, e1277305 (2017).","journal-title":"Oncoimmunology"},{"key":"1653_CR315","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/JLB.3MA0420-278RR","volume":"107","author":"G Chabab","year":"2020","unstructured":"Chabab, G. et al. Identification of a regulatory Vdelta1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. J. Leukoc. Biol. 107, 1057\u20131067 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"1653_CR316","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.4049\/jimmunol.161.8.4138","volume":"161","author":"N Seo","year":"1998","unstructured":"Seo, N., Tokura, Y., Furukawa, F. & Takigawa, M. Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type gammadelta T and alphabeta T cells coinfiltrating in early B16 melanoma lesions. J. Immunol. 161, 4138\u20134145 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR317","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.2702","volume":"14","author":"N Schmolka","year":"2013","unstructured":"Schmolka, N. et al. Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory gammadelta T cell subsets. Nat. Immunol. 14, 1093\u20131100 (2013).","journal-title":"Nat. Immunol."},{"key":"1653_CR318","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2017.06.004","volume":"38","author":"G Chitadze","year":"2017","unstructured":"Chitadze, G., Oberg, H. H., Wesch, D. & Kabelitz, D. The ambiguous role of gammadelta T lymphocytes in antitumor immunity. Trends Immunol. 38, 668\u2013678 (2017).","journal-title":"Trends Immunol."},{"key":"1653_CR319","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.4049\/jimmunol.0901334","volume":"183","author":"R Casetti","year":"2009","unstructured":"Casetti, R. et al. Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation. J. Immunol. 183, 3574\u20133577 (2009).","journal-title":"J. Immunol."},{"key":"1653_CR320","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63572-w","volume":"10","author":"L Kouakanou","year":"2020","unstructured":"Kouakanou, L. et al. Vitamin C supports conversion of human gammadelta T cells into FOXP3-expressing regulatory cells by epigenetic regulation. Sci. Rep. 10, 6550 (2020).","journal-title":"Sci. Rep."},{"key":"1653_CR321","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/2326-6066.CIR-16-0348","volume":"5","author":"E Lo Presti","year":"2017","unstructured":"Lo Presti, E. et al. Squamous cell tumors recruit gammadelta T cells producing either IL17 or IFNgamma depending on the tumor stage. Cancer Immunol. Res. 5, 397\u2013407 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"1653_CR322","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cei.13436","volume":"201","author":"SK Sureshbabu","year":"2020","unstructured":"Sureshbabu, S. K., Chaukar, D. & Chiplunkar, S. V. Hypoxia regulates the differentiation and anti-tumor effector functions of gammadeltaT cells in oral cancer. Clin. Exp. Immunol. 201, 40\u201357 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"1653_CR323","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s43018-022-00376-z","volume":"3","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. A local human Vdelta1 T cell population is associated with survival in nonsmall-cell lung cancer. Nat. Cancer 3, 696\u2013709 (2022).","journal-title":"Nat. Cancer"},{"key":"1653_CR324","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1073\/pnas.1818488116","volume":"116","author":"G Pizzolato","year":"2019","unstructured":"Pizzolato, G. et al. Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVdelta1 and TCRVdelta2 gammadelta T lymphocytes. Proc. Natl Acad. Sci. USA 116, 11906\u201311915 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR325","doi-asserted-by":"publisher","first-page":"eaax9364","DOI":"10.1126\/scitranslmed.aax9364","volume":"11","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. An innate-like Vdelta1(+) gammadelta T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci. Transl. Med. 11, eaax9364 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1653_CR326","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4049\/jimmunol.173.3.1587","volume":"173","author":"ED Ponomarev","year":"2004","unstructured":"Ponomarev, E. D. et al. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 173, 1587\u20131595 (2004).","journal-title":"J. Immunol."},{"key":"1653_CR327","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1084\/jem.20130877","volume":"211","author":"HR Conti","year":"2014","unstructured":"Conti, H. R. et al. Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections. J. Exp. Med. 211, 2075\u20132084 (2014).","journal-title":"J. Exp. Med."},{"key":"1653_CR328","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.immuni.2010.10.014","volume":"33","author":"SG Park","year":"2010","unstructured":"Park, S. G. et al. T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T cells. Immunity 33, 791\u2013803 (2010).","journal-title":"Immunity"},{"key":"1653_CR329","doi-asserted-by":"publisher","first-page":"560","DOI":"10.4049\/jimmunol.0900241","volume":"183","author":"Y Cui","year":"2009","unstructured":"Cui, Y. et al. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 183, 560\u2013567 (2009).","journal-title":"J. Immunol."},{"key":"1653_CR330","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8687","volume":"6","author":"S Shibata","year":"2015","unstructured":"Shibata, S. et al. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gammadelta-T cells. Nat. Commun. 6, 7687 (2015).","journal-title":"Nat. Commun."},{"key":"1653_CR331","doi-asserted-by":"publisher","first-page":"e1347742","DOI":"10.1080\/2162402X.2017.1347742","volume":"6","author":"S Meraviglia","year":"2017","unstructured":"Meraviglia, S. et al. Distinctive features of tumor-infiltrating gammadelta T lymphocytes in human colorectal cancer. Oncoimmunology 6, e1347742 (2017).","journal-title":"Oncoimmunology"},{"key":"1653_CR332","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.4049\/jimmunol.1201892","volume":"189","author":"C Ma","year":"2012","unstructured":"Ma, C. et al. Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J. Immunol. 189, 5029\u20135036 (2012).","journal-title":"J. Immunol."},{"key":"1653_CR333","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.abj8695","volume":"377","author":"BS Reis","year":"2022","unstructured":"Reis, B. S. et al. TCR-Vgammadelta usage distinguishes protumor from antitumor intestinal gammadelta T cell subsets. Science 377, 276\u2013284 (2022).","journal-title":"Science"},{"key":"1653_CR334","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.trecan.2022.08.006","volume":"8","author":"S Mensurado","year":"2022","unstructured":"Mensurado, S. & Silva-Santos, B. Battle of the gammadelta T cell subsets in the gut. Trends Cancer 8, 881\u2013883 (2022).","journal-title":"Trends Cancer"},{"key":"1653_CR335","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29012-1","volume":"13","author":"N Zakeri","year":"2022","unstructured":"Zakeri, N. et al. Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma. Nat. Commun. 13, 1372 (2022).","journal-title":"Nat. Commun."},{"key":"1653_CR336","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3389\/fimmu.2018.02636","volume":"9","author":"C Khairallah","year":"2018","unstructured":"Khairallah, C., Chu, T. H. & Sheridan, B. S. Tissue adaptations of memory and tissue-resident gamma delta T cells. Front. Immunol. 9, 2636 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR337","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.3389\/fimmu.2018.02827","volume":"9","author":"K Steinbach","year":"2018","unstructured":"Steinbach, K., Vincenti, I. & Merkler, D. Resident-memory T cells in tissue-restricted immune responses: for better or worse? Front. Immunol. 9, 2827 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR338","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"1653_CR339","doi-asserted-by":"publisher","first-page":"e1284723","DOI":"10.1080\/2162402X.2017.1284723","volume":"6","author":"M Tosolini","year":"2017","unstructured":"Tosolini, M. et al. Assessment of tumor-infiltrating TCRVgamma9Vdelta2 gammadelta lymphocyte abundance by deconvolution of human cancers microarrays. Oncoimmunology 6, e1284723 (2017).","journal-title":"Oncoimmunology"},{"key":"1653_CR340","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ijc.30134","volume":"139","author":"RS Patil","year":"2016","unstructured":"Patil, R. S. et al. IL17 producing gammadeltaT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. Int. J. Cancer 139, 869\u2013881 (2016).","journal-title":"Int. J. Cancer"},{"key":"1653_CR341","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","volume":"27","author":"MR Rutkowski","year":"2015","unstructured":"Rutkowski, M. R. et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell 27, 27\u201340 (2015).","journal-title":"Cancer Cell"},{"key":"1653_CR342","doi-asserted-by":"crossref","first-page":"E9056","DOI":"10.1073\/pnas.1712883114","volume":"114","author":"D Van Hede","year":"2017","unstructured":"Van Hede, D. et al. Human papillomavirus oncoproteins induce a reorganization of epithelial-associated gammadelta T cells promoting tumor formation. Proc. Natl Acad. Sci. USA 114, E9056\u2013E9065 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR343","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin, C. et al. Commensal microbiota promote lung cancer development via gammadelta T cells. Cell. 176, 998\u20131013.e1016 (2019).","journal-title":"Cell."},{"key":"1653_CR344","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"1653_CR345","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.20100269","volume":"208","author":"Y Ma","year":"2011","unstructured":"Ma, Y. et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J. Exp. Med. 208, 491\u2013503 (2011).","journal-title":"J. Exp. Med."},{"key":"1653_CR346","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.4049\/jimmunol.181.5.3456","volume":"181","author":"S Hamada","year":"2008","unstructured":"Hamada, S. et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J. Immunol. 181, 3456\u20133463 (2008).","journal-title":"J. Immunol."},{"key":"1653_CR347","doi-asserted-by":"publisher","first-page":"112054","DOI":"10.1016\/j.celrep.2023.112054","volume":"42","author":"R Xu","year":"2023","unstructured":"Xu, R. et al. TNFR2(+) regulatory T cells protect against bacteremic pneumococcal pneumonia by suppressing IL-17A-producing gammadelta T cells in the lung. Cell Rep. 42, 112054 (2023).","journal-title":"Cell Rep."},{"key":"1653_CR348","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai, Y. et al. A critical role of the IL-1beta-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J. Invest. Dermatol. 139, 146\u2013156 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"1653_CR349","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.intimp.2013.01.022","volume":"16","author":"D Kabelitz","year":"2013","unstructured":"Kabelitz, D., Peters, C., Wesch, D. & Oberg, H. H. Regulatory functions of \u03b3\u03b4 T cells. Int. Immunopharmacol. 16, 382\u2013387 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"1653_CR350","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00018-018-2788-x","volume":"75","author":"C Peters","year":"2018","unstructured":"Peters, C., Kabelitz, D. & Wesch, D. Regulatory functions of \u03b3\u03b4 T cells. Cell Mol. Life Sci. 75, 2125\u20132135 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"1653_CR351","doi-asserted-by":"publisher","first-page":"12520","DOI":"10.1073\/pnas.1607136113","volume":"113","author":"C Peters","year":"2016","unstructured":"Peters, C., H\u00e4sler, R., Wesch, D. & Kabelitz, D. Human V\u03b42 T cells are a major source of interleukin-9. Proc. Natl Acad. Sci. USA 113, 12520\u201312525 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR352","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","volume":"71","author":"C Peters","year":"2014","unstructured":"Peters, C., Oberg, H. H., Kabelitz, D. & Wesch, D. Phenotype and regulation of immunosuppressive V\u03b42-expressing \u03b3\u03b4 T cells. Cell Mol. Life Sci. 71, 1943\u20131960 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"1653_CR353","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.4049\/jimmunol.1102654","volume":"188","author":"N Himoudi","year":"2012","unstructured":"Himoudi, N. et al. Human \u03b3\u03b4 T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J. Immunol. 188, 1708\u20131716 (2012).","journal-title":"J. Immunol."},{"key":"1653_CR354","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/cei\/uxab029","volume":"207","author":"XW Yang","year":"2022","unstructured":"Yang, X. W. et al. Impairment of antigen-presenting function of peripheral \u03b3\u03b4 T cells in patients with sepsis. Clin. Exp. Immunol. 207, 104\u2013112 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"1653_CR355","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi, S. WHO\u2019s Global Tuberculosis Report 2022. Lancet Microbe 4, e20 (2023).","journal-title":"Lancet Microbe"},{"key":"1653_CR356","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrmicro2387","volume":"8","author":"SM Behar","year":"2010","unstructured":"Behar, S. M., Divangahi, M. & Remold, H. G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol. 8, 668\u2013674 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"1653_CR357","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra, P., Grigsby, S. J. & Philips, J. A. Immune evasion and provocation by Mycobacterium tuberculosis. Nat. Rev. Microbiol. 20, 750\u2013766 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"1653_CR358","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cell.2010.02.030","volume":"140","author":"M Behr","year":"2010","unstructured":"Behr, M., Schurr, E. & Gros, P. TB: screening for responses to a vile visitor. Cell. 140, 615\u2013618 (2010).","journal-title":"Cell."},{"key":"1653_CR359","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrmicro2797","volume":"10","author":"C Lienhardt","year":"2012","unstructured":"Lienhardt, C. et al. Global tuberculosis control: lessons learnt and future prospects. Nat. Rev. Microbiol. 10, 407\u2013416 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"1653_CR360","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature12799","volume":"505","author":"CJ Cambier","year":"2014","unstructured":"Cambier, C. J. et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505, 218\u2013222 (2014).","journal-title":"Nature"},{"key":"1653_CR361","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-pathol-011811-132458","volume":"7","author":"JA Philips","year":"2012","unstructured":"Philips, J. A. & Ernst, J. D. Tuberculosis pathogenesis and immunity. Annu. Rev. Pathol. 7, 353\u2013384 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"1653_CR362","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.cell.2014.11.024","volume":"159","author":"CJ Cambier","year":"2014","unstructured":"Cambier, C. J., Falkow, S. & Ramakrishnan, L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell 159, 1497\u20131509 (2014).","journal-title":"Cell"},{"key":"1653_CR363","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2010.02.012","volume":"140","author":"D Kumar","year":"2010","unstructured":"Kumar, D. et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140, 731\u2013743 (2010).","journal-title":"Cell"},{"key":"1653_CR364","doi-asserted-by":"publisher","first-page":"e121899","DOI":"10.1172\/jci.insight.121899","volume":"3","author":"CK Vorkas","year":"2018","unstructured":"Vorkas, C. K. et al. Mucosal-associated invariant and gammadelta T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight. 3, e121899 (2018).","journal-title":"JCI Insight."},{"key":"1653_CR365","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/JCI133119","volume":"130","author":"CA Kulicke","year":"2020","unstructured":"Kulicke, C. A., Lewinsohn, D. A. & Lewinsohn, D. M. Clonal enrichments of Vdelta2- gammadelta T cells in Mycobacterium tuberculosis-infected human lungs. J. Clin. Invest. 130, 68\u201370 (2020).","journal-title":"J. Clin. Invest."},{"key":"1653_CR366","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3389\/fimmu.2018.01346","volume":"9","author":"J Maertzdorf","year":"2018","unstructured":"Maertzdorf, J. et al. Mycobacterium tuberculosis invasion of the human lung: first contact. Front. Immunol. 9, 1346 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR367","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.3389\/fimmu.2019.02282","volume":"10","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Identification of the ligands of TCR\u03b3\u03b4 by screening the immune repertoire of \u03b3\u03b4T cells from patients with tuberculosis. Front. Immunol. 10, 2282 (2019).","journal-title":"Front. Immunol."},{"key":"1653_CR368","doi-asserted-by":"publisher","first-page":"e1007567","DOI":"10.1371\/journal.ppat.1007567","volume":"15","author":"MP D\u2019Souza","year":"2019","unstructured":"D\u2019Souza, M. P. et al. Casting a wider net: immunosurveillance by nonclassical MHC molecules. PLoS Pathog. 15, e1007567 (2019).","journal-title":"PLoS Pathog."},{"key":"1653_CR369","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/ni.2630","volume":"14","author":"I Van Rhijn","year":"2013","unstructured":"Van Rhijn, I. et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat. Immunol. 14, 706\u2013713 (2013).","journal-title":"Nat. Immunol."},{"key":"1653_CR370","doi-asserted-by":"publisher","first-page":"a018473","DOI":"10.1101\/cshperspect.a018473","volume":"4","author":"G De Libero","year":"2014","unstructured":"De Libero, G., Singhal, A., Lepore, M. & Mori, L. Nonclassical T cells and their antigens in tuberculosis. Cold Spring Harb. Perspect. Med. 4, a018473 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1653_CR371","doi-asserted-by":"publisher","first-page":"eaau6759","DOI":"10.1126\/sciimmunol.aau6759","volume":"3","author":"R Martinez-Barricarte","year":"2018","unstructured":"Martinez-Barricarte, R. et al. Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23. Sci. Immunol. 3, eaau6759 (2018).","journal-title":"Sci. Immunol."},{"key":"1653_CR372","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","volume":"8","author":"Q Philippot","year":"2023","unstructured":"Philippot, Q. et al. Human IL-23 is essential for IFN-gamma-dependent immunity to mycobacteria. Sci. Immunol. 8, eabq5204 (2023).","journal-title":"Sci. Immunol."},{"key":"1653_CR373","doi-asserted-by":"publisher","first-page":"e20220484","DOI":"10.1084\/jem.20220484","volume":"220","author":"M Ogishi","year":"2023","unstructured":"Ogishi, M. et al. Inherited human ITK deficiency impairs IFN-gamma immunity and underlies tuberculosis. J. Exp. Med. 220, e20220484 (2023).","journal-title":"J. Exp. Med."},{"key":"1653_CR374","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41591-021-01388-5","volume":"27","author":"M Ogishi","year":"2021","unstructured":"Ogishi, M. et al. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child. Nat. Med. 27, 1646\u20131654 (2021).","journal-title":"Nat. Med."},{"key":"1653_CR375","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.aaa4282","volume":"349","author":"S Okada","year":"2015","unstructured":"Okada, S. et al. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349, 606\u2013613 (2015).","journal-title":"Science"},{"key":"1653_CR376","doi-asserted-by":"publisher","first-page":"18638","DOI":"10.1073\/pnas.1922595117","volume":"117","author":"M Papadopoulou","year":"2020","unstructured":"Papadopoulou, M. et al. Fetal public Vgamma9Vdelta2 T cells expand and gain potent cytotoxic functions early after birth. Proc. Natl Acad. Sci. USA 117, 18638\u201318648 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR377","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4049\/jimmunol.161.2.1045","volume":"161","author":"DF Hoft","year":"1998","unstructured":"Hoft, D. F., Brown, R. M. & Roodman, S. T. Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161, 1045\u20131054 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR378","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coi.2016.06.005","volume":"42","author":"ZW Chen","year":"2016","unstructured":"Chen, Z. W. Protective immune responses of major Vgamma2Vdelta2 T-cell subset in M. tuberculosis infection. Curr. Opin. Immunol. 42, 105\u2013112 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"1653_CR379","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1073\/pnas.1811380116","volume":"116","author":"L Shen","year":"2019","unstructured":"Shen, L. et al. Immunization of Vgamma2Vdelta2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates. Proc. Natl Acad. Sci. USA 116, 6371\u20136378 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR380","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1126\/science.1068819","volume":"295","author":"Y Shen","year":"2002","unstructured":"Shen, Y. et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295, 2255\u20132258 (2002).","journal-title":"Science"},{"key":"1653_CR381","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/imr.12927","volume":"298","author":"L Shen","year":"2020","unstructured":"Shen, L. et al. Fast-acting gammadelta T-cell subpopulation and protective immunity against infections. Immunol. Rev. 298, 254\u2013263 (2020).","journal-title":"Immunol. Rev."},{"key":"1653_CR382","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.4049\/jimmunol.1602019","volume":"198","author":"A Qaqish","year":"2017","unstructured":"Qaqish, A. et al. Adoptive transfer of phosphoantigen-specific gammadelta T cell subset attenuates mycobacterium tuberculosis infection in nonhuman primates. J. Immunol. 198, 4753\u20134763 (2017).","journal-title":"J. Immunol."},{"key":"1653_CR383","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cmi.2012.46","volume":"10","author":"ZW Chen","year":"2013","unstructured":"Chen, Z. W. Multifunctional immune responses of HMBPP-specific Vgamma2Vdelta2 T cells in M. tuberculosis and other infections. Cell Mol. Immunol. 10, 58\u201364 (2013).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR384","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1080\/22221751.2022.2095930","volume":"11","author":"H Shen","year":"2022","unstructured":"Shen, H. et al. Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vgamma2Vdelta2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis(1). Emerg. Microbes Infect. 11, 1790\u20131805 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"1653_CR385","doi-asserted-by":"publisher","first-page":"e1003501","DOI":"10.1371\/journal.ppat.1003501","volume":"9","author":"CY Chen","year":"2013","unstructured":"Chen, C. Y. et al. Phosphoantigen\/IL2 expansion and differentiation of Vgamma2Vdelta2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog. 9, e1003501 (2013).","journal-title":"PLoS Pathog."},{"key":"1653_CR386","doi-asserted-by":"publisher","first-page":"eade3525","DOI":"10.1126\/sciimmunol.ade3525","volume":"8","author":"R Roy Chowdhury","year":"2023","unstructured":"Roy Chowdhury, R. et al. NK-like CD8(+) gammadelta T cells are expanded in persistent Mycobacterium tuberculosis infection. Sci. Immunol. 8, eade3525 (2023).","journal-title":"Sci. Immunol."},{"key":"1653_CR387","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","volume":"1","author":"SG Deeks","year":"2015","unstructured":"Deeks, S. G., Overbaugh, J., Phillips, A. & Buchbinder, S. HIV infection. Nat. Rev. Dis. Primers 1, 15035 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1653_CR388","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","volume":"6","author":"S Moir","year":"2011","unstructured":"Moir, S., Chun, T. W. & Fauci, A. S. Pathogenic mechanisms of HIV disease. Annu. Rev. Pathol. 6, 223\u2013248 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1653_CR389","doi-asserted-by":"publisher","first-page":"a017871","DOI":"10.1101\/cshperspect.a017871","volume":"5","author":"J Bruchfeld","year":"2015","unstructured":"Bruchfeld, J., Correia-Neves, M. & Kallenius, G. Tuberculosis and HIV coinfection. Cold Spring Harb. Perspect. Med. 5, a017871 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1653_CR390","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LCK Bell","year":"2018","unstructured":"Bell, L. C. K. & Noursadeghi, M. Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection. Nat. Rev. Microbiol. 16, 80\u201390 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"1653_CR391","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1086\/587107","volume":"46","author":"H Li","year":"2008","unstructured":"Li, H. et al. Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China. Clin. Infect. Dis. 46, 1466\u20131472 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"1653_CR392","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/eji.1830241219","volume":"24","author":"T Hinz","year":"1994","unstructured":"Hinz, T. et al. T cell receptor gamma delta repertoire in HIV-1-infected individuals. Eur. J. Immunol. 24, 3044\u20133049 (1994).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR393","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/cmi.2014.77","volume":"12","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Distortion of memory Vdelta2 gammadelta T cells contributes to immune dysfunction in chronic HIV infection. Cell Mol. Immunol. 12, 604\u2013614 (2015).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR394","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1365-2141.1998.00630.x","volume":"100","author":"R Rossol","year":"1998","unstructured":"Rossol, R. et al. Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections. Br. J. Haematol. 100, 728\u2013734 (1998).","journal-title":"Br. J. Haematol."},{"key":"1653_CR395","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2010-05-283549","volume":"116","author":"LD Harris","year":"2010","unstructured":"Harris, L. D. et al. Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 116, 4148\u20134157 (2010).","journal-title":"Blood"},{"key":"1653_CR396","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1182\/blood-2012-03-420117","volume":"120","author":"H Li","year":"2012","unstructured":"Li, H. & Pauza, C. D. The alpha4beta7 integrin binds HIV envelope but does not mediate bystander killing of gammadelta T cells. Blood 120, 698\u2013699 (2012).","journal-title":"Blood"},{"key":"1653_CR397","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/jmv.23447","volume":"85","author":"C Restrepo","year":"2013","unstructured":"Restrepo, C. et al. HIV Gag-specific immune response mediated by double negative (CD3(+)CD4(-)CD8(-)) T cells in HIV-exposed seronegative individuals. J. Med. Virol. 85, 200\u2013209 (2013).","journal-title":"J. Med. Virol."},{"key":"1653_CR398","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1182\/blood-2011-11-390153","volume":"119","author":"K Hudspeth","year":"2012","unstructured":"Hudspeth, K. et al. Engagement of NKp30 on Vdelta1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood 119, 4013\u20134016 (2012).","journal-title":"Blood"},{"key":"1653_CR399","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1046\/j.1365-2141.2002.03555.x","volume":"118","author":"TS Dobmeyer","year":"2002","unstructured":"Dobmeyer, T. S. et al. Reciprocal alterations of Th1\/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients. Br. J. Haematol. 118, 282\u2013288 (2002).","journal-title":"Br. J. Haematol."},{"key":"1653_CR400","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/cmi.2012.50","volume":"10","author":"H Li","year":"2013","unstructured":"Li, H. et al. Depletion and dysfunction of Vgamma2Vdelta2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol. Immunol. 10, 42\u201349 (2013).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR401","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1086\/342410","volume":"186","author":"F Martini","year":"2002","unstructured":"Martini, F. et al. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption. J. Infect. Dis. 186, 847\u2013850 (2002).","journal-title":"J. Infect. Dis."},{"key":"1653_CR402","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/14653249.2011.623693","volume":"14","author":"B Poonia","year":"2012","unstructured":"Poonia, B. & Pauza, C. D. Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate\/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. Cytotherapy 14, 173\u2013181 (2012).","journal-title":"Cytotherapy"},{"key":"1653_CR403","doi-asserted-by":"publisher","first-page":"e120121","DOI":"10.1172\/jci.insight.120121","volume":"3","author":"C Garrido","year":"2018","unstructured":"Garrido, C. et al. Gammadelta T cells: an immunotherapeutic approach for HIV cure strategies. JCI Insight. 3, e120121 (2018).","journal-title":"JCI Insight."},{"key":"1653_CR404","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41591-020-0799-2","volume":"26","author":"SW Kazer","year":"2020","unstructured":"Kazer, S. W. et al. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection. Nat. Med. 26, 511\u2013518 (2020).","journal-title":"Nat. Med."},{"key":"1653_CR405","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1080\/22221751.2020.1826361","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg. Microbes Infect. 9, 2333\u20132347 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"1653_CR406","first-page":"687","volume":"5","author":"CD Pauza","year":"2014","unstructured":"Pauza, C. D. et al. gammadelta T cells in HIV disease: past, present, and future. Front. Immunol. 5, 687 (2014).","journal-title":"Front. Immunol."},{"key":"1653_CR407","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJMp2213920","volume":"388","author":"WM El-Sadr","year":"2023","unstructured":"El-Sadr, W. M., Vasan, A. & El-Mohandes, A. Facing the new Covid-19 reality. N. Engl. J. Med. 388, 385\u2013387 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR408","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019Kovski","year":"2021","unstructured":"V\u2019Kovski, P. et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1653_CR409","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR410","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1126\/science.abi9745","volume":"373","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science 373, 642\u2013648 (2021).","journal-title":"Science"},{"key":"1653_CR411","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.adc9448","volume":"376","author":"G Vogel","year":"2022","unstructured":"Vogel, G. New subvariants are masters of immune evasion. Science 376, 679\u2013680 (2022).","journal-title":"Science"},{"key":"1653_CR412","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41586-021-04352-y","volume":"602","author":"LG Thorne","year":"2022","unstructured":"Thorne, L. G. et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature 602, 487\u2013495 (2022).","journal-title":"Nature"},{"key":"1653_CR413","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","volume":"186","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186, 279\u2013286.e278 (2023).","journal-title":"Cell"},{"key":"1653_CR414","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The signal pathways and treatment of cytokine storm in COVID-19. Sig. Transduct. Target Ther. 6, 255 (2021).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR415","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR416","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s41591-021-01500-9","volume":"27","author":"RQ Cron","year":"2021","unstructured":"Cron, R. Q., Caricchio, R. & Chatham, W. W. Calming the cytokine storm in COVID-19. Nat. Med. 27, 1674\u20131675 (2021).","journal-title":"Nat. Med."},{"key":"1653_CR417","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","volume":"26","author":"MJ Carter","year":"2020","unstructured":"Carter, M. J. et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat. Med. 26, 1701\u20131707 (2020).","journal-title":"Nat. Med."},{"key":"1653_CR418","doi-asserted-by":"publisher","first-page":"102885","DOI":"10.1016\/j.ebiom.2020.102885","volume":"57","author":"I Odak","year":"2020","unstructured":"Odak, I. et al. Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine 57, 102885 (2020).","journal-title":"EBioMedicine"},{"key":"1653_CR419","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"1653_CR420","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"1653_CR421","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s42003-022-04310-y","volume":"5","author":"AC Fears","year":"2022","unstructured":"Fears, A. C. et al. The dynamics of gammadelta T cell responses in nonhuman primates during SARS-CoV-2 infection. Commun. Biol. 5, 1380 (2022).","journal-title":"Commun. Biol."},{"key":"1653_CR422","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22242-9","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Host-derived lipids orchestrate pulmonary gammadelta T cell response to provide early protection against influenza virus infection. Nat. Commun. 12, 1914 (2021).","journal-title":"Nat. Commun."},{"key":"1653_CR423","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-Omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495.e1420 (2020).","journal-title":"Cell"},{"key":"1653_CR424","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41392-021-00526-2","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Dynamic blood single-cell immune responses in patients with COVID-19. Sig. Transduct. Target Ther. 6, 110 (2021).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR425","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e1819 (2021).","journal-title":"Cell"},{"key":"1653_CR426","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1084\/jem.20181960","volume":"215","author":"JM Jameson","year":"2018","unstructured":"Jameson, J. M. gammadelta T cells: a disappearing act with a big reveal. J. Exp. Med. 215, 2962\u20132963 (2018).","journal-title":"J. Exp. Med."},{"key":"1653_CR427","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1084\/jem.20181439","volume":"215","author":"I Sandrock","year":"2018","unstructured":"Sandrock, I. et al. Genetic models reveal origin, persistence and non-redundant functions of IL-17-producing gammadelta T cells. J. Exp. Med. 215, 3006\u20133018 (2018).","journal-title":"J. Exp. Med."},{"key":"1653_CR428","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12913","volume":"298","author":"MH Jee","year":"2020","unstructured":"Jee, M. H., Mraz, V., Geisler, C. & Bonefeld, C. M. gammadelta T cells and inflammatory skin diseases. Immunol. Rev. 298, 61\u201373 (2020).","journal-title":"Immunol. Rev."},{"key":"1653_CR429","doi-asserted-by":"publisher","first-page":"621956","DOI":"10.3389\/fimmu.2021.621956","volume":"12","author":"H Bugaut","year":"2021","unstructured":"Bugaut, H. & Aractingi, S. Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies. Front. Immunol. 12, 621956 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR430","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jaci.2022.12.823","volume":"151","author":"SH Kim","year":"2023","unstructured":"Kim, S. H. et al. Pellino-1 promotes intrinsic activation of skin-resident IL-17A-producing T cells in psoriasis. J. Allergy Clin. Immunol. 151, 1317\u20131328 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1653_CR431","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaci.2018.01.054","volume":"142","author":"Y Ueharaguchi","year":"2018","unstructured":"Ueharaguchi, Y. et al. Thromboxane A(2) facilitates IL-17A production from Vgamma4(+) gammadelta T cells and promotes psoriatic dermatitis in mice. J. Allergy Clin. Immunol. 142, 680\u2013683.e682 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1653_CR432","doi-asserted-by":"publisher","first-page":"eaao1685","DOI":"10.1126\/scisignal.aao1685","volume":"11","author":"T Zheng","year":"2018","unstructured":"Zheng, T. et al. p38alpha signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation. Sci. Signal. 11, eaao1685 (2018).","journal-title":"Sci. Signal."},{"key":"1653_CR433","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3504","volume":"17","author":"D Cibrian","year":"2016","unstructured":"Cibrian, D. et al. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat. Immunol. 17, 985\u2013996 (2016).","journal-title":"Nat. Immunol."},{"key":"1653_CR434","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/s41418-020-0500-9","volume":"27","author":"Q Yang","year":"2020","unstructured":"Yang, Q. et al. Roles of mTORC1 and mTORC2 in controlling gammadelta T1 and gammadelta T17 differentiation and function. Cell Death Differ. 27, 2248\u20132262 (2020).","journal-title":"Cell Death Differ."},{"key":"1653_CR435","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.celrep.2019.05.019","volume":"27","author":"Y Cai","year":"2019","unstructured":"Cai, Y. et al. Differential roles of the mTOR-STAT3 signaling in dermal gammadelta T cell effector function in skin inflammation. Cell Rep. 27, 3034\u20133048.e3035 (2019).","journal-title":"Cell Rep."},{"key":"1653_CR436","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1073\/pnas.1508990112","volume":"112","author":"F Ramirez-Valle","year":"2015","unstructured":"Ramirez-Valle, F., Gray, E. E. & Cyster, J. G. Inflammation induces dermal Vgamma4+ gammadeltaT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses. Proc. Natl Acad. Sci. USA 112, 8046\u20138051 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR437","doi-asserted-by":"publisher","first-page":"104136","DOI":"10.1016\/j.ebiom.2022.104136","volume":"82","author":"N Liu","year":"2022","unstructured":"Liu, N. et al. Dynamic trafficking patterns of IL-17-producing gammadelta T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitis. EBioMedicine 82, 104136 (2022).","journal-title":"EBioMedicine"},{"key":"1653_CR438","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/art.42124","volume":"74","author":"CT Nguyen","year":"2022","unstructured":"Nguyen, C. T. et al. Peripheral gammadelta T cells regulate neutrophil expansion and recruitment in experimental psoriatic arthritis. Arthritis Rheumatol. 74, 1524\u20131534 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1653_CR439","doi-asserted-by":"publisher","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","volume":"111","author":"I Khmaladze","year":"2014","unstructured":"Khmaladze, I. et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc. Natl Acad. Sci. USA 111, E3669\u2013E3678 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR440","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature13199","volume":"510","author":"L Riol-Blanco","year":"2014","unstructured":"Riol-Blanco, L. et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 510, 157\u2013161 (2014).","journal-title":"Nature"},{"key":"1653_CR441","doi-asserted-by":"publisher","first-page":"102435","DOI":"10.1016\/j.jaut.2020.102435","volume":"111","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Selective targeting of PI3Kdelta suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. J. Autoimmun. 111, 102435 (2020).","journal-title":"J. Autoimmun."},{"key":"1653_CR442","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.jid.2020.03.973","volume":"140","author":"GV Pinget","year":"2020","unstructured":"Pinget, G. V. et al. Immune modulation of monocytes dampens the IL-17(+) gammadelta T cell response and associated psoriasis pathology in mice. J. Invest. Dermatol. 140, 2398\u20132407.e2391 (2020).","journal-title":"J. Invest. Dermatol."},{"key":"1653_CR443","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1111\/bph.15077","volume":"177","author":"BDS Soley","year":"2020","unstructured":"Soley, B. D. S. et al. B(1) and B(2) kinin receptor blockade improves psoriasis-like disease. Br. J. Pharmacol. 177, 3535\u20133551 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"1653_CR444","doi-asserted-by":"publisher","first-page":"635076","DOI":"10.3389\/fimmu.2021.635076","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Hyperforin ameliorates imiquimod-induced psoriasis-like murine skin inflammation by modulating IL-17A-producing gammadelta T cells. Front. Immunol. 12, 635076 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR445","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1093\/rheumatology\/kead022","volume":"62","author":"C Mortier","year":"2023","unstructured":"Mortier, C. et al. RORgammat inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating gammadelta-T cells. Rheumatology (Oxford) 62, 3169\u20133178 (2023).","journal-title":"Rheumatology (Oxford)"},{"key":"1653_CR446","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","volume":"145","author":"D Cibrian","year":"2020","unstructured":"Cibrian, D. et al. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation. J. Allergy Clin. Immunol. 145, 199\u2013214.e111 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1653_CR447","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.celrep.2019.03.082","volume":"27","author":"Y Han","year":"2019","unstructured":"Han, Y. et al. IL-38 ameliorates skin inflammation and limits IL-17 production from gammadelta T cells. Cell Rep. 27, 835\u2013846.e835 (2019).","journal-title":"Cell Rep."},{"key":"1653_CR448","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1073\/pnas.1704958114","volume":"114","author":"AE Getschman","year":"2017","unstructured":"Getschman, A. E. et al. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model. Proc. Natl Acad. Sci. USA 114, 12460\u201312465 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR449","doi-asserted-by":"publisher","first-page":"993057","DOI":"10.3389\/fimmu.2023.993057","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review. Front. Immunol. 14, 993057 (2023).","journal-title":"Front. Immunol."},{"key":"1653_CR450","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/CCID.S67534","volume":"7","author":"AS Lonnberg","year":"2014","unstructured":"Lonnberg, A. S., Zachariae, C. & Skov, L. Targeting of interleukin-17 in the treatment of psoriasis. Clin. Cosmet Investig. Dermatol. 7, 251\u2013259 (2014).","journal-title":"Clin. Cosmet Investig. Dermatol."},{"key":"1653_CR451","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjd.15015","volume":"177","author":"DM Saunte","year":"2017","unstructured":"Saunte, D. M., Mrowietz, U., Puig, L. & Zachariae, C. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management. Br. J. Dermatol. 177, 47\u201362 (2017).","journal-title":"Br. J. Dermatol."},{"key":"1653_CR452","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jid.2020.01.020","volume":"140","author":"Z Shi","year":"2020","unstructured":"Shi, Z. et al. Short-term exposure to a western diet induces psoriasiform dermatitis by promoting accumulation of IL-17A-producing gammadelta T cells. J. Invest. Dermatol. 140, 1815\u20131823 (2020).","journal-title":"J. Invest. Dermatol."},{"key":"1653_CR453","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14292-1","volume":"7","author":"S Nakamizo","year":"2017","unstructured":"Nakamizo, S. et al. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing gammadelta T cells. Sci. Rep. 7, 14076 (2017).","journal-title":"Sci. Rep."},{"key":"1653_CR454","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","volume":"592","author":"P Bielecki","year":"2021","unstructured":"Bielecki, P. et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature 592, 128\u2013132 (2021).","journal-title":"Nature"},{"key":"1653_CR455","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","volume":"148","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J. Allergy Clin. Immunol. 148, 1281\u20131292 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1653_CR456","doi-asserted-by":"publisher","first-page":"eaba6500","DOI":"10.1126\/science.aba6500","volume":"371","author":"G Reynolds","year":"2021","unstructured":"Reynolds, G. et al. Developmental cell programs are co-opted in inflammatory skin disease. Science 371, eaba6500 (2021).","journal-title":"Science"},{"key":"1653_CR457","doi-asserted-by":"publisher","first-page":"eabl9165","DOI":"10.1126\/sciimmunol.abl9165","volume":"7","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Classification of human chronic inflammatory skin disease based on single-cell immune profiling. Sci. Immunol. 7, eabl9165 (2022).","journal-title":"Sci. Immunol."},{"key":"1653_CR458","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0016-5085(91)90524-O","volume":"101","author":"K Fukushima","year":"1991","unstructured":"Fukushima, K. et al. Immunohistochemical characterization, distribution, and ultrastructure of lymphocytes bearing T-cell receptor gamma\/delta in inflammatory bowel disease. Gastroenterology 101, 670\u2013678 (1991).","journal-title":"Gastroenterology"},{"key":"1653_CR459","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/ecco-jcc\/jjx039","volume":"11","author":"I Catalan-Serra","year":"2017","unstructured":"Catalan-Serra, I., Sandvik, A. K., Bruland, T. & Andreu-Ballester, J. C. Gammadelta T cells in Crohn\u2019s disease: a new player in the disease pathogenesis? J. Crohns Colitis 11, 1135\u20131145 (2017).","journal-title":"J. Crohns Colitis"},{"key":"1653_CR460","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/gut.47.2.215","volume":"47","author":"MM Yeung","year":"2000","unstructured":"Yeung, M. M. et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut 47, 215\u2013227 (2000).","journal-title":"Gut"},{"key":"1653_CR461","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF03401672","volume":"3","author":"LD McVay","year":"1997","unstructured":"McVay, L. D. et al. Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol. Med. 3, 183\u2013203 (1997).","journal-title":"Mol. Med."},{"key":"1653_CR462","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/gut.48.4.489","volume":"48","author":"JC Hoffmann","year":"2001","unstructured":"Hoffmann, J. C. et al. Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion. Gut 48, 489\u2013495 (2001).","journal-title":"Gut"},{"key":"1653_CR463","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4049\/jimmunol.173.2.1390","volume":"173","author":"K Inagaki-Ohara","year":"2004","unstructured":"Inagaki-Ohara, K. et al. Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J. Immunol. 173, 1390\u20131398 (2004).","journal-title":"J. Immunol."},{"key":"1653_CR464","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1073\/pnas.212290499","volume":"99","author":"Y Chen","year":"2002","unstructured":"Chen, Y. et al. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc. Natl Acad. Sci. USA 99, 14338\u201314343 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR465","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.4049\/jimmunol.171.10.5507","volume":"171","author":"T Tsuchiya","year":"2003","unstructured":"Tsuchiya, T. et al. Role of gamma delta T cells in the inflammatory response of experimental colitis mice. J. Immunol. 171, 5507\u20135513 (2003).","journal-title":"J. Immunol."},{"key":"1653_CR466","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41586-022-05259-y","volume":"610","author":"Y Matsuzawa-Ishimoto","year":"2022","unstructured":"Matsuzawa-Ishimoto, Y. et al. The gammadelta IEL effector API5 masks genetic susceptibility to Paneth cell death. Nature 610, 547\u2013554 (2022).","journal-title":"Nature"},{"key":"1653_CR467","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.4049\/jimmunol.1601146","volume":"197","author":"M Kadivar","year":"2016","unstructured":"Kadivar, M., Petersson, J., Svensson, L. & Marsal, J. CD8alphabeta+ gammadelta T cells: a novel T cell subset with a potential role in inflammatory bowel disease. J. Immunol. 197, 4584\u20134592 (2016).","journal-title":"J. Immunol."},{"key":"1653_CR468","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2007.11.056","volume":"134","author":"M Nanno","year":"2008","unstructured":"Nanno, M. et al. Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology 134, 481\u2013490 (2008).","journal-title":"Gastroenterology"},{"key":"1653_CR469","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1053\/j.gastro.2021.11.028","volume":"162","author":"MD Hu","year":"2022","unstructured":"Hu, M. D. et al. gammadelta intraepithelial lymphocytes facilitate pathological epithelial cell shedding via CD103-mediated granzyme release. Gastroenterology 162, 877\u2013889.e877 (2022).","journal-title":"Gastroenterology"},{"key":"1653_CR470","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41564-021-00948-2","volume":"6","author":"PH Papotto","year":"2021","unstructured":"Papotto, P. H., Yilmaz, B. & Silva-Santos, B. Crosstalk between gammadelta T cells and the microbiota. Nat. Microbiol. 6, 1110\u20131117 (2021).","journal-title":"Nat. Microbiol."},{"key":"1653_CR471","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nm.4068","volume":"22","author":"C Benakis","year":"2016","unstructured":"Benakis, C. et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat. Med. 22, 516\u2013523 (2016).","journal-title":"Nat. Med."},{"key":"1653_CR472","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1053\/j.gastro.2018.02.019","volume":"154","author":"D Tedesco","year":"2018","unstructured":"Tedesco, D. et al. Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic gammadelta T-cell receptor-positive cells and pathogenesis of cholestatic liver disease. Gastroenterology 154, 2178\u20132193 (2018).","journal-title":"Gastroenterology"},{"key":"1653_CR473","doi-asserted-by":"publisher","first-page":"109332","DOI":"10.1016\/j.celrep.2021.109332","volume":"36","author":"L Dupraz","year":"2021","unstructured":"Dupraz, L. et al. Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal gammadelta T cells. Cell Rep. 36, 109332 (2021).","journal-title":"Cell Rep."},{"key":"1653_CR474","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S2468-1253(16)30111-X","volume":"2","author":"MU Mirkov","year":"2017","unstructured":"Mirkov, M. U., Verstockt, B. & Cleynen, I. Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol. Hepatol. 2, 224\u2013234 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1653_CR475","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","volume":"387","author":"I Cleynen","year":"2016","unstructured":"Cleynen, I. et al. Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387, 156\u2013167 (2016).","journal-title":"Lancet"},{"key":"1653_CR476","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(09)61576-2","volume":"374","author":"F Coulombe","year":"2009","unstructured":"Coulombe, F. & Behr, M. A. Crohn\u2019s disease as an immune deficiency? Lancet 374, 769\u2013770 (2009).","journal-title":"Lancet"},{"key":"1653_CR477","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411, 599\u2013603 (2001).","journal-title":"Nature"},{"key":"1653_CR478","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411, 603\u2013606 (2001).","journal-title":"Nature"},{"key":"1653_CR479","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","volume":"359","author":"J Hampe","year":"2002","unstructured":"Hampe, J. et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn\u2019s disease: a cohort study. Lancet 359, 1661\u20131665 (2002).","journal-title":"Lancet"},{"key":"1653_CR480","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)66582-8","volume":"365","author":"DA van Heel","year":"2005","unstructured":"van Heel, D. A. et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn\u2019s disease. Lancet 365, 1794\u20131796 (2005).","journal-title":"Lancet"},{"key":"1653_CR481","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1084\/jem.20122490","volume":"210","author":"W Jiang","year":"2013","unstructured":"Jiang, W. et al. Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes. J. Exp. Med. 210, 2465\u20132476 (2013).","journal-title":"J. Exp. Med."},{"key":"1653_CR482","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2014.06.015","volume":"41","author":"D Ramanan","year":"2014","unstructured":"Ramanan, D. et al. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity. 41, 311\u2013324 (2014).","journal-title":"Immunity."},{"key":"1653_CR483","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1073\/pnas.0907722106","volume":"106","author":"T Petnicki-Ocwieja","year":"2009","unstructured":"Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl Acad. Sci. USA 106, 15813\u201315818 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR484","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e722 (2019).","journal-title":"Cell"},{"key":"1653_CR485","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"178","author":"JC Martin","year":"2019","unstructured":"Martin, J. C. et al. Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell 178, 1493\u20131508.e1420 (2019).","journal-title":"Cell"},{"key":"1653_CR486","doi-asserted-by":"publisher","first-page":"eabb4432","DOI":"10.1126\/sciimmunol.abb4432","volume":"5","author":"BS Boland","year":"2020","unstructured":"Boland, B. S. et al. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci. Immunol. 5, eabb4432 (2020).","journal-title":"Sci. Immunol."},{"key":"1653_CR487","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-019-0992-y","volume":"567","author":"K Parikh","year":"2019","unstructured":"Parikh, K. et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature 567, 49\u201355 (2019).","journal-title":"Nature"},{"key":"1653_CR488","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","volume":"159","author":"V Mitsialis","year":"2020","unstructured":"Mitsialis, V. et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease. Gastroenterology 159, 591\u2013608.e510 (2020).","journal-title":"Gastroenterology"},{"key":"1653_CR489","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield, K. E. et al. The immunology of multiple sclerosis. Nat. Rev. Immunol. 22, 734\u2013750 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR490","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou, C. A., Fugger, L. & Friese, M. A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15, 545\u2013558 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR491","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1653_CR492","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","volume":"186","author":"M Charabati","year":"2023","unstructured":"Charabati, M., Wheeler, M. A., Weiner, H. L. & Quintana, F. J. Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting. Cell 186, 1309\u20131327 (2023).","journal-title":"Cell"},{"key":"1653_CR493","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu, C. S., Farooqi, N., O\u2019Brien, K. & Gran, B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079\u20131106 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"1653_CR494","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.4049\/jimmunol.149.4.1444","volume":"149","author":"RA Sobel","year":"1992","unstructured":"Sobel, R. A. & Kuchroo, V. K. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J. Immunol. 149, 1444\u20131451 (1992).","journal-title":"J. Immunol."},{"key":"1653_CR495","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1084\/jem.175.4.993","volume":"175","author":"KW Wucherpfennig","year":"1992","unstructured":"Wucherpfennig, K. W. et al. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 175, 993\u20131002 (1992).","journal-title":"J. Exp. Med."},{"key":"1653_CR496","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0165-5728(93)90253-U","volume":"46","author":"J Hvas","year":"1993","unstructured":"Hvas, J. et al. Gamma delta T cell receptor repertoire in brain lesions of patients with multiple sclerosis. J. Neuroimmunol. 46, 225\u2013234 (1993).","journal-title":"J. Neuroimmunol."},{"key":"1653_CR497","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.4049\/jimmunol.154.9.4883","volume":"154","author":"P Stinissen","year":"1995","unstructured":"Stinissen, P. et al. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. J. Immunol. 154, 4883\u20134894 (1995).","journal-title":"J. Immunol."},{"key":"1653_CR498","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/jaut.2001.0547","volume":"17","author":"YL Gao","year":"2001","unstructured":"Gao, Y. L., Rajan, A. J., Raine, C. S. & Brosnan, C. F. gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis. J. Autoimmun. 17, 261\u2013271 (2001).","journal-title":"J. Autoimmun."},{"key":"1653_CR499","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/jaut.1998.0263","volume":"12","author":"MA Jensen","year":"1999","unstructured":"Jensen, M. A., Dayal, A. & Arnason, B. G. Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis. J. Autoimmun. 12, 73\u201380 (1999).","journal-title":"J. Autoimmun."},{"key":"1653_CR500","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.4049\/jimmunol.174.8.4678","volume":"174","author":"ED Ponomarev","year":"2005","unstructured":"Ponomarev, E. D. & Dittel, B. N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 174, 4678\u20134687 (2005).","journal-title":"J. Immunol."},{"key":"1653_CR501","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/156652409787314516","volume":"9","author":"SE Blink","year":"2009","unstructured":"Blink, S. E. & Miller, S. D. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr. Mol. Med. 9, 15\u201322 (2009).","journal-title":"Curr. Mol. Med."},{"key":"1653_CR502","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cellimm.2014.04.013","volume":"290","author":"SE Blink","year":"2014","unstructured":"Blink, S. E. et al. gammadelta T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cell Immunol. 290, 39\u201351 (2014).","journal-title":"Cell Immunol."},{"key":"1653_CR503","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41423-019-0221-5","volume":"16","author":"L Van Kaer","year":"2019","unstructured":"Van Kaer, L. et al. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Cell Mol. Immunol. 16, 531\u2013539 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR504","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.4049\/jimmunol.160.12.5955","volume":"160","author":"AJ Rajan","year":"1998","unstructured":"Rajan, A. J., Klein, J. D. & Brosnan, C. F. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. J. Immunol. 160, 5955\u20135962 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR505","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4049\/jimmunol.157.2.941","volume":"157","author":"AJ Rajan","year":"1996","unstructured":"Rajan, A. J., Gao, Y. L., Raine, C. S. & Brosnan, C. F. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 157, 941\u2013949 (1996).","journal-title":"J. Immunol."},{"key":"1653_CR506","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S","volume":"29","author":"TW Spahn","year":"1999","unstructured":"Spahn, T. W., Issazadah, S., Salvin, A. J. & Weiner, H. L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur. J. Immunol. 29, 4060\u20134071 (1999).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR507","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4049\/jimmunol.173.1.682","volume":"173","author":"A Odyniec","year":"2004","unstructured":"Odyniec, A. et al. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production. J. Immunol. 173, 682\u2013694 (2004).","journal-title":"J. Immunol."},{"key":"1653_CR508","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano, A. J. et al. Unexpected role of interferon-gamma in regulating neuronal connectivity and social behaviour. Nature 535, 425\u2013429 (2016).","journal-title":"Nature"},{"key":"1653_CR509","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","volume":"21","author":"K Alves de Lima","year":"2020","unstructured":"Alves de Lima, K. et al. Meningeal gammadelta T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat. Immunol. 21, 1421\u20131429 (2020).","journal-title":"Nat. Immunol."},{"key":"1653_CR510","doi-asserted-by":"publisher","first-page":"eaay5199","DOI":"10.1126\/sciimmunol.aay5199","volume":"4","author":"M Ribeiro","year":"2019","unstructured":"Ribeiro, M. et al. Meningeal gammadelta T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci. Immunol. 4, eaay5199 (2019).","journal-title":"Sci. Immunol."},{"key":"1653_CR511","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.immuni.2020.01.002","volume":"52","author":"AM McGinley","year":"2020","unstructured":"McGinley, A. M. et al. Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1beta-producing myeloid cells that promote pathogenic T cells. Immunity 52, 342\u2013356.e346 (2020).","journal-title":"Immunity"},{"key":"1653_CR512","doi-asserted-by":"publisher","first-page":"623451","DOI":"10.3389\/fimmu.2021.623451","volume":"12","author":"S Ren","year":"2021","unstructured":"Ren, S. et al. Lactobacillus acidipiscis induced regulatory gamma delta T cells and attenuated experimental autoimmune encephalomyelitis. Front. Immunol. 12, 623451 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR513","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41577-023-00876-8","volume":"23","author":"A Flemming","year":"2023","unstructured":"Flemming, A. Dectin-1 on colonic gammadelta T cells mediates vulnerability to psychosocial stress. Nat. Rev. Immunol. 23, 271 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR514","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/jpm13030422","volume":"13","author":"MS Popoviciu","year":"2023","unstructured":"Popoviciu, M. S. et al. Type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine. J. Pers. Med. 13, 422 (2023).","journal-title":"J. Pers. Med."},{"key":"1653_CR515","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese, A. Autoreactive T cells in type 1 diabetes. J. Clin. Invest. 127, 2881\u20132891 (2017).","journal-title":"J. Clin. Invest."},{"key":"1653_CR516","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4049\/jimmunol.1002630","volume":"186","author":"N Feng","year":"2011","unstructured":"Feng, N., Vegh, P., Rothenberg, E. V. & Yui, M. A. Lineage divergence at the first TCR-dependent checkpoint: preferential \u03b3\u03b4 and impaired \u03b1\u03b2 T cell development in nonobese diabetic mice. J. Immunol. 186, 826\u2013837 (2011).","journal-title":"J. Immunol."},{"key":"1653_CR517","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/jaut.1997.0129","volume":"10","author":"DI Godfrey","year":"1997","unstructured":"Godfrey, D. I., Kinder, S. J., Silvera, P. & Baxter, A. G. Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes. J. Autoimmun. 10, 279\u2013285 (1997).","journal-title":"J. Autoimmun."},{"key":"1653_CR518","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1084\/jem.20112593","volume":"209","author":"M Mingueneau","year":"2012","unstructured":"Mingueneau, M. et al. Thymic negative selection is functional in NOD mice. J. Exp. Med. 209, 623\u2013637 (2012).","journal-title":"J. Exp. Med."},{"key":"1653_CR519","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jaut.2009.12.008","volume":"34","author":"L Zhang","year":"2010","unstructured":"Zhang, L. et al. Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9-23. J. Autoimmun. 34, 478\u2013484 (2010).","journal-title":"J. Autoimmun."},{"key":"1653_CR520","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0165-2478(99)00066-8","volume":"68","author":"A Kretowski","year":"1999","unstructured":"Kretowski, A. et al. Gammadelta T-cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B-cells impairment. Immunol. Lett. 68, 289\u2013293 (1999).","journal-title":"Immunol. Lett."},{"key":"1653_CR521","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/jaut.1993.1009","volume":"6","author":"FP Lang","year":"1993","unstructured":"Lang, F. P. et al. The temporal association between gamma delta T cells and the natural history of insulin-dependent diabetes. J. Autoimmun. 6, 107\u2013119 (1993).","journal-title":"J. Autoimmun."},{"key":"1653_CR522","doi-asserted-by":"publisher","first-page":"665","DOI":"10.17219\/acem\/60714","volume":"25","author":"A Zubkiewicz-Kucharska","year":"2016","unstructured":"Zubkiewicz-Kucharska, A. & Noczy\u0144ska, A. Abnormal distribution of gamma-delta T lymphocytes and their subsets in type 1 diabetes. Adv. Clin. Exp. Med. 25, 665\u2013671 (2016).","journal-title":"Adv. Clin. Exp. Med."},{"key":"1653_CR523","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2567.2009.03166.x","volume":"129","author":"G Han","year":"2010","unstructured":"Han, G. et al. Interleukin-17-producing gammadelta+ T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-beta. Immunology 129, 197\u2013206 (2010).","journal-title":"Immunology"},{"key":"1653_CR524","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.4049\/jimmunol.1203502","volume":"190","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. \u03b3\u03b4 T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model. J. Immunol. 190, 5392\u20135401 (2013).","journal-title":"J. Immunol."},{"key":"1653_CR525","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/biom12101406","volume":"12","author":"RL O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, R. L. et al. A distinctive \u03b3\u03b4 T cell repertoire in NOD mice weakens immune regulation and favors diabetic disease. Biomolecules 12, 1406 (2022).","journal-title":"Biomolecules"},{"key":"1653_CR526","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bjd.12886","volume":"171","author":"M Buysschaert","year":"2014","unstructured":"Buysschaert, M. et al. Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal \u03b3\u03b4 T-cell number: a prospective case-series study. Br. J. Dermatol. 171, 155\u2013161 (2014).","journal-title":"Br. J. Dermatol."},{"key":"1653_CR527","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41423-022-00894-x","volume":"19","author":"X Mu","year":"2022","unstructured":"Mu, X. et al. Glucose metabolism controls human gammadelta T-cell-mediated tumor immunosurveillance in diabetes. Cell Mol. Immunol. 19, 944\u2013956 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR528","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"1653_CR529","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41590-020-00848-3","volume":"22","author":"N Lopes","year":"2021","unstructured":"Lopes, N. et al. Distinct metabolic programs established in the thymus control effector functions of gammadelta T cell subsets in tumor microenvironments. Nat. Immunol. 22, 179\u2013192 (2021).","journal-title":"Nat. Immunol."},{"key":"1653_CR530","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ni.2587","volume":"14","author":"V Jojic","year":"2013","unstructured":"Jojic, V. et al. Identification of transcriptional regulators in the mouse immune system. Nat. Immunol. 14, 633\u2013643 (2013).","journal-title":"Nat. Immunol."},{"key":"1653_CR531","doi-asserted-by":"publisher","first-page":"641883","DOI":"10.3389\/fimmu.2021.641883","volume":"12","author":"Y Li","year":"2021","unstructured":"Li, Y., Wu, Y. & Hu, Y. Metabolites in the tumor microenvironment reprogram functions of immune effector cells through epigenetic modifications. Front. Immunol. 12, 641883 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR532","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.immuni.2010.04.016","volume":"32","author":"R Mukasa","year":"2010","unstructured":"Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616\u2013627 (2010).","journal-title":"Immunity"},{"key":"1653_CR533","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41590-020-00860-7","volume":"22","author":"JH Park","year":"2021","unstructured":"Park, J. H. et al. Tumor hypoxia represses gammadelta T cell-mediated antitumor immunity against brain tumors. Nat. Immunol. 22, 336\u2013346 (2021).","journal-title":"Nat. Immunol."},{"key":"1653_CR534","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3389\/fimmu.2018.01367","volume":"9","author":"GM Siegers","year":"2018","unstructured":"Siegers, G. M., Dutta, I., Lai, R. & Postovit, L. M. Functional plasticity of gamma delta T cells and breast tumor targets in hypoxia. Front. Immunol. 9, 1367 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR535","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.it.2018.01.005","volume":"39","author":"DG Franchina","year":"2018","unstructured":"Franchina, D. G., Dostert, C. & Brenner, D. Reactive oxygen species: involvement in T cell signaling and metabolism. Trends Immunol. 39, 489\u2013502 (2018).","journal-title":"Trends Immunol."},{"key":"1653_CR536","doi-asserted-by":"publisher","first-page":"e2004990","DOI":"10.1371\/journal.pbio.2004990","volume":"16","author":"S Mensurado","year":"2018","unstructured":"Mensurado, S. et al. Tumor-associated neutrophils suppress pro-tumoral IL-17+ gammadelta T cells through induction of oxidative stress. PLoS Biol. 16, e2004990 (2018).","journal-title":"PLoS Biol."},{"key":"1653_CR537","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung, E. C. & Vousden, K. H. The role of ROS in tumour development and progression. Nat. Rev. Cancer 22, 280\u2013297 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1653_CR538","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382\u2013386 (2018).","journal-title":"Nature"},{"key":"1653_CR539","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41388-018-0627-z","volume":"38","author":"L Li","year":"2019","unstructured":"Li, L. et al. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral gammadelta T cell equilibrium via tumor-derived exosomes. Oncogene 38, 2830\u20132843 (2019).","journal-title":"Oncogene"},{"key":"1653_CR540","doi-asserted-by":"publisher","first-page":"eaaz3426","DOI":"10.1126\/scitranslmed.aaz3426","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Exosomes derived from Vdelta2-T cells control Epstein-Barr virus-associated tumors and induce T cell antitumor immunity. Sci. Transl. Med. 12, eaaz3426 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1653_CR541","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2012.12.015","volume":"58","author":"Y Yi","year":"2013","unstructured":"Yi, Y. et al. The functional impairment of HCC-infiltrating gammadelta T cells, partially mediated by regulatory T cells in a TGFbeta- and IL-10-dependent manner. J. Hepatol. 58, 977\u2013983 (2013).","journal-title":"J. Hepatol."},{"key":"1653_CR542","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/eji.201343664","volume":"44","author":"F Sabbione","year":"2014","unstructured":"Sabbione, F. et al. Neutrophils suppress gammadelta T-cell function. Eur. J. Immunol. 44, 819\u2013830 (2014).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR543","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00018-013-1495-x","volume":"71","author":"S Kalyan","year":"2014","unstructured":"Kalyan, S. et al. Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood gammadelta T cells. Cell Mol. Life Sci. 71, 2335\u20132346 (2014).","journal-title":"Cell Mol. Life Sci."},{"key":"1653_CR544","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3389\/fimmu.2019.01690","volume":"10","author":"HH Oberg","year":"2019","unstructured":"Oberg, H. H., Wesch, D., Kalyan, S. & Kabelitz, D. Regulatory interactions between neutrophils, tumor cells and T cells. Front. Immunol. 10, 1690 (2019).","journal-title":"Front. Immunol."},{"key":"1653_CR545","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fimmu.2018.01271","volume":"9","author":"A Sacchi","year":"2018","unstructured":"Sacchi, A. et al. Myeloid-derived suppressor cells specifically suppress IFN-gamma production and antitumor cytotoxic activity of Vdelta2 T cells. Front. Immunol. 9, 1271 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR546","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.12925","volume":"298","author":"D Wesch","year":"2020","unstructured":"Wesch, D., Kabelitz, D. & Oberg, H. H. Tumor resistance mechanisms and their consequences on gammadelta T cell activation. Immunol. Rev. 298, 84\u201398 (2020).","journal-title":"Immunol. Rev."},{"key":"1653_CR547","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino, M. S., Larkin, J. & Long, G. V. Immune checkpoint inhibitors in melanoma. Lancet 398, 1002\u20131014 (2021).","journal-title":"Lancet"},{"key":"1653_CR548","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow, A., Perica, K., Klebanoff, C. A. & Wolchok, J. D. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat. Rev. Clin. Oncol. 19, 775\u2013790 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1653_CR549","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria, O. et al. Harnessing innate immunity in cancer therapy. Nature 574, 45\u201356 (2019).","journal-title":"Nature"},{"key":"1653_CR550","doi-asserted-by":"publisher","first-page":"e20211431","DOI":"10.1084\/jem.20211431","volume":"220","author":"SC Edwards","year":"2023","unstructured":"Edwards, S. C. et al. PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A-producing \u03b3\u03b4 T cells. J. Exp. Med. 220, e20211431 (2023).","journal-title":"J. Exp. Med."},{"key":"1653_CR551","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41590-023-01448-7","volume":"24","author":"C Rancan","year":"2023","unstructured":"Rancan, C. et al. Exhausted intratumoral V\u03b42(-) \u03b3\u03b4 T cells in human kidney cancer retain effector function. Nat. Immunol. 24, 612\u2013624 (2023).","journal-title":"Nat. Immunol."},{"key":"1653_CR552","doi-asserted-by":"publisher","first-page":"763773","DOI":"10.3389\/fmed.2021.763773","volume":"8","author":"F Brauneck","year":"2021","unstructured":"Brauneck, F. et al. Bone marrow-resident V\u03b41 T cells co-express TIGIT with PD-1, TIM-3 or CD39 in AML and Myeloma. Front. Med. 8, 763773 (2021).","journal-title":"Front. Med."},{"key":"1653_CR553","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1182\/blood-2012-11-464685","volume":"122","author":"J Gertner-Dardenne","year":"2013","unstructured":"Gertner-Dardenne, J. et al. The co-receptor BTLA negatively regulates human V\u03b39V\u03b42 T-cell proliferation: a potential way of immune escape for lymphoma cells. Blood 122, 922\u2013931 (2013).","journal-title":"Blood"},{"key":"1653_CR554","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.immuni.2013.10.017","volume":"39","author":"V Bekiaris","year":"2013","unstructured":"Bekiaris, V. et al. The inhibitory receptor BTLA controls \u03b3\u03b4 T cell homeostasis and inflammatory responses. Immunity 39, 1082\u20131094 (2013).","journal-title":"Immunity"},{"key":"1653_CR555","doi-asserted-by":"publisher","first-page":"1748991","DOI":"10.1080\/2162402X.2020.1748991","volume":"9","author":"H Lu","year":"2020","unstructured":"Lu, H. et al. B7-H3 inhibits the IFN-\u03b3-dependent cytotoxicity of V\u03b39V\u03b42 T cells against colon cancer cells. Oncoimmunology 9, 1748991 (2020).","journal-title":"Oncoimmunology"},{"key":"1653_CR556","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0883-8","volume":"15","author":"L Schofield","year":"2017","unstructured":"Schofield, L. et al. Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of \u03b3\u03b4 T cell function and decreases the risk of clinical malaria in children living in Papua New Guinea. BMC Med. 15, 114 (2017).","journal-title":"BMC Med."},{"key":"1653_CR557","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 13, 82 (2023).","journal-title":"Blood Cancer J."},{"key":"1653_CR558","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/480S33a","volume":"480","author":"H Brody","year":"2011","unstructured":"Brody, H. Multiple myeloma. Nature 480, S33 (2011).","journal-title":"Nature"},{"key":"1653_CR559","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"1653_CR560","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR561","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar, R. et al. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364, 2496\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR562","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/leu.2016.126","volume":"30","author":"VI Gaidzik","year":"2016","unstructured":"Gaidzik, V. I. et al. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia 30, 2160\u20132168 (2016).","journal-title":"Leukemia"},{"key":"1653_CR563","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","volume":"130","author":"J Taylor","year":"2017","unstructured":"Taylor, J., Xiao, W. & Abdel-Wahab, O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood 130, 410\u2013423 (2017).","journal-title":"Blood"},{"key":"1653_CR564","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1182\/blood-2011-08-368225","volume":"118","author":"KH Metzeler","year":"2011","unstructured":"Metzeler, K. H. et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood 118, 6920\u20136929 (2011).","journal-title":"Blood"},{"key":"1653_CR565","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3322\/caac.21632","volume":"70","author":"MC Turner","year":"2020","unstructured":"Turner, M. C. et al. Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J. Clin. 70, 460\u2013479 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"1653_CR566","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1200\/JCO.21.01841","volume":"40","author":"E Pasqual","year":"2022","unstructured":"Pasqual, E. et al. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J. Clin. Oncol. 40, 1439\u20131449 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1653_CR567","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/annonc\/mds631","volume":"24","author":"RB Walter","year":"2013","unstructured":"Walter, R. B., Buckley, S. A. & White, E. Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study. Ann. Oncol. 24, 1370\u20131377 (2013).","journal-title":"Ann. Oncol."},{"key":"1653_CR568","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","volume":"7","author":"SM Kimani","year":"2020","unstructured":"Kimani, S. M. et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV 7, e641\u2013e651 (2020).","journal-title":"Lancet HIV"},{"key":"1653_CR569","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.1016\/S2352-3018(20)30227-7","volume":"7","author":"A Noy","year":"2020","unstructured":"Noy, A. HIV and lymphoma: from oncological futility to treatment. Lancet HIV 7, e598\u2013e600 (2020).","journal-title":"Lancet HIV"},{"key":"1653_CR570","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.semcancer.2019.06.005","volume":"64","author":"K Hemminki","year":"2020","unstructured":"Hemminki, K. et al. Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence. Semin Cancer Biol. 64, 114\u2013121 (2020).","journal-title":"Semin Cancer Biol."},{"key":"1653_CR571","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3324\/haematol.2011.056283","volume":"97","author":"SM Ramadan","year":"2012","unstructured":"Ramadan, S. M. et al. Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica 97, 805\u2013817 (2012).","journal-title":"Haematologica"},{"key":"1653_CR572","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2018.02.007","volume":"190","author":"D Verhoeven","year":"2018","unstructured":"Verhoeven, D., Stoppelenburg, A. J., Meyer-Wentrup, F. & Boes, M. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy. Clin. Immunol. 190, 22\u201331 (2018).","journal-title":"Clin. Immunol."},{"key":"1653_CR573","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Sig. Transduct. Target Ther. 6, 263 (2021).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR574","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cancers10040104","volume":"10","author":"BM Craver","year":"2018","unstructured":"Craver, B. M., El Alaoui, K., Scherber, R. M. & Fleischman, A. G. The critical role of inflammation in the pathogenesis and progression of myeloid malignancies. Cancers (Basel). 10, 104 (2018).","journal-title":"Cancers (Basel)."},{"key":"1653_CR575","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte, D., Jansen, L. & Brenner, H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J. 10, 56 (2020).","journal-title":"Blood Cancer J."},{"key":"1653_CR576","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.molmed.2009.04.005","volume":"15","author":"J Rey","year":"2009","unstructured":"Rey, J. et al. Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors. Trends Mol. Med. 15, 275\u2013284 (2009).","journal-title":"Trends Mol. Med."},{"key":"1653_CR577","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.4049\/jimmunol.1103710","volume":"188","author":"J Gertner-Dardenne","year":"2012","unstructured":"Gertner-Dardenne, J. et al. Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J. Immunol. 188, 4701\u20134708 (2012).","journal-title":"J. Immunol."},{"key":"1653_CR578","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3324\/haematol.2009.020602","volume":"95","author":"AQ Gomes","year":"2010","unstructured":"Gomes, A. Q. et al. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells. Haematologica 95, 1397\u20131404 (2010).","journal-title":"Haematologica"},{"key":"1653_CR579","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/CJI.0000000000000043","volume":"37","author":"S Gundermann","year":"2014","unstructured":"Gundermann, S. et al. A comprehensive analysis of primary acute myeloid leukemia identifies biomarkers predicting susceptibility to human allogeneic Vgamma9Vdelta2 T cells. J. Immunother. 37, 321\u2013330 (2014).","journal-title":"J. Immunother."},{"key":"1653_CR580","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/14653249.2012.700766","volume":"14","author":"A Knight","year":"2012","unstructured":"Knight, A., Mackinnon, S. & Lowdell, M. W. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Cytotherapy 14, 1110\u20131118 (2012).","journal-title":"Cytotherapy"},{"key":"1653_CR581","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1182\/blood.V73.8.2077.2077","volume":"73","author":"A Bensussan","year":"1989","unstructured":"Bensussan, A., Lagabrielle, J. F. & Degos, L. TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. Blood 73, 2077\u20132080 (1989).","journal-title":"Blood"},{"key":"1653_CR582","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.3390\/cancers13246212","volume":"13","author":"S Schonefeldt","year":"2021","unstructured":"Schonefeldt, S. et al. The diverse roles of gammadelta T cells in cancer: from rapid immunity to aggressive lymphoma. Cancers (Basel). 13, 6212 (2021).","journal-title":"Cancers (Basel)."},{"key":"1653_CR583","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/cmi.2012.39","volume":"10","author":"JJ Fournie","year":"2013","unstructured":"Fournie, J. J. et al. What lessons can be learned from gammadelta T cell-based cancer immunotherapy trials? Cell Mol. Immunol. 10, 35\u201341 (2013).","journal-title":"Cell Mol. Immunol."},{"key":"1653_CR584","first-page":"OC04-06","volume":"10","author":"P Kotian","year":"2016","unstructured":"Kotian, P., Boloor, A. & Sreenivasan, S. Study of adverse effect profile of parenteral zoledronic acid in female patients with osteoporosis. J. Clin. Diagn. Res. 10, OC04-06 (2016).","journal-title":"J. Clin. Diagn. Res."},{"key":"1653_CR585","doi-asserted-by":"publisher","first-page":"e0246441","DOI":"10.1371\/journal.pone.0246441","volume":"16","author":"C Jackson","year":"2021","unstructured":"Jackson, C., Freeman, A. L. J., Szlamka, Z. & Spiegelhalter, D. J. The adverse effects of bisphosphonates in breast cancer: a systematic review and network meta-analysis. PLoS One 16, e0246441 (2021).","journal-title":"PLoS One"},{"key":"1653_CR586","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","volume":"67","author":"F Dieli","year":"2007","unstructured":"Dieli, F. et al. Targeting human gammadelta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res. 67, 7450\u20137457 (2007).","journal-title":"Cancer Res."},{"key":"1653_CR587","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bjc.2011.293","volume":"105","author":"AJ Nicol","year":"2011","unstructured":"Nicol, A. J. et al. Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. Br. J. Cancer 105, 778\u2013786 (2011).","journal-title":"Br. J. Cancer"},{"key":"1653_CR588","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00262-011-1021-7","volume":"60","author":"H Kobayashi","year":"2011","unstructured":"Kobayashi, H. et al. Phase I\/II study of adoptive transfer of gammadelta T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma. Cancer Immunol. Immunother. 60, 1075\u20131084 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR589","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fimmu.2020.00699","volume":"11","author":"P Merli","year":"2020","unstructured":"Merli, P. et al. Immune modulation properties of zoledronic acid on TcRgammadelta T-lymphocytes after TcRalphabeta\/CD19-depleted haploidentical stem cell transplantation: an analysis on 46 pediatric patients affected by acute leukemia. Front. Immunol. 11, 699 (2020).","journal-title":"Front. Immunol."},{"key":"1653_CR590","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nri3227","volume":"12","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J., Bushell, A. & Hester, J. Regulatory immune cells in transplantation. Nat. Rev. Immunol. 12, 417\u2013430 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR591","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri2000","volume":"7","author":"WD Shlomchik","year":"2007","unstructured":"Shlomchik, W. D. Graft-versus-host disease. Nat. Rev. Immunol. 7, 340\u2013352 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR592","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","volume":"39","author":"KT Godder","year":"2007","unstructured":"Godder, K. T. et al. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 39, 751\u2013757 (2007).","journal-title":"Bone Marrow Transplant"},{"key":"1653_CR593","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","volume":"5","author":"LS Lamb Jr.","year":"1996","unstructured":"Lamb, L. S. Jr. et al. Increased frequency of TCR gamma delta + T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. J. Hematother. 5, 503\u2013509 (1996).","journal-title":"J. Hematother."},{"key":"1653_CR594","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0032472031000141295","volume":"1","author":"LS Lamb Jr.","year":"1999","unstructured":"Lamb, L. S. Jr. et al. Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1, 7\u201319 (1999).","journal-title":"Cytotherapy"},{"key":"1653_CR595","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","volume":"21","author":"R Perko","year":"2015","unstructured":"Perko, R. et al. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. Biol. Blood Marrow Transplant 21, 130\u2013136 (2015).","journal-title":"Biol. Blood Marrow Transplant"},{"key":"1653_CR596","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","volume":"125","author":"I Airoldi","year":"2015","unstructured":"Airoldi, I. et al. gammadelta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alphabeta+\/CD19+ lymphocytes. Blood 125, 2349\u20132358 (2015).","journal-title":"Blood"},{"key":"1653_CR597","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","volume":"130","author":"F Locatelli","year":"2017","unstructured":"Locatelli, F. et al. Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion. Blood 130, 677\u2013685 (2017).","journal-title":"Blood"},{"key":"1653_CR598","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1182\/bloodadvances.2020002444","volume":"5","author":"MA de Witte","year":"2021","unstructured":"de Witte, M. A. et al. alphabeta T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies. Blood Adv. 5, 240\u2013249 (2021).","journal-title":"Blood Adv."},{"key":"1653_CR599","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","volume":"131","author":"R Handgretinger","year":"2018","unstructured":"Handgretinger, R. & Schilbach, K. The potential role of gammadelta T cells after allogeneic HCT for leukemia. Blood 131, 1063\u20131072 (2018).","journal-title":"Blood"},{"key":"1653_CR600","doi-asserted-by":"publisher","first-page":"625165","DOI":"10.3389\/fimmu.2021.625165","volume":"12","author":"L Minculescu","year":"2021","unstructured":"Minculescu, L. et al. Granulocyte colony-stimulating factor effectively mobilizes TCR gammadelta and NK cells providing an allograft potentially enhanced for the graft-versus-leukemia effect for allogeneic stem cell transplantation. Front. Immunol. 12, 625165 (2021).","journal-title":"Front. Immunol."},{"key":"1653_CR601","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3389\/fimmu.2019.01997","volume":"10","author":"L Minculescu","year":"2019","unstructured":"Minculescu, L. et al. Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of TCR gamma delta cells 2 months after allogeneic stem cell transplantation. Front. Immunol. 10, 1997 (2019).","journal-title":"Front. Immunol."},{"key":"1653_CR602","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1016\/j.clml.2023.02.003","volume":"23","author":"J Vydra","year":"2023","unstructured":"Vydra, J. et al. A phase I trial of allogeneic gammadelta T lymphocytes from haploidentical donors in patients with refractory or relapsed acute myeloid leukemia. Clin. Lymphoma Myeloma Leuk. 23, e232\u2013e239 (2023).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"1653_CR603","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-45","volume":"12","author":"M Wilhelm","year":"2014","unstructured":"Wilhelm, M. et al. Successful adoptive transfer and in vivo expansion of haploidentical gammadelta T cells. J. Transl. Med. 12, 45 (2014).","journal-title":"J. Transl. Med."},{"key":"1653_CR604","first-page":"e10301","volume":"12","author":"R Hoard","year":"2020","unstructured":"Hoard, R., Shahin, G., Andreca, F. D. & Osswald, M. Gamma-delta T-cell lymphoma following allogeneic stem cell transplant for primary myelofibrosis. Cureus 12, e10301 (2020).","journal-title":"Cureus"},{"key":"1653_CR605","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1182\/blood.2019004118","volume":"136","author":"B Pro","year":"2020","unstructured":"Pro, B., Allen, P. & Behdad, A. Hepatosplenic T-cell lymphoma: a rare but challenging entity. Blood 136, 2018\u20132026 (2020).","journal-title":"Blood"},{"key":"1653_CR606","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s13402-022-00745-x","volume":"46","author":"W Song","year":"2023","unstructured":"Song, W. et al. Single cell profiling of gammadelta hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression. Cell Oncol. (Dordr) 46, 211\u2013226 (2023).","journal-title":"Cell Oncol. (Dordr)"},{"key":"1653_CR607","doi-asserted-by":"publisher","first-page":"e003441","DOI":"10.1136\/jitc-2021-003441","volume":"9","author":"A Makkouk","year":"2021","unstructured":"Makkouk, A. et al. Off-the-shelf Vdelta1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. J. Immunother. Cancer 9, e003441 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1653_CR608","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/DAD.0000000000000608","volume":"38","author":"NS Ramani","year":"2016","unstructured":"Ramani, N. S. et al. Primary cutaneous gamma-delta (gamma\/delta) T-cell lymphoma: an unusual case with very subtle histopathological findings. Am. J. Dermatopathol. 38, e147\u2013e149 (2016).","journal-title":"Am. J. Dermatopathol."},{"key":"1653_CR609","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44228-022-00011-9","volume":"4","author":"IN Muhsen","year":"2022","unstructured":"Muhsen, I. N. et al. Clinical, diagnostic and prognostic characteristics of primary cutaneous gamma delta T-cell lymphomas. Clin. Hematol. Int. 4, 1\u201310 (2022).","journal-title":"Clin. Hematol. Int."},{"key":"1653_CR610","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-73","volume":"12","author":"S Chen","year":"2013","unstructured":"Chen, S. et al. The evolution of malignant and reactive gammadelta + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol. Cancer 12, 73 (2013).","journal-title":"Mol. Cancer"},{"key":"1653_CR611","doi-asserted-by":"publisher","first-page":"137","DOI":"10.14740\/jh535","volume":"8","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Gamma-delta T-cell acute lymphoblastic leukemia\/lymphoma: immunophenotype of three adult cases. J. Hematol. 8, 137\u2013140 (2019).","journal-title":"J. Hematol."},{"key":"1653_CR612","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/10428194.2019.1650174","volume":"61","author":"G Mirji","year":"2020","unstructured":"Mirji, G., Banavali, S., Sengar, M. & Chiplunkar, S. V. Immunophenotype and function define TCRgammadelta + T-ALL as a distinct subgroup from TCRalphabeta + T-ALL patients. Leuk. Lymphoma 61, 108\u2013117 (2020).","journal-title":"Leuk. Lymphoma"},{"key":"1653_CR613","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim, W. A., & June, C. H. The principles of engineering immune cells to treat cancer. Cell 168, 724\u2013740 (2017).","journal-title":"Cell"},{"key":"1653_CR614","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439\u2013448 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR615","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"JH Park","year":"2018","unstructured":"Park, J. H. et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N. Engl. J. Med. 378, 449\u2013459 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR616","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","volume":"3","author":"M Kalos","year":"2011","unstructured":"Kalos, M. et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1653_CR617","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1653_CR618","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1200\/JCO.20.03458","volume":"39","author":"RM Myers","year":"2021","unstructured":"Myers, R. M. et al. Humanized CD19-targeted chimeric antigen receptor (CAR) T cells in CAR-naive and CAR-exposed children and young adults with relapsed or refractory acute lymphoblastic leukemia. J. Clin. Oncol. 39, 3044\u20133055 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1653_CR619","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","volume":"127","author":"JH Park","year":"2016","unstructured":"Park, J. H., Geyer, M. B. & Brentjens, R. J. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood 127, 3312\u20133320 (2016).","journal-title":"Blood"},{"key":"1653_CR620","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147\u2013167 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1653_CR621","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3389\/fimmu.2020.01973","volume":"11","author":"EL Siegler","year":"2020","unstructured":"Siegler, E. L. & Kenderian, S. S. Neurotoxicity and cytokine release syndrome after chimeric antigen receptor T cell therapy: insights into mechanisms and novel therapies. Front. Immunol. 11, 1973 (2020).","journal-title":"Front. Immunol."},{"key":"1653_CR622","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","volume":"8","author":"BD Santomasso","year":"2018","unstructured":"Santomasso, B. D. et al. Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discov. 8, 958\u2013971 (2018).","journal-title":"Cancer Discov."},{"key":"1653_CR623","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu, S. S. et al. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat. Rev. Clin. Oncol. 15, 47\u201362 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1653_CR624","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cell.2020.08.022","volume":"183","author":"KR Parker","year":"2020","unstructured":"Parker, K. R. et al. Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies. Cell 183, 126\u2013142 e117 (2020).","journal-title":"Cell"},{"key":"1653_CR625","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/mt.2012.267","volume":"21","author":"DC Deniger","year":"2013","unstructured":"Deniger, D. C. et al. Bispecific T-cells expressing polyclonal repertoire of endogenous gammadelta T-cell receptors and introduced CD19-specific chimeric antigen receptor. Mol. Ther. 21, 638\u2013647 (2013).","journal-title":"Mol. Ther."},{"key":"1653_CR626","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fimmu.2020.01347","volume":"11","author":"M Rozenbaum","year":"2020","unstructured":"Rozenbaum, M. et al. Gamma-delta CAR-T cells show CAR-directed and independent activity against leukemia. Front. Immunol. 11, 1347 (2020).","journal-title":"Front. Immunol."},{"key":"1653_CR627","doi-asserted-by":"publisher","first-page":"e005400","DOI":"10.1136\/jitc-2022-005400","volume":"10","author":"D Sanchez Martinez","year":"2022","unstructured":"Sanchez Martinez, D. et al. Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia. J. Immunother. Cancer 10, e005400 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"1653_CR628","doi-asserted-by":"publisher","first-page":"e1373","DOI":"10.1002\/cti2.1373","volume":"11","author":"KP Nishimoto","year":"2022","unstructured":"Nishimoto, K. P. et al. Allogeneic CD20-targeted gammadelta T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models. Clin Transl Immunology 11, e1373 (2022).","journal-title":"Clin Transl Immunology"},{"key":"1653_CR629","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki, T. et al. Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. Cancer Discov. 10, 406\u2013421 (2020).","journal-title":"Cancer Discov."},{"key":"1653_CR630","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij, O. et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat. Cancer 1, 493\u2013506 (2020).","journal-title":"Nat. Cancer"},{"key":"1653_CR631","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22804-x","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat. Commun. 12, 2559 (2021).","journal-title":"Nat. Commun."},{"key":"1653_CR632","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00262-011-1111-6","volume":"61","author":"B Altvater","year":"2012","unstructured":"Altvater, B. et al. Activated human gammadelta T cells induce peptide-specific CD8\u2009+\u2009T-cell responses to tumor-associated self-antigens. Cancer Immunol. Immunother. 61, 385\u2013396 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR633","doi-asserted-by":"publisher","first-page":"eabj0835","DOI":"10.1126\/scitranslmed.abj0835","volume":"13","author":"A De Gassart","year":"2021","unstructured":"De Gassart, A. et al. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vgamma9Vdelta2 T cell-mediated antitumor immune response. Sci. Transl. Med. 13, eabj0835 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1653_CR634","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/0008-5472.CAN-13-0675","volume":"74","author":"HH Oberg","year":"2014","unstructured":"Oberg, H. H. et al. Novel bispecific antibodies increase gammadelta T-cell cytotoxicity against pancreatic cancer cells. Cancer Res. 74, 1349\u20131360 (2014).","journal-title":"Cancer Res."},{"key":"1653_CR635","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1038\/s41375-021-01122-7","volume":"35","author":"R Ganesan","year":"2021","unstructured":"Ganesan, R. et al. Selective recruitment of gammadelta T cells by a bispecific antibody for the treatment of acute myeloid leukemia. Leukemia 35, 2274\u20132284 (2021).","journal-title":"Leukemia"},{"key":"1653_CR636","doi-asserted-by":"publisher","first-page":"e1375641","DOI":"10.1080\/2162402X.2017.1375641","volume":"7","author":"RCG de Bruin","year":"2017","unstructured":"de Bruin, R. C. G. et al. A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vgamma9Vdelta2-T cells. Oncoimmunology 7, e1375641 (2017).","journal-title":"Oncoimmunology"},{"key":"1653_CR637","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/2326-6066.CIR-20-0138","volume":"9","author":"I de Weerdt","year":"2021","unstructured":"de Weerdt, I. et al. A bispecific antibody antagonizes prosurvival CD40 signaling and promotes Vgamma9Vdelta2 T cell-mediated antitumor responses in human B-cell malignancies. Cancer Immunol. Res. 9, 50\u201361 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"1653_CR638","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1158\/1078-0432.CCR-20-4576","volume":"27","author":"I de Weerdt","year":"2021","unstructured":"de Weerdt, I. et al. A bispecific single-domain antibody boosts autologous Vgamma9Vdelta2-T cell responses toward CD1d in chronic lymphocytic leukemia. Clin. Cancer Res. 27, 1744\u20131755 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1653_CR639","doi-asserted-by":"publisher","first-page":"e003850","DOI":"10.1136\/jitc-2021-003850","volume":"9","author":"E van Diest","year":"2021","unstructured":"van Diest, E. et al. Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. J. Immunother. Cancer 9, e003850 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1653_CR640","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.xcrm.2023.100961","volume":"4","author":"R Lameris","year":"2023","unstructured":"Lameris, R. et al. A bispecific T cell engager recruits both type 1 NKT and Vgamma9Vdelta2-T cells for the treatment of CD1d-expressing hematological malignancies. Cell Rep. Med. 4, 100961 (2023).","journal-title":"Cell Rep. Med."},{"key":"1653_CR641","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41587-020-0487-2","volume":"38","author":"K Garber","year":"2020","unstructured":"Garber, K. gammadelta T cells bring unconventional cancer-targeting to the clinic - again. Nat. Biotechnol. 38, 389\u2013391 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1653_CR642","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida, A. R. et al. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept. Clin. Cancer Res. 22, 5795\u20135804 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1653_CR643","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/2326-6066.CIR-18-0647","volume":"7","author":"B Di Lorenzo","year":"2019","unstructured":"Di Lorenzo, B. et al. Broad cytotoxic targeting of acute myeloid leukemia by polyclonal delta one T cells. Cancer Immunol. Res. 7, 552\u2013558 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1653_CR644","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-13-3451","volume":"20","author":"DC Deniger","year":"2014","unstructured":"Deniger, D. C. et al. Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies. Clin. Cancer Res. 20, 5708\u20135719 (2014).","journal-title":"Clin. Cancer Res."},{"key":"1653_CR645","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.omto.2020.04.013","volume":"17","author":"WX Ang","year":"2020","unstructured":"Ang, W. X. et al. Electroporation of NKG2D RNA CAR improves Vgamma9Vdelta2 T cell responses against human solid tumor xenografts. Mol. Ther. Oncolytics. 17, 421\u2013430 (2020).","journal-title":"Mol. Ther. Oncolytics."},{"key":"1653_CR646","first-page":"79","volume":"11","author":"X Zhai","year":"2021","unstructured":"Zhai, X. et al. MUC1-Tn-targeting chimeric antigen receptor-modified Vgamma9Vdelta2 T cells with enhanced antigen-specific anti-tumor activity. Am. J. Cancer Res. 11, 79\u201391 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"1653_CR647","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood-2010-12-325993","volume":"118","author":"V Marcu-Malina","year":"2011","unstructured":"Marcu-Malina, V. et al. Redirecting alphabeta T cells against cancer cells by transfer of a broadly tumor-reactive gammadeltaT-cell receptor. Blood 118, 50\u201359 (2011).","journal-title":"Blood"},{"key":"1653_CR648","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3389\/fimmu.2018.01062","volume":"9","author":"T Straetemans","year":"2018","unstructured":"Straetemans, T. et al. GMP-grade manufacturing of T cells engineered to express a defined gammadeltaTCR. Front. Immunol. 9, 1062 (2018).","journal-title":"Front. Immunol."},{"key":"1653_CR649","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40425-019-0558-4","volume":"7","author":"I Johanna","year":"2019","unstructured":"Johanna, I. et al. Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells. J. Immunother. Cancer 7, 69 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1653_CR650","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01722-0","volume":"22","author":"Z Gao","year":"2023","unstructured":"Gao, Z. et al. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Mol. Cancer 22, 31 (2023).","journal-title":"Mol. Cancer"},{"key":"1653_CR651","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","volume":"7","author":"GH Ran","year":"2022","unstructured":"Ran, G. H. et al. Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Sig. Transduct. Target Ther. 7, 205 (2022).","journal-title":"Sig. Transduct. Target Ther."},{"key":"1653_CR652","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood.2022016200","volume":"141","author":"MM Berrien-Elliott","year":"2023","unstructured":"Berrien-Elliott, M. M., Jacobs, M. T. & Fehniger, T. A. Allogeneic natural killer cell therapy. Blood 141, 856\u2013868 (2023).","journal-title":"Blood"},{"key":"1653_CR653","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","volume":"131","author":"R Handgretinger","year":"2018","unstructured":"Handgretinger, R. & Schilbach, K. The potential role of \u03b3\u03b4 T cells after allogeneic HCT for leukemia. Blood 131, 1063\u20131072 (2018).","journal-title":"Blood"},{"key":"1653_CR654","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","volume":"14","author":"Y Gong","year":"2021","unstructured":"Gong, Y. et al. Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy. J. Hematol. Oncol. 14, 73 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"1653_CR655","doi-asserted-by":"publisher","first-page":"14378","DOI":"10.1073\/pnas.1611098113","volume":"113","author":"PL Ryan","year":"2016","unstructured":"Ryan, P. L. et al. Heterogeneous yet stable Vdelta2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc. Natl Acad. Sci. USA 113, 14378\u201314383 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR656","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ni.2394","volume":"13","author":"CR Willcox","year":"2012","unstructured":"Willcox, C. R. et al. Cytomegalovirus and tumor stress surveillance by binding of a human gammadelta T cell antigen receptor to endothelial protein C receptor. Nat. Immunol. 13, 872\u2013879 (2012).","journal-title":"Nat. Immunol."},{"key":"1653_CR657","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20041851","volume":"201","author":"F Halary","year":"2005","unstructured":"Halary, F. et al. Shared reactivity of Vdelta2(neg) gammadelta T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J. Exp. Med. 201, 1567\u20131578 (2005).","journal-title":"J. Exp. Med."},{"key":"1653_CR658","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/leu.2012.374","volume":"27","author":"W Scheper","year":"2013","unstructured":"Scheper, W. et al. gammadeltaT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 27, 1328\u20131338 (2013).","journal-title":"Leukemia"},{"key":"1653_CR659","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hep.26697","volume":"59","author":"L Hammerich","year":"2014","unstructured":"Hammerich, L. et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 59, 630\u2013642 (2014).","journal-title":"Hepatology"},{"key":"1653_CR660","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity 54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"1653_CR661","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR662","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05560-2","volume":"14","author":"AH Mohseni","year":"2023","unstructured":"Mohseni, A. H. et al. Potential links between the microbiota and T cell immunity determine the tumor cell fate. Cell Death Dis. 14, 154 (2023).","journal-title":"Cell Death Dis."},{"key":"1653_CR663","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2020.09.009","volume":"53","author":"F Legoux","year":"2020","unstructured":"Legoux, F., Salou, M. & Lantz, O. MAIT cell development and functions: the microbial connection. Immunity 53, 710\u2013723 (2020).","journal-title":"Immunity"},{"key":"1653_CR664","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1126\/science.aaw2719","volume":"366","author":"F Legoux","year":"2019","unstructured":"Legoux, F. et al. Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science 366, 494\u2013499 (2019).","journal-title":"Science"},{"key":"1653_CR665","doi-asserted-by":"crossref","unstructured":"Fidelle, M. et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science 380, eabo2296, (2023).","DOI":"10.1126\/science.abo2296"},{"key":"1653_CR666","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.immuni.2019.07.005","volume":"51","author":"L Ji","year":"2019","unstructured":"Ji, L. & Hu, X. Sweet memories of 8 empowered by butyrate. Immunity 51, 201\u2013203 (2019).","journal-title":"Immunity"},{"key":"1653_CR667","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8(\u2009+\u2009) T cells. Immunity 51, 285\u2013297 e285 (2019).","journal-title":"Immunity"},{"key":"1653_CR668","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature21080","volume":"542","author":"C Schiering","year":"2017","unstructured":"Schiering, C. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242\u2013245 (2017).","journal-title":"Nature"},{"key":"1653_CR669","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.immuni.2021.11.005","volume":"55","author":"E Kim","year":"2022","unstructured":"Kim, E. et al. Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4(+) T cells. Immunity 55, 145\u2013158.e147 (2022).","journal-title":"Immunity"},{"key":"1653_CR670","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-023-00890-w","volume":"23","author":"D Ramanan","year":"2023","unstructured":"Ramanan, D. et al. Regulatory T cells in the face of the intestinal microbiota. Nat. Rev. Immunol. 23, 1\u201314 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR671","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","volume":"43","author":"A Haghikia","year":"2022","unstructured":"Haghikia, A. et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur. Heart J. 43, 518\u2013533 (2022).","journal-title":"Eur. Heart J."},{"key":"1653_CR672","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05901-2","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun, M. et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat. Commun. 9, 3555 (2018).","journal-title":"Nat. Commun."},{"key":"1653_CR673","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.chom.2021.09.010","volume":"29","author":"V Woo","year":"2021","unstructured":"Woo, V. et al. Commensal segmented filamentous bacteria-derived retinoic acid primes host defense to intestinal infection. Cell Host Microbe 29, 1744\u20131756 e1745 (2021).","journal-title":"Cell Host Microbe"},{"key":"1653_CR674","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/19490976.2017.1299311","volume":"8","author":"M Kim","year":"2017","unstructured":"Kim, M. & Kim, C. H. Regulation of humoral immunity by gut microbial products. Gut Microbes 8, 392\u2013399 (2017).","journal-title":"Gut Microbes"},{"key":"1653_CR675","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"1653_CR676","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-immunol-042718-041841","volume":"37","author":"EM Brown","year":"2019","unstructured":"Brown, E. M., Kenny, D. J. & Xavier, R. J. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu. Rev. Immunol. 37, 599\u2013624 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1653_CR677","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","volume":"23","author":"E Miyauchi","year":"2023","unstructured":"Miyauchi, E. et al. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat. Rev. Immunol. 23, 9\u201323 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR678","doi-asserted-by":"publisher","first-page":"e1665973","DOI":"10.1080\/2162402X.2019.1665973","volume":"8","author":"XZ Huang","year":"2019","unstructured":"Huang, X. Z. et al. Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients. Oncoimmunology 8, e1665973 (2019).","journal-title":"Oncoimmunology"},{"key":"1653_CR679","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"1653_CR680","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.jhepr.2023.100747","volume":"5","author":"DJ Pinato","year":"2023","unstructured":"Pinato, D. J. et al. Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma. JHEP Rep. 5, 100747 (2023).","journal-title":"JHEP Rep."},{"key":"1653_CR681","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00923-w","volume":"13","author":"E Hayase","year":"2021","unstructured":"Hayase, E. & Jenq, R. R. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer. Genome Med. 13, 107 (2021).","journal-title":"Genome Med."},{"key":"1653_CR682","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","volume":"78","author":"L Derosa","year":"2020","unstructured":"Derosa, L. et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur. Urol. 78, 195\u2013206 (2020).","journal-title":"Eur. Urol."},{"key":"1653_CR683","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.annonc.2020.01.006","volume":"31","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials. Ann. Oncol. 31, 525\u2013531 (2020).","journal-title":"Ann. Oncol."},{"key":"1653_CR684","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","volume":"5","author":"DJ Pinato","year":"2019","unstructured":"Pinato, D. J. et al. Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. JAMA Oncol. 5, 1774\u20131778 (2019).","journal-title":"JAMA Oncol."},{"key":"1653_CR685","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/annonc\/mdz206","volume":"30","author":"A Elkrief","year":"2019","unstructured":"Elkrief, A. et al. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Ann. Oncol. 30, 1572\u20131579 (2019).","journal-title":"Ann. Oncol."},{"key":"1653_CR686","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer, C. N. et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374, 1632\u20131640 (2021).","journal-title":"Science"},{"key":"1653_CR687","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"1653_CR688","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084\u20131089 (2015).","journal-title":"Science"},{"key":"1653_CR689","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender, M. J. et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell 186, 1846\u20131862.e1826 (2023).","journal-title":"Cell"},{"key":"1653_CR690","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch, E. N. et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371, 602\u2013609 (2021).","journal-title":"Science"},{"key":"1653_CR691","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar, D. et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 371, 595\u2013602 (2021).","journal-title":"Science"},{"key":"1653_CR692","doi-asserted-by":"publisher","first-page":"eabq4006","DOI":"10.1126\/scitranslmed.abq4006","volume":"15","author":"TM Halsey","year":"2023","unstructured":"Halsey, T. M. et al. Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis. Sci. Transl. Med. 15, eabq4006 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1653_CR693","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes, M. R. et al. Targeting the gut microbiota for cancer therapy. Nat. Rev. Cancer 22, 703\u2013722 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1653_CR694","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1158\/2159-8290.CD-21-0236","volume":"11","author":"L Derosa","year":"2021","unstructured":"Derosa, L. et al. Microbiota-centered interventions: the next breakthrough in immuno-oncology? Cancer Discov. 11, 2396\u20132412 (2021).","journal-title":"Cancer Discov."},{"key":"1653_CR695","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat. Med. 24, 1804\u20131808 (2018).","journal-title":"Nat. Med."},{"key":"1653_CR696","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","volume":"28","author":"M Smith","year":"2022","unstructured":"Smith, M. et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat. Med. 28, 713\u2013723 (2022).","journal-title":"Nat. Med."},{"key":"1653_CR697","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer, C. K. et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat. Med. 29, 906\u2013916 (2023).","journal-title":"Nat. Med."},{"key":"1653_CR698","doi-asserted-by":"publisher","first-page":"2096994","DOI":"10.1080\/19490976.2022.2096994","volume":"14","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Phospholipid metabolites of the gut microbiota promote hypoxia-induced intestinal injury via CD1d-dependent gammadelta T cells. Gut Microbes 14, 2096994 (2022).","journal-title":"Gut Microbes"},{"key":"1653_CR699","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00262-022-03260-y","volume":"72","author":"T Ganapathy","year":"2023","unstructured":"Ganapathy, T., Radhakrishnan, R., Sakshi, S. & Martin, S. CAR \u03b3\u03b4 T cells for cancer immunotherapy. Is the field more yellow than green? Cancer Immunol. Immunother. 72, 277\u2013286 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR700","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.3390\/ijms241310873","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. CAR-modified V\u03b39V\u03b42 T cells propagated using a novel bisphosphonate prodrug for allogeneic adoptive immunotherapy. Int. J. Mol. Sci. 24, 10873 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1653_CR701","doi-asserted-by":"publisher","first-page":"e51805","DOI":"10.1371\/journal.pone.0051805","volume":"8","author":"LS Lamb Jr.","year":"2013","unstructured":"Lamb, L. S. Jr. et al. Engineered drug resistant \u03b3\u03b4 T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy. PloS One 8, e51805 (2013).","journal-title":"PloS One"},{"key":"1653_CR702","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00536-8","volume":"11","author":"LS Lamb","year":"2021","unstructured":"Lamb, L. S. et al. A combined treatment regimen of MGMT-modified \u03b3\u03b4 T cells and temozolomide chemotherapy is effective against primary high grade gliomas. Sci. Rep. 11, 21133 (2021).","journal-title":"Sci. Rep."},{"key":"1653_CR703","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2023.41.16_suppl.2007","volume":"41","author":"T Goswami","year":"2023","unstructured":"Goswami, T. et al. INB-200 phase I study of gene modified autologous gamma-delta (\u03b3\u03b4) T cells in patients with newly diagnosed glioblastoma multiforme (GBM) receiving maintenance temozolomide (TMZ). J. Clin. Oncol. 41, 2007\u20132007 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1653_CR704","doi-asserted-by":"publisher","first-page":"915837","DOI":"10.3389\/fimmu.2022.915837","volume":"13","author":"J Saura-Esteller","year":"2022","unstructured":"Saura-Esteller, J. et al. Gamma delta T-cell based cancer immunotherapy: past-present-future. Front. Immunol. 13, 915837 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR705","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s00262-020-02638-0","volume":"69","author":"Q Guo","year":"2020","unstructured":"Guo, Q. et al. TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of \u03b3\u03b4 T cells. Cancer Immunol. Immunother. 69, 2571\u20132587 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR706","doi-asserted-by":"publisher","first-page":"889051","DOI":"10.3389\/fimmu.2022.889051","volume":"13","author":"R Dong","year":"2022","unstructured":"Dong, R., Zhang, Y., Xiao, H. & Zeng, X. Engineering \u03b3\u03b4 T cells: recognizing and activating on their own way. Front. Immunol. 13, 889051 (2022).","journal-title":"Front. Immunol."},{"key":"1653_CR707","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-023-01402-y","volume":"16","author":"C Li","year":"2023","unstructured":"Li, C. et al. Novel CD19-specific \u03b3\/\u03b4 TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma. J. Hematol. Oncol. 16, 5 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"1653_CR708","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00262-007-0279-2","volume":"56","author":"SR Mattarollo","year":"2007","unstructured":"Mattarollo, S. R., Kenna, T., Nieda, M. & Nicol, A. J. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol. Immunother. 56, 1285\u20131297 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"1653_CR709","doi-asserted-by":"publisher","first-page":"e25821","DOI":"10.4161\/onci.25821","volume":"2","author":"M Todaro","year":"2013","unstructured":"Todaro, M. et al. Combining conventional chemotherapy and gammadelta T cell-based immunotherapy to target cancer-initiating cells. Oncoimmunology 2, e25821 (2013).","journal-title":"Oncoimmunology"},{"key":"1653_CR710","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.4049\/jimmunol.2200185","volume":"209","author":"AY Lai","year":"2022","unstructured":"Lai, A. Y. et al. Cutting Edge: bispecific gammadelta T cell engager containing heterodimeric BTN2A1 and BTN3A1 promotes targeted activation of Vgamma9Vdelta2(+) T cells in the presence of costimulation by CD28 or NKG2D. J. Immunol. 209, 1475\u20131480 (2022).","journal-title":"J. Immunol."},{"key":"1653_CR711","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2019.12.010","volume":"503","author":"H Antushevich","year":"2020","unstructured":"Antushevich, H. Fecal microbiota transplantation in disease therapy. Clin. Chim. Acta 503, 90\u201398 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"1653_CR712","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1136\/gutjnl-2021-326264","volume":"71","author":"NL Ting","year":"2022","unstructured":"Ting, N. L., Lau, H. C. & Yu, J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 71, 1412\u20131425 (2022).","journal-title":"Gut"},{"key":"1653_CR713","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703 (2022).","journal-title":"Nat. Med."},{"key":"1653_CR714","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16, 690\u2013704 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1653_CR715","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/322836a0","volume":"322","author":"JS Heilig","year":"1986","unstructured":"Heilig, J. S. & Tonegawa, S. Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature 322, 836\u2013840 (1986).","journal-title":"Nature"},{"key":"1653_CR716","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.4049\/jimmunol.163.6.3076","volume":"163","author":"DJ Gerber","year":"1999","unstructured":"Gerber, D. J. et al. IL-4-producing \u03b3\u03b4 T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen. J. Immunol. 163, 3076\u20133082 (1999).","journal-title":"J. Immunol."},{"key":"1653_CR717","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.4049\/jimmunol.142.6.2112","volume":"142","author":"Y Takagaki","year":"1989","unstructured":"Takagaki, Y. et al. T cell receptor-gamma and-delta genes preferentially utilized by adult thymocytes for the surface expression. J. Immunol. 142, 2112\u20132121 (1989).","journal-title":"J. Immunol."},{"key":"1653_CR718","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1073\/pnas.86.13.5094","volume":"86","author":"S Itohara","year":"1989","unstructured":"Itohara, S. et al. Monoclonal antibodies specific to native murine T-cell receptor gamma delta: analysis of gamma delta T cells during thymic ontogeny and in peripheral lymphoid organs. Proc. Natl Acad. Sci. USA 86, 5094\u20135098 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR719","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.90.1.322","volume":"90","author":"Y-X Fu","year":"1993","unstructured":"Fu, Y.-X. et al. In vivo response of murine gamma delta T cells to a heat shock protein-derived peptide. Proc. Natl Acad. Sci. USA 90, 322\u2013326 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR720","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1073\/pnas.89.10.4348","volume":"89","author":"RL O\u2019brien","year":"1992","unstructured":"O\u2019brien, R. L. et al. Heat shock protein Hsp60-reactive gamma delta cells: a large, diversified T-lymphocyte subset with highly focused specificity. Proc. Natl Acad. Sci. USA 89, 4348\u20134352 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR721","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/intimm\/10.8.1067","volume":"10","author":"D Wesch","year":"1998","unstructured":"Wesch, D., Hinz, T. & Kabelitz, D. Analysis of the TCR Vgamma repertoire in healthy donors and HIV-1-infected individuals. Int. Immunol. 10, 1067\u20131075 (1998).","journal-title":"Int. Immunol."},{"key":"1653_CR722","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/341447a0","volume":"341","author":"S Porcelli","year":"1989","unstructured":"Porcelli, S. et al. Recognition of cluster of differentiation 1 antigens by human CD4\u2009\u2212\u2009CD8\u2009>\u2009\u2212 cytolytic T lymphocyte. Nature 341, 447\u2013450 (1989).","journal-title":"Nature"},{"key":"1653_CR723","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/eji.1830200336","volume":"20","author":"F Faure","year":"1990","unstructured":"Faure, F., Jitsukawa, S., Miossec, C. & Hercend, T. CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood \u03b3\/\u03b4 cells. Eur. J. Immunol. 20, 703\u2013706 (1990).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR724","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1084\/jem.184.6.2109","volume":"184","author":"MS Vincent","year":"1996","unstructured":"Vincent, M. S. et al. Apoptosis of Fashigh CD4+ synovial T cells by Borrelia-reactive Fas-ligandhigh \u03b3\u03b4 T cells in Lyme arthritis. J. Exp. Med. 184, 2109\u20132118 (1996).","journal-title":"J. Exp. Med."},{"key":"1653_CR725","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.4049\/jimmunol.161.10.5762","volume":"161","author":"MS Vincent","year":"1998","unstructured":"Vincent, M. S. et al. Lyme arthritis synovial \u03b3\u03b4 T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. J. Immunol. 161, 5762\u20135771 (1998).","journal-title":"J. Immunol."},{"key":"1653_CR726","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1991.tb00585.x","volume":"120","author":"J Bluestone","year":"1991","unstructured":"Bluestone, J. et al. Repertoire development and ligand specificity of murine TCR gamma delta cells. Immunol. Rev. 120, 5\u201333 (1991).","journal-title":"Immunol. Rev."},{"key":"1653_CR727","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0092-8674(94)90170-8","volume":"76","author":"H Schild","year":"1994","unstructured":"Schild, H. et al. The nature of major histocompatibility complex recognition by \u03b3\u03b4 T cells. Cell 76, 29\u201337 (1994).","journal-title":"Cell"},{"key":"1653_CR728","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.168.2.491","volume":"168","author":"C Bottino","year":"1988","unstructured":"Bottino, C. et al. Two subsets of human T lymphocytes expressing gamma\/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J. Exp. Med. 168, 491\u2013505 (1988).","journal-title":"J. Exp. Med."},{"key":"1653_CR729","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.8146660","volume":"264","author":"P Constant","year":"1994","unstructured":"Constant, P. et al. Stimulation of human \u03b3\u03b4 T cells by nonpeptidic mycobacterial ligands. Science 264, 267\u2013270 (1994).","journal-title":"Science"},{"key":"1653_CR730","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/346572a0","volume":"346","author":"CJ Rust","year":"1990","unstructured":"Rust, C. J., Verreck, F., Vietor, H. & Koning, F. Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V\u03b39 region. Nature 346, 572\u2013574 (1990).","journal-title":"Nature"},{"key":"1653_CR731","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.4049\/jimmunol.152.7.3324","volume":"152","author":"EY Loh","year":"1994","unstructured":"Loh, E. Y. et al. Gene transfer studies of T cell receptor-gamma delta recognition. Specificity for staphylococcal enterotoxin A is conveyed by V gamma 9 alone. J. Immunol. 152, 3324\u20133332 (1994).","journal-title":"J. Immunol."},{"key":"1653_CR732","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41385-021-00447-x","volume":"15","author":"C Khairallah","year":"2022","unstructured":"Khairallah, C. et al. A blend of broadly-reactive and pathogen-selected V\u03b34 V\u03b41 T cell receptors confer broad bacterial reactivity of resident memory \u03b3\u03b4 T cells. Mucosal. Immunol. 15, 176\u2013187 (2022).","journal-title":"Mucosal. Immunol."},{"key":"1653_CR733","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev.iy.11.040193.003225","volume":"11","author":"W Haas","year":"1993","unstructured":"Haas, W., Pereira, P. & Tonegawa, S. Gamma\/delta cells. Annu. Rev. Immunol. 11, 637\u2013685 (1993).","journal-title":"Annu. Rev. Immunol."},{"key":"1653_CR734","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1365-2141.1997.d01-2027.x","volume":"96","author":"D Kabelitz","year":"1997","unstructured":"Kabelitz, D. et al. Clonal expansion of V\u03b33\/V\u03b43\u2010expressing \u03b3\u03b4 T cells in an HIV\u20101\/2\u2010negative patient with CD4 T\u2010cell deficiency. Br. J. Haematol. 96, 266\u2013271 (1997).","journal-title":"Br. J. Haematol."},{"key":"1653_CR735","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2004.05.003","volume":"113","author":"T Kenna","year":"2004","unstructured":"Kenna, T. et al. Distinct subpopulations of \u03b3\u03b4 T cells are present in normal and tumor-bearing human liver. Clin Immunol 113, 56\u201363 (2004).","journal-title":"Clin Immunol"},{"key":"1653_CR736","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/imcb.12303","volume":"98","author":"M van der Heiden","year":"2020","unstructured":"van der Heiden, M. et al. Characterization of the \u03b3\u03b4 T\u2010cell compartment during infancy reveals clear differences between the early neonatal period and 2 years of age. Immunol Cell Biol 98, 79\u201387 (2020).","journal-title":"Immunol Cell Biol"},{"key":"1653_CR737","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4049\/jimmunol.1300121","volume":"191","author":"BA Mangan","year":"2013","unstructured":"Mangan, B. A. et al. Cutting edge: CD1d restriction and Th1\/Th2\/Th17 cytokine secretion by human V\u03b43 T cells. J. Immunol. 191, 30\u201334 (2013).","journal-title":"J. Immunol."},{"key":"1653_CR738","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0092-8674(88)90139-0","volume":"55","author":"DM Asarnow","year":"1988","unstructured":"Asarnow, D. M. et al. Limited diversity of \u03b3\u03b4 antigen receptor genes of Thy-1+ dendritic epidermal cells. Cell 55, 837\u2013847 (1988).","journal-title":"Cell"},{"key":"1653_CR739","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1126\/science.1828619","volume":"252","author":"WL Havran","year":"1991","unstructured":"Havran, W. L., Chien, Y.-H. & Allison, J. P. Recognition of self antigens by skin-derived T cells with invariant \u03b3\u03b4 antigen receptors. Science 252, 1430\u20131432 (1991).","journal-title":"Science"},{"key":"1653_CR740","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/333855a0","volume":"333","author":"T Goodman","year":"1988","unstructured":"Goodman, T. & Lefran\u00e7ois, L. Expression of the \u03b3-\u03b4 T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature 333, 855\u2013858 (1988).","journal-title":"Nature"},{"key":"1653_CR741","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/336479a0","volume":"336","author":"M Bonneville","year":"1988","unstructured":"Bonneville, M. et al. Intestinal intraepithelial lymphocytes are a distinct set of \u03b3\u03b4 T cells. Nature 336, 479\u2013481 (1988).","journal-title":"Nature"},{"key":"1653_CR742","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0092-8674(89)90609-0","volume":"59","author":"JJ Lafaille","year":"1989","unstructured":"Lafaille, J. J. et al. Junctional sequences of T cell receptor \u03b3\u03b4 genes: implications for \u03b3\u03b4 T cell lineages and for a novel intermediate of V-(D)-J joining. Cell 59, 859\u2013870 (1989).","journal-title":"Cell"},{"key":"1653_CR743","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1073\/pnas.88.1.43","volume":"88","author":"A Bandeira","year":"1991","unstructured":"Bandeira, A. et al. Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc. Natl Acad. Sci. USA 88, 43\u201347 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR744","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1084\/jem.173.2.471","volume":"173","author":"D Guy-Grand","year":"1991","unstructured":"Guy-Grand, D. et al. Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J. Exp. Med. 173, 471\u2013481 (1991).","journal-title":"J. Exp. Med."},{"key":"1653_CR745","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1073\/pnas.86.14.5527","volume":"86","author":"S Kyes","year":"1989","unstructured":"Kyes, S. et al. Diversity in T-cell receptor gamma gene usage in intestinal epithelium. Proc. Natl Acad. Sci. USA 86, 5527\u20135531 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1653_CR746","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/eji.201343759","volume":"43","author":"I Prinz","year":"2013","unstructured":"Prinz, I., Silva-Santos, B. & Pennington, D. J. Functional development of gammadelta T cells. Eur. J. Immunol. 43, 1988\u20131994 (2013).","journal-title":"Eur. J. Immunol."},{"key":"1653_CR747","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri797","volume":"2","author":"SR Carding","year":"2002","unstructured":"Carding, S. R. & Egan, P. J. \u03b3\u03b4 T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336\u2013345 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1653_CR748","doi-asserted-by":"publisher","first-page":"845974","DOI":"10.3389\/fimmu.2022.845974","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Apoptosis, pyroptosis, and ferroptosis conspiringly induce immunosuppressive hepatocellular carcinoma microenvironment and gammadelta T-cell imbalance. Front. Immunol. 13, 845974 (2022).","journal-title":"Front. Immunol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01653-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:02:59Z","timestamp":1700596979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01653-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":748,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01653-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K. is a member of the Scientific Advisory Boards of ImCheck Therapeutics, Lava Therapeutics, In8Bio, PhosphoGam. The other authors declare no conflict of interest on this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}